| Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster-randomized trial 2010 · intervention group · Children aged 6 to 36 months in the Kyrgyz Republic | 12.5 mg | 60 days | 1,103 |
| Delivery of iron-fortified yoghurt, through a dairy value chain program, increases hemoglobin concentration among children 24 to 59 months old in Northern Senegal: A cluster-randomized control trial 2017 · Intervention group (MNFY+BCC) · Children aged 24–59 months at baseline in dairy-farming households in Northern Senegal | 2.1 mg | 1 year | 204 |
| [Efficacy of iron supplementation with or without vitamin A for anemia control] 2007 · iron supplementation alone · Schoolchildren aged 6–14 years with iron deficiency anemia | 5.71 mg | 30 weeks | 144 |
| Ferrous bisglycinate 25 mg iron is as effective as ferrous sulfate 50 mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial 2014 · ferrous bisglycinate · Healthy ethnic Danish pregnant women, from 15–19 weeks of gestation until delivery | 25 mg | — | 40 |
| Intermittent oral iron supplementation during pregnancy 2001 · weekly · Women aged 14 to 24 weeks pregnant | 14.3 mg | 20 weeks | 26 |
| Effects of iron and zinc supplementation in Indonesian infants on micronutrient status and growth 2001 · iron · Indonesian infants, 4 months of age | 10 mg | 26 weeks | — |
| Iron deficiency in infancy: applying a physiologic framework for prediction 2006 · high-iron group — vitamins with iron · Healthy Chilean infants, term-born and weighing at least 3 kg at birth; assigned at age 6 months and taking less than 250 mL/day by bottle | 15 mg | 26 weeks | — |
| Effect of iron fortification of nursery complementary food on iron status of infants in the DPRKorea 2008 · iron (Fe) group · Infants aged 6–12 months attending nurseries in the DPRK | 10 mg | 26 weeks | — |
| Effect of iron fortification on malaria incidence in infants and young children in Ghana: a randomized trial 2013 · iron group · Children aged 6–35 months living in a rural, malaria-endemic community in central Ghana | 12.5 mg | 150 days | — |
| Prebiotic galacto-oligosaccharides mitigate the adverse effects of iron fortification on the gut microbiome: a randomised controlled study in Kenyan infants 2017 · Fe group · Kenyan infants aged 6.5–9.5 months | 5 mg | 120 days | — |
| The Effectiveness of Different Doses of Iron Supplementation and the Prenatal Determinants of Maternal Iron Status in Pregnant Spanish Women: ECLIPSES Study 2019 · Stratum 2, 20 mg/d iron · Pregnant women over 18 years old with initial hemoglobin above 130 g/L at week 12 and no anemia | 20 mg | 24 weeks | — |
| Antenatal Iron-Rich Food Intervention Prevents Iron-Deficiency Anemia but Does Not Affect Serum Hepcidin in Pregnant Women 2022 · IRF-20 · Pregnant women recruited at 11–13 weeks of gestation in South China without iron-deficiency anemia | 20 mg | — | — |
| The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group 1994 · epoetin group · Very-low-birth-weight infants, treated from 3 days of age | 2 mg | 29 days | — |
| The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group 1994 · control group · Very-low-birth-weight infants, treated from 3 days of age | 2 mg | 29 days | — |
| A randomised placebo-controlled trial to determine the effect of iron supplementation on pregnancy outcome in pregnant women with haemoglobin > or = 13.2 g/dl 2007 · case group · Pregnant women in the early second trimester with haemoglobin ≥13.2 g/dl | 50 mg | — | 370 |
| Effect of prenatal zinc supplementation on birthweight 2009 · Control group · Pregnant women recruited by 16 weeks’ gestation in Ghana; age range 16–44 years; no stated diagnosed condition, with women taking other zinc supplements or with severe anaemia excluded. | 20 mg | — | 301 |
| Effect of prenatal zinc supplementation on birthweight 2009 · Iron-zinc group · Pregnant women recruited by 16 weeks’ gestation in Ghana; age range 16–44 years; no stated diagnosed condition, with women taking other zinc supplements or with severe anaemia excluded. | 20 mg | — | 299 |
| Randomized, controlled trial of single versus 3-times-daily ferrous sulfate drops for treatment of anemia 2001 · Once-daily group · Anemic children aged 6–24 months with hemoglobin values of 70–99 g/L | 40 mg | 60 days | 280 |
| Randomized, controlled trial of single versus 3-times-daily ferrous sulfate drops for treatment of anemia 2001 · 3-times-daily group · Anemic children aged 6–24 months with hemoglobin values of 70–99 g/L | 40 mg | 60 days | 277 |
| Iron supplementation during pregnancy, anemia, and birth weight: a randomized controlled trial 2003 · iron · Pregnant women enrolled before 20 weeks of gestation who were initially iron-replete and nonanemic | 30 mg | — | 146 |
| Cyclical iron supplementation to reduce anemia among Brazilian preschoolers: a randomized controlled trial 2013 · Cyclical Group · Children aged 24–59 months, anemic and non-anemic | 30 mg | 300 days | 48 |
| Ferrous bisglycinate 25 mg iron is as effective as ferrous sulfate 50 mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial 2014 · ferrous sulfate · Healthy ethnic Danish pregnant women, from 15–19 weeks of gestation until delivery | 50 mg | — | 40 |
| Effect of micronutrients and iron supplementation on hemoglobin, iron status, and plasma hepatitis C and HIV RNA levels in female injection drug users: a controlled clinical trial 2007 · iron group · Adult women who were hepatitis C-positive and injected drugs; HIV-negative and HIV-positive participants | 18 mg | 1 year | — |
| Effectiveness of a large-scale iron-fortified milk distribution program on anemia and iron deficiency in low-income young children in Mexico 2010 · Iron-fortified milk (FM) · Children aged 12–30 months from low-income families in Mexico | 5.28 mg | 1 year | — |
| Reducing iron deficiency anemia in Bolivian school children: calcium and iron combined versus iron supplementation alone 2014 · Fe group · Children aged 6 to 10 years in Bolivia | 30 mg | 90 days | — |
| The effect of providing lipid-based nutrient supplements on morbidity in rural Malawian infants and young children: a randomized controlled trial 2016 · 10 g LNS/d group · Infants aged 6 months in rural Malawi | 6 mg | 1 year | — |
| The effect of providing lipid-based nutrient supplements on morbidity in rural Malawian infants and young children: a randomized controlled trial 2016 · 20 g LNS/d group · Infants aged 6 months in rural Malawi | 6 mg | 1 year | — |
| The effect of providing lipid-based nutrient supplements on morbidity in rural Malawian infants and young children: a randomized controlled trial 2016 · 40 g LNS/d group · Infants aged 6 months in rural Malawi | 6 mg | 1 year | — |
| Prenatal and Postnatal Supplementation with Lipid-Based Nutrient Supplements Reduces Anemia and Iron Deficiency in 18-Month-Old Bangladeshi Children: A Cluster-Randomized Effectiveness Trial 2018 · LNS-LNS · Pregnant women and their children in Bangladesh; children received supplementation from 6 to 24 months of age | 29 mg | — | — |
| The Effectiveness of Different Doses of Iron Supplementation and the Prenatal Determinants of Maternal Iron Status in Pregnant Spanish Women: ECLIPSES Study 2019 · Stratum 2, 40 mg/d iron · Pregnant women over 18 years old with initial hemoglobin above 130 g/L at week 12 and no anemia | 40 mg | 24 weeks | — |
| Antenatal Iron-Rich Food Intervention Prevents Iron-Deficiency Anemia but Does Not Affect Serum Hepcidin in Pregnant Women 2022 · IRF-40 · Pregnant women recruited at 11–13 weeks of gestation in South China without iron-deficiency anemia | 40 mg | — | — |
| Cost-effectiveness of universal iron supplementation and iron-containing micronutrient powders for anemia among young children in rural Bangladesh: analysis of a randomized, placebo-controlled trial 2022 · iron syrup with placebo powder · Children screened at 8 months of age in rural Bangladesh; both sexes; no condition required for eligibility | 1.79 mg | 90 days | 1,101 |
| Effect of small-quantity lipid-based nutrient supplements on growth, psychomotor development, iron status, and morbidity among 6- to 12-mo-old infants in South Africa: a randomized controlled trial 2019 · SQ-LNS · Infants enrolled at 6 months of age in a peri-urban South African setting; no specific disease or deficiency was required. | 5.8 mg | 26 weeks | 250 |
| Side effects of oral iron prophylaxis in pregnancy--myth or reality? 2006 · 20 mg group · Healthy pregnant women; age and sex beyond pregnancy not specified | 20 mg | — | 99 |
| Multi-Nutrient Fortified Dairy-Based Drink Reduces Anaemia without Observed Adverse Effects on Gut Microbiota in Anaemic Malnourished Nigerian Toddlers: A Randomised Dose-Response Study 2021 · 200 mL group · Nigerian toddlers aged 12–36 months with mild-to-moderate anaemia and mild-to-moderate acute malnutrition | 2.24 mg | 26 weeks | 62 |
| Multi-Nutrient Fortified Dairy-Based Drink Reduces Anaemia without Observed Adverse Effects on Gut Microbiota in Anaemic Malnourished Nigerian Toddlers: A Randomised Dose-Response Study 2021 · 400 mL group · Nigerian toddlers aged 12–36 months with mild-to-moderate anaemia and mild-to-moderate acute malnutrition | 4.48 mg | 26 weeks | 61 |
| Multi-Nutrient Fortified Dairy-Based Drink Reduces Anaemia without Observed Adverse Effects on Gut Microbiota in Anaemic Malnourished Nigerian Toddlers: A Randomised Dose-Response Study 2021 · 600 mL group · Nigerian toddlers aged 12–36 months with mild-to-moderate anaemia and mild-to-moderate acute malnutrition | 6.72 mg | 26 weeks | 61 |
| Iron supplementation limits the deleterious effects of repeated blood donation on endurance sport performance but not on iron status 2020 · 20 mg iron group · Moderately trained, iron-replete young men | 20 mg | 4 weeks | 12 |
| Effects of an energy and micronutrient supplement on motor development and motor activity in undernourished children in Indonesia 2000 · E · Undernourished children in Indonesia recruited at 12 or 18 months of age | 12 mg | 1 year | — |
| Effects of an energy and micronutrient supplement on growth and activity, correcting for non-supplemental sources of energy input in undernourished children in Indonesia 2000 · E · 12- and 18-month-old undernourished children with length-for-age ≤1 SD below the reference median and weight-for-length between 1 and 2 SD below the reference median | 12 mg | 1 year | — |
| Effects of an energy and micronutrient supplement on growth and activity, correcting for non-supplemental sources of energy input in undernourished children in Indonesia 2000 · M · 12- and 18-month-old undernourished children with length-for-age ≤1 SD below the reference median and weight-for-length between 1 and 2 SD below the reference median | 12 mg | 1 year | — |
| Effects of an energy and micronutrient supplement on skeletal maturation in undernourished children in Indonesia 2000 · E · Undernourished children recruited at 12 or 18 months of age | 12 mg | 1 year | — |
| Effects of an energy and micronutrient supplement on skeletal maturation in undernourished children in Indonesia 2000 · M · Undernourished children recruited at 12 or 18 months of age | 12 mg | 1 year | — |
| Effects of an energy and micronutrient supplement on mental development and behavior under natural conditions in undernourished children in Indonesia 2000 · E · 12- and 18-month-old undernourished children in Indonesia, with length-for-age ≤ −1 SD and weight-for-length between −1 and −2 SD | 12 mg | 1 year | — |
| Effects of an energy and micronutrient supplement on mental development and behavior under natural conditions in undernourished children in Indonesia 2000 · M · 12- and 18-month-old undernourished children in Indonesia, with length-for-age ≤ −1 SD and weight-for-length between −1 and −2 SD | 12 mg | 1 year | — |
| Iron supplementation affects growth and morbidity of breast-fed infants: results of a randomized trial in Sweden and Honduras 2002 · placebo from 4 to 6 months and iron supplements from 6 to 9 months · Full-term, breast-fed infants in Sweden and Honduras, assigned at 4 months of age | 1 mg | 90 days | — |
| Iron supplementation affects growth and morbidity of breast-fed infants: results of a randomized trial in Sweden and Honduras 2002 · iron supplements from 4 to 9 months · Full-term, breast-fed infants in Sweden and Honduras, assigned at 4 months of age | 1 mg | 150 days | — |
| A community-based randomized controlled trial of iron and zinc supplementation in Indonesian infants: effects on growth and development 2004 · Fe group · Indonesian infants aged 6–12 months | 10 mg | 26 weeks | — |
| Iron and zinc supplementation promote motor development and exploratory behavior among Bangladeshi infants 2004 · iron · Infants from rural Bangladesh, 6–12 months old, at risk of micronutrient deficiencies | 2.86 mg | 26 weeks | — |
| Effect of iron supplementation during pregnancy on the behaviour of children at early school age: long-term follow-up of a randomised controlled trial 2008 · Fe group · Pregnant women; maternal age and diagnosed condition not stated | 20 mg | — | — |
| Zinc supplementation improved length growth only in anemic infants in a multi-country trial of iron and zinc supplementation in South-East Asia 2008 · iron supplementation · Infants aged 4–6 months in Indonesia, Thailand, and Vietnam | 10 mg | 26 weeks | — |
| Home intervention improves cognitive and social-emotional scores in iron-deficient anemic infants 2010 · 6-month cohort with IDA (intervention or surveillance) · Infants with iron-deficiency anemia identified at 6 months | 15 mg | 1 year | — |
| Infant Iron Deficiency and Iron Supplementation Predict Adolescent Internalizing, Externalizing, and Social Problems 2018 · liquid vitamins with iron · Healthy infants randomized at 6 months of age who consumed less than 250 mL/day of cow milk or formula | 10 mg | 26 weeks | — |
| Cognitive Performance in Indian School-Going Adolescents Is Positively Affected by Consumption of Iron-Biofortified Pearl Millet: A 6-Month Randomized Controlled Efficacy Trial 2018 · iron-biofortified pearl millet · Indian boys and girls aged 12–16 years | 19.6 mg | 26 weeks | — |
| Prenatal iron supplementation adjusted to maternal iron stores reduces behavioural problems in 4-year-old children 2024 · Stratum 2, 20 mg/day iron group · Non-anaemic pregnant women with initial haemoglobin >130 g/L; dose was assigned before 12 gestational weeks and results were stratified by initial serum ferritin | 20 mg | — | — |
| Effect of Prenatal Iron Supplementation Adapted to Hemoglobin Levels in Early Pregnancy on Fetal and Neonatal Growth-ECLIPSES Study 2024 · Stratum 2: 20 mg/day iron group · Healthy non-anemic pregnant women aged over 18 years, with hemoglobin above 130 g/L at early pregnancy | 20 mg | — | — |
| Low-Dose Prophylactic Oral Iron Supplementation (Ferrous Fumarate, Ferrous Bisglycinate, and Ferrous Sulphate) in Pregnancy Is Not Associated With Clinically Significant Gastrointestinal Complaints: Results From Two Randomized Studies 2024 · 20 mg ferrous fumarate group · Healthy ethnic Danish women over 18 with an uncomplicated singleton pregnancy | 20 mg | — | — |
| Low-Dose Prophylactic Oral Iron Supplementation (Ferrous Fumarate, Ferrous Bisglycinate, and Ferrous Sulphate) in Pregnancy Is Not Associated With Clinically Significant Gastrointestinal Complaints: Results From Two Randomized Studies 2024 · Bisglycinate group · Healthy ethnic Danish women over 18 with an uncomplicated singleton pregnancy | 25 mg | — | — |
| Improvements in cognitive performance for schoolchildren in Zaire, Africa, following an iron supplement and treatment for intestinal parasites 1993 · iron supplement group · First-year primary school children in rural Zaire; sex and age not reported | 20 mg | 30 days | — |
| Effect of supplementation with zinc and other micronutrients on malaria in Tanzanian children: a randomised trial 2011 · Multi-nutrients without Zinc · Children aged 6–60 months enrolled in a rural area of Tanzania; children with height-for-age z-scores above −1.5 SD were excluded. | 18 mg | 251 days | 155 |
| Effects of prenatal micronutrients supplementation timing on pregnancy-induced hypertension: Secondary analysis of a double-blind randomized controlled trial 2021 · IFA group · Pregnant nulliparous Chinese women aged 20 or older, enrolled before 20 gestational weeks, with haemoglobin above 10.0 g/dl | 30 mg | — | 6,252 |
| Micronutrient supplementation during pregnancy and the risk of pregnancy-induced hypertension: A randomized clinical trial 2019 · IFA group · Nulliparous pregnant women aged 20 years or older, enrolled before 20 weeks of gestation, with hemoglobin at least 10.0 g/dL | 30 mg | — | 5,933 |
| Effects of Prenatal Micronutrient Supplementation on Spontaneous Preterm Birth: A Double-Blind Randomized Controlled Trial in China 2017 · IFA group · Pregnant women aged 20 years or older, nulliparous, enrolled before 20 gestational weeks, with hemoglobin above 10.0 g/dL | 30 mg | — | 5,920 |
| Micronutrient supplementation during pregnancy and the risk of pregnancy-induced hypertension: A randomized clinical trial 2019 · MMN group · Nulliparous pregnant women aged 20 years or older, enrolled before 20 weeks of gestation, with hemoglobin at least 10.0 g/dL | 30 mg | — | 5,914 |
| Effects of Prenatal Micronutrient Supplementation on Spontaneous Preterm Birth: A Double-Blind Randomized Controlled Trial in China 2017 · MMN group · Pregnant women aged 20 years or older, nulliparous, enrolled before 20 gestational weeks, with hemoglobin above 10.0 g/dL | 30 mg | — | 5,910 |
| Effect of prenatal multiple micronutrient supplements and medium-quantity lipid-based nutritional supplements on maternal weight gain and infant birth weight in rural Niger: a cluster-randomised trial 2025 · MQ-LNS · Pregnant women in rural Niger enrolled at up to 30 weeks' gestation | 30 mg | — | 1,144 |
| Effect of prenatal multiple micronutrient supplements and medium-quantity lipid-based nutritional supplements on maternal weight gain and infant birth weight in rural Niger: a cluster-randomised trial 2025 · MMN · Pregnant women in rural Niger enrolled at up to 30 weeks' gestation | 30 mg | — | 1,083 |
| Excess risk of preterm birth with periconceptional iron supplementation in a malaria endemic area: analysis of secondary data on birth outcomes in a double blind randomized controlled safety trial in Burkina Faso 2019 · weekly iron and folic acid · Nulliparous, non-pregnant women aged 15–24 years in a malaria-endemic area of Burkina Faso who became pregnant during or shortly after supplementation | 8.57 mg | 548 days | 980 |
| Risk of malaria in young children after periconceptional iron supplementation 2021 · Iron · Nulliparous young women in Burkina Faso; age range and sex beyond female are not specified; no diagnosed condition stated | 8.57 mg | 548 days | 980 |
| Iron Supplementation in Iron-Replete and Nonanemic Pregnant Women in Tanzania: A Randomized Clinical Trial 2015 · iron group · Pregnant HIV-uninfected primigravidae or secundigravidae women, enrolled at or before 27 weeks of gestation, iron-replete and non-anemic | 60 mg | 148 days | 750 |
| Cost-effectiveness of invitation to food supplementation early in pregnancy combined with multiple micronutrients on infant survival: analysis of data from MINIMat randomized trial, Bangladesh 2015 · EMMS · Pregnant women in rural Bangladesh, irrespective of nutritional status | 30 mg | — | 740 |
| Iron supplement in pregnancy and development of gestational diabetes--a randomised placebo-controlled trial 2009 · iron supplement group · Pregnant women with singleton pregnancies under 16 weeks’ gestation, haemoglobin 8–14 g/dl, and no pre-existing diabetes or haemoglobinopathies | 60 mg | — | 565 |
| Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial 2023 · Standard of care group · Pregnant women aged 13 years or older in the second trimester (13–26 weeks), with moderate or severe anaemia and a negative Plasmodium falciparum rapid diagnostic test | 120 mg | 90 days | 432 |
| Postpartum maternal and infant haematological effects of second-trimester ferric carboxymaltose versus standard-of-care oral iron in Malawi: longitudinal follow-up of a randomised controlled trial 2024 · Standard-of-care group · Pregnant women in Malawi, aged approximately 22 years on average, at 13–26 weeks’ gestation with moderate or severe anaemia | 120 mg | 90 days | 400 |
| Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial 2017 · oral iron · Adults with nondialysis-dependent CKD and iron-deficiency anemia | 608 mg | 52 weeks | 312 |
| FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia 2014 · Oral iron · Adults aged 18 years or older with non-dialysis-dependent chronic kidney disease, iron-deficiency anaemia, and no recent erythropoiesis-stimulating agent use | 200 mg | 52 weeks | 308 |
| Ferric carboxymaltose for anemia in late pregnancy: a randomized controlled trial 2025 · SOC (oral iron) · Pregnant women aged 27–35 weeks with moderate or severe anemia in Malawi | 120 mg | 90 days | 292 |
| Multivitamin and iron supplementation to prevent periconceptional anemia in rural tanzanian women: a randomized, controlled trial 2015 · Folic acid + iron · Non-pregnant women and adolescent girls aged 15–29 years in rural Tanzania | 30 mg | 26 weeks | 267 |
| Effect of Daily Antenatal Iron Supplementation on Plasmodium Infection in Kenyan Women: A Randomized Clinical Trial 2015 · 60 mg elemental iron group · Rural Kenyan women aged 15 to 45 years with singleton pregnancies at 13 to 23 weeks’ gestation and hemoglobin concentration of 9 g/dL or greater | 60 mg | — | 237 |
| Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease 2017 · ferric citrate · Adults with nondialysis-dependent CKD stages 3–5 and iron deficiency anemia; phase 2 participants also had elevated or high-normal serum phosphate | 3 g | 16 weeks | 190 |
| Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial 2008 · ferrous sulfate · Women less than 10 days after delivery with postpartum anemia and hemoglobin 10 g/dL or less | 975 mg | 6 weeks | 148 |
| Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial 2022 · Oral ferric maltol · Adults aged 18 years or older with quiescent or mild-to-moderate inflammatory bowel disease and iron-deficiency anemia | 60 mg | 52 weeks | 125 |
| Effect of iron supplementation on the iron status of pregnant women: consequences for newborns 1997 · iron-supplemented group · Pregnant women selected at approximately 28 weeks of gestation | 100 mg | — | 99 |
| Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness 2009 · enteral iron supplementation · Anemic, critically ill surgical patients with an expected ICU stay of at least 5 days | 975 mg | 4 weeks | 97 |
| Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial 2000 · placebo group · Adults undergoing primary hip arthroplasty with hemoglobin 98 to 137 g/L who did not predonate blood | 450 mg | 6 weeks | 78 |
| Delaying the start of iron until 28 days after antimalarial treatment is associated with lower incidence of subsequent illness in children with malaria and iron deficiency 2017 · Immediate group · Children aged 6–59 months with malaria and iron deficiency anemia | 2 mg/kg | 27 days | 50 |
| Delaying the start of iron until 28 days after antimalarial treatment is associated with lower incidence of subsequent illness in children with malaria and iron deficiency 2017 · Delayed group · Children aged 6–59 months with malaria and iron deficiency anemia | 2 mg/kg | 27 days | 50 |
| Effectiveness of Shuanghuang Yangxue Decoction for Treating Cancer-Related Anemia With Serum Iron Deficiency in Lung Cancer Patients: A Randomized Clinical Trial 2025 · Control group · Adults aged 18–80 with lung cancer, mild to moderate cancer-related anemia, serum iron deficiency, and qi and blood deficiency syndrome | 200 mg | 4 weeks | 50 |
| Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy 2013 · control group · Non-anemic patients with gynecologic cancer receiving adjuvant platinum-based chemotherapy | 600 mg | — | 32 |
| Elective coronary and valve surgery without blood transfusion in patients treated with recombinant human erythropoietin (epoetin-alpha) 2000 · group A · Patients undergoing elective open-heart surgery | 1.58 g | 3 weeks | 30 |
| Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation 2011 · 400 mg iron (controls) · Patients with refractory bleeding from gastrointestinal vascular malformations | 400 mg | 120 days | 27 |
| Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy 2010 · control group · Anemic gynecologic cancer patients receiving platinum-based chemotherapy who required RBC transfusion; age not reported | 600 mg | — | 22 |
| Effects of early human recombinant erythropoietin therapy on the transfusion in healthy preterm infants 2008 · treatment group · Preterm infants with gestational age 28–34 weeks and birth weight 1000–1750 g | 3 mg/kg | 4 weeks | 20 |
| Effects of early human recombinant erythropoietin therapy on the transfusion in healthy preterm infants 2008 · control group · Preterm infants with gestational age 28–34 weeks and birth weight 1000–1750 g | 3 mg/kg | 4 weeks | 20 |
| Effects of iron and zinc supplementation in Indonesian infants on micronutrient status and growth 2001 · iron + zinc · Indonesian infants, 4 months of age | 10 mg | 26 weeks | — |
| Home-fortification with iron and zinc sprinkles or iron sprinkles alone successfully treats anemia in infants and young children 2003 · Fe (iron-only comparison group) · Anemic infants in rural Ghana; mean age 10.3 ± 2.5 months | 80 mg | 60 days | — |
| Prevention of iron deficiency anemia in adolescent and adult pregnancies 2003 · iron supplementation · Pregnant adolescent women aged 18 years or younger and adult women aged 19 years or older; healthy and iron-sufficient at their first prenatal visit | 60 mg | — | — |
| A double-blind randomized controlled trial of antenatal mebendazole to reduce low birthweight in a hookworm-endemic area of Peru 2006 · mebendazole plus iron · Pregnant women aged 18–44 years in their second trimester in a hookworm-endemic area of Peru | 60 mg | — | — |
| Combined iron and zinc supplementation in infants improved iron and zinc status, but interactions reduced efficacy in a multicountry trial in southeast Asia 2007 · iron and zinc · Infants aged 4–6 months | 10 mg | 26 weeks | — |
| Comparison of ferrous sulfate and ferrous glycinate chelate for the treatment of iron deficiency anemia in gastrectomized patients 2008 · group 1 · Gastrectomized patients with iron deficiency anemia | 400 mg | 120 days | — |
| Comparison of ferrous sulfate and ferrous glycinate chelate for the treatment of iron deficiency anemia in gastrectomized patients 2008 · group 2 · Gastrectomized patients with iron deficiency anemia | 250 mg | 120 days | — |
| Iron supplements reduce the risk of iron deficiency anemia in marginally low birth weight infants 2010 · 1 mg/kg per day group · Healthy marginally low birth weight infants (2000–2500 g), from 6 weeks to 6 months of age | 1 mg/kg | 20 weeks | — |
| Iron supplements reduce the risk of iron deficiency anemia in marginally low birth weight infants 2010 · 2 mg/kg per day group · Healthy marginally low birth weight infants (2000–2500 g), from 6 weeks to 6 months of age | 2 mg/kg | 20 weeks | — |
| Equity in adherence to and effect of prenatal food and micronutrient supplementation on child mortality: results from the MINIMat randomized trial, Bangladesh 2014 · EFe30F (early food invitation; 30 mg iron + 400 μg folic acid) · Pregnant women in rural Bangladesh, enrolled before 14 weeks’ gestation | 30 mg | — | — |
| Equity in adherence to and effect of prenatal food and micronutrient supplementation on child mortality: results from the MINIMat randomized trial, Bangladesh 2014 · UFe30F (usual food invitation; 30 mg iron + 400 μg folic acid) · Pregnant women in rural Bangladesh, enrolled before 14 weeks’ gestation | 30 mg | — | — |
| Modifying effects of maternal Hb concentration on infant birth weight in women receiving prenatal iron-containing supplements: a randomised controlled trial 2016 · IFA group · Pregnant women aged at least 20 years, nulliparous, with Hb concentration ≥100 g/L and enrolled before 20 weeks of gestation | 30 mg | — | — |
| Randomised open-label trial comparing intravenous iron and an erythropoiesis-stimulating agent versus oral iron to treat preoperative anaemia in cardiac surgery (INITIATE trial) 2022 · control group · Elective cardiac surgery patients with low preoperative haemoglobin and iron deficiency | 600 mg | — | — |
| Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery 1997 · epoetin beta group (with iron) · Patients undergoing primary elective open-heart surgery in whom autologous blood donation was contraindicated | 300 mg | 2 weeks | — |
| Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants 1997 · DI (daily iron plus weekly Deltaprim) · Infants born in a malaria-hyperendemic area of Tanzania; supplementation from 8 to 24 weeks of age | 2 mg/kg | 16 weeks | — |
| Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants 1997 · IP (daily iron plus weekly placebo) · Infants born in a malaria-hyperendemic area of Tanzania; supplementation from 8 to 24 weeks of age | 2 mg/kg | 16 weeks | — |
| Small-quantity, lipid-based nutrient supplements provided to women during pregnancy and 6 mo postpartum and to their infants from 6 mo of age increase the mean attained length of 18-mo-old children in semi-urban Ghana: a randomized controlled trial 2016 · MMN · Pregnant women aged 18 years or older enrolled at up to 20 weeks of gestation; their infants received no supplement | 20 mg | — | 439 |
| Supplementation with Small-Quantity Lipid-Based Nutrient Supplements Does Not Increase Child Morbidity in a Semiurban Setting in Ghana: A Secondary Outcome Noninferiority Analysis of the International Lipid-Based Nutrient Supplements (iLiNS)-DYAD Randomized Controlled Trial 2020 · MMN group · Pregnant and lactating women aged 18 years or older, enrolled by 20 weeks’ gestation; offspring received no supplement | 20 mg | — | 439 |
| Psychosocial stimulation benefits development in nonanemic children but not in anemic, iron-deficient children 2013 · IDA children (iron treatment) · Children aged 6–24 months with iron deficiency anemia | 30 mg | 183 days | 225 |
| Side effects of oral iron prophylaxis in pregnancy--myth or reality? 2006 · 40 mg group · Healthy pregnant women; age and sex beyond pregnancy not specified | 40 mg | — | 100 |
| Acceptability of micronutrient sprinkles: a new food-based approach for delivering iron to First Nations and Inuit children in Northern Canada 2005 · sprinkles group · First Nations and Inuit children aged 4 to 18 months who were non-anemic | 30 mg | 26 weeks | 49 |
| Efficacy and Safety of 5-Aminolevulinic Acid Combined with Iron on Skeletal Muscle Mass Index and Physical Performance of Patients with Sarcopenia: A Multicenter, Double-Blinded, Randomized-Controlled Trial (ALADDIN Study) 2023 · ALA 100/SFC 29 group · Men and women aged 65 years or older with sarcopenia | 29 mg | 12 weeks | 22 |
| Efficacy and Safety of 5-Aminolevulinic Acid Combined with Iron on Skeletal Muscle Mass Index and Physical Performance of Patients with Sarcopenia: A Multicenter, Double-Blinded, Randomized-Controlled Trial (ALADDIN Study) 2023 · ALA 150/SFC 29 group · Men and women aged 65 years or older with sarcopenia | 29 mg | 12 weeks | 19 |
| Efficacy and Safety of 5-Aminolevulinic Acid Combined with Iron on Skeletal Muscle Mass Index and Physical Performance of Patients with Sarcopenia: A Multicenter, Double-Blinded, Randomized-Controlled Trial (ALADDIN Study) 2023 · ALA 50/SFC 29 group · Men and women aged 65 years or older with sarcopenia | 29 mg | 12 weeks | 18 |
| Early detection of the anthracycline-induced cardiotoxicity. A non-invasive haemodynamic study 1997 · EPI + C0Q10 · breast cancer patients receiving epirubicin; age and sex beyond the breast cancer population are not specified | 50 mg | 9 weeks | 10 |
| Effect of iron supplementation on cognition in Greek preschoolers 2004 · Iron supplementation · Healthy preschool children aged 3–4 years in Greece, including children with anemia and children with good iron status | 15 mg | 60 days | — |
| Tolerability of iron: a comparison of bis-glycino iron II and ferrous sulfate 1991 · bis-glycino iron II (chelate) · women; age and health condition not specified | 50 mg | 2 weeks | — |
| Tolerability of iron: a comparison of bis-glycino iron II and ferrous sulfate 1991 · ferrous sulfate · women; age and health condition not specified | 50 mg | 2 weeks | — |
| Gastric delivery system for iron supplementation 1990 · GDS · Women participating in the trial; age and health condition not specified | 50 mg | — | — |
| Gastric delivery system for iron supplementation 1990 · conventional ferrous sulphate · Women participating in the trial; age and health condition not specified | 50 mg | — | — |
| Home intervention improves cognitive and social-emotional scores in iron-deficient anemic infants 2010 · 12-month cohort with IDA (intervention or surveillance) · Infants with iron-deficiency anemia identified at 12 months | 30 mg | 26 weeks | — |
| The efficacy of early iron supplementation on postpartum depression, a randomized double-blind placebo-controlled trial 2017 · iron-treated group · Non-anemic mothers with postpartum depression, one week after delivery; age and sex beyond being mothers not specified | 50 mg | 6 weeks | — |
| Increasing Iron Status through Dietary Supplementation in Iron-Depleted, Sedentary Women Increases Endurance Performance at Both Near-Maximal and Submaximal Exercise Intensities 2019 · iron supplementation with aerobic exercise training · Sedentary, previously untrained iron-depleted, nonanemic women aged 18–26 years | 42 mg | 8 weeks | — |
| Increasing Iron Status through Dietary Supplementation in Iron-Depleted, Sedentary Women Increases Endurance Performance at Both Near-Maximal and Submaximal Exercise Intensities 2019 · iron supplementation without aerobic exercise training · Sedentary, previously untrained iron-depleted, nonanemic women aged 18–26 years | 42 mg | 8 weeks | — |
| Prenatal iron supplementation adjusted to maternal iron stores reduces behavioural problems in 4-year-old children 2024 · Stratum 1, 40 mg/day iron control group · Non-anaemic pregnant women with initial haemoglobin 110–130 g/L; dose was assigned before 12 gestational weeks | 40 mg | — | — |
| Prenatal iron supplementation adjusted to maternal iron stores reduces behavioural problems in 4-year-old children 2024 · Stratum 2, 40 mg/day iron control group · Non-anaemic pregnant women with initial haemoglobin >130 g/L; dose was assigned before 12 gestational weeks | 40 mg | — | — |
| Effect of Prenatal Iron Supplementation Adapted to Hemoglobin Levels in Early Pregnancy on Fetal and Neonatal Growth-ECLIPSES Study 2024 · Stratum 2: 40 mg/day iron group · Healthy non-anemic pregnant women aged over 18 years, with hemoglobin above 130 g/L at early pregnancy | 40 mg | — | — |
| Low-Dose Prophylactic Oral Iron Supplementation (Ferrous Fumarate, Ferrous Bisglycinate, and Ferrous Sulphate) in Pregnancy Is Not Associated With Clinically Significant Gastrointestinal Complaints: Results From Two Randomized Studies 2024 · 40 mg ferrous fumarate group · Healthy ethnic Danish women over 18 with an uncomplicated singleton pregnancy | 40 mg | — | — |
| Low-Dose Prophylactic Oral Iron Supplementation (Ferrous Fumarate, Ferrous Bisglycinate, and Ferrous Sulphate) in Pregnancy Is Not Associated With Clinically Significant Gastrointestinal Complaints: Results From Two Randomized Studies 2024 · Sulphate group · Healthy ethnic Danish women over 18 with an uncomplicated singleton pregnancy | 50 mg | — | — |
| Zinc supplementation reduced morbidity, but neither zinc nor iron supplementation affected growth or body composition of Mexican preschoolers 1997 · zinc + iron · Mexican preschool children in a rural community | 20 mg | 1 year | — |
| Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial 2008 · Multiple micronutrients · Pregnant women resident in disadvantaged rural counties in Shaanxi Province, China; eligible women enrolled before 28 weeks’ gestation | 30 mg | — | 1,899 |
| Equity in adherence to and effect of prenatal food and micronutrient supplementation on child mortality: results from the MINIMat randomized trial, Bangladesh 2014 · EMMS (early food invitation; multiple micronutrients) · Pregnant women in rural Bangladesh, enrolled before 14 weeks’ gestation | 30 mg | — | — |
| Equity in adherence to and effect of prenatal food and micronutrient supplementation on child mortality: results from the MINIMat randomized trial, Bangladesh 2014 · UMMS (usual food invitation; multiple micronutrients) · Pregnant women in rural Bangladesh, enrolled before 14 weeks’ gestation | 30 mg | — | — |
| Modifying effects of maternal Hb concentration on infant birth weight in women receiving prenatal iron-containing supplements: a randomised controlled trial 2016 · MMN group · Pregnant women aged at least 20 years, nulliparous, with Hb concentration ≥100 g/L and enrolled before 20 weeks of gestation | 30 mg | — | — |
| Effectiveness of a home fortification programme with multiple micronutrients on infant and young child development: a cluster-randomised trial in rural Bihar, India 2018 · intervention group · Children aged 6–18 months in rural Bihar, India | 12.5 mg | 1 year | 2,170 |
| Cost-effectiveness of universal iron supplementation and iron-containing micronutrient powders for anemia among young children in rural Bangladesh: analysis of a randomized, placebo-controlled trial 2022 · MNPs with placebo syrup · Children screened at 8 months of age in rural Bangladesh; both sexes; no condition required for eligibility | 12.5 mg | 90 days | 1,099 |
| Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial 2008 · Iron-folic acid · Pregnant women resident in disadvantaged rural counties in Shaanxi Province, China; eligible women enrolled before 28 weeks’ gestation | 60 mg | — | 1,912 |
| Single-dose intravenous iron vs oral iron for treatment of maternal iron deficiency anemia: a randomized clinical trial 2025 · Oral iron · Pregnant people with singleton pregnancies at 14 to 17 weeks and moderate iron deficiency anemia (hemoglobin 7.0–9.9 g/dL) | 120 mg | — | 1,450 |
| Effect of prenatal multiple micronutrient supplements and medium-quantity lipid-based nutritional supplements on maternal weight gain and infant birth weight in rural Niger: a cluster-randomised trial 2025 · IFA · Pregnant women in rural Niger enrolled at up to 30 weeks' gestation | 60 mg | — | 1,105 |
| Prenatal fortified balanced energy-protein supplementation and birth outcomes in rural Burkina Faso: A randomized controlled efficacy trial 2022 · Control (IFA only) · Pregnant women aged 15–40 years in rural Burkina Faso | 65 mg | — | 909 |
| Prenatal fortified balanced energy-protein supplementation and birth outcomes in rural Burkina Faso: A randomized controlled efficacy trial 2022 · Intervention (IFA plus fortified BEP) · Pregnant women aged 15–40 years in rural Burkina Faso | 65 mg | — | 879 |
| Cost-effectiveness of invitation to food supplementation early in pregnancy combined with multiple micronutrients on infant survival: analysis of data from MINIMat randomized trial, Bangladesh 2015 · UFe60F · Pregnant women in rural Bangladesh, irrespective of nutritional status | 60 mg | — | 738 |
| Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial 2024 · oral ferrous sulphate group · Pregnant women aged 15–49 years, 20–32 weeks’ gestation, with haemoglobin below 10 g/dL | 600 mg | — | 529 |
| Predictors of Anaemia Among Young Children Receiving Daily Micronutrient Powders (MNPs) for 24 Weeks in Bangladesh: A Secondary Analysis of the Zinc in Powders Trial 2025 · standard MNP daily group · Children aged 9–11 months at enrolment in Bangladesh | 10 mg | 24 weeks | 481 |
| Providing lipid-based nutrient supplement during pregnancy does not reduce the risk of maternal P falciparum parasitaemia and reproductive tract infections: a randomised controlled trial 2017 · MMN · Pregnant women aged at least 15 years with ultrasound-confirmed pregnancy under 20 gestational weeks and no chronic medical condition, allergies, or evident pregnancy complications | 20 mg | — | 466 |
| Providing lipid-based nutrient supplement during pregnancy does not reduce the risk of maternal P falciparum parasitaemia and reproductive tract infections: a randomised controlled trial 2017 · IFA · Pregnant women aged at least 15 years with ultrasound-confirmed pregnancy under 20 gestational weeks and no chronic medical condition, allergies, or evident pregnancy complications | 60 mg | — | 463 |
| Providing lipid-based nutrient supplement during pregnancy does not reduce the risk of maternal P falciparum parasitaemia and reproductive tract infections: a randomised controlled trial 2017 · SQ-LNS · Pregnant women aged at least 15 years with ultrasound-confirmed pregnancy under 20 gestational weeks and no chronic medical condition, allergies, or evident pregnancy complications | 20 mg | — | 462 |
| Association between prenatal provision of lipid-based nutrient supplements and caesarean delivery: Findings from a randomised controlled trial in Malawi 2022 · IFA group · Pregnant women aged 15 years or older, enrolled before 20 completed gestational weeks, without chronic health conditions, in Malawi | 60 mg | — | 420 |
| Impact of weekly iron folic acid supplementation with and without vitamin B12 on anaemic adolescent girls: a randomised clinical trial 2016 · Group B · Anaemic adolescent girls aged 11–18 years | 14.3 mg | 26 weeks | 224 |
| Impact of weekly iron folic acid supplementation with and without vitamin B12 on anaemic adolescent girls: a randomised clinical trial 2016 · Group A · Anaemic adolescent girls aged 11–18 years | 14.3 mg | 26 weeks | 222 |
| Regular vitamin C supplementation during pregnancy reduces hospitalization: outcomes of a Ugandan rural cohort study 2010 · Control group · Pregnant women aged at least 18, enrolled at 4–12 gestational weeks in Uganda | 200 mg | — | 197 |
| Randomized control trial comparing effectiveness of weekly versus daily antenatal oral iron supplementation in preventing anemia during pregnancy 2018 · weekly supplementation group · Non-anemic pregnant women at 14–22 weeks’ gestation | 17.1 mg | — | 149 |
| Randomized control trial comparing effectiveness of weekly versus daily antenatal oral iron supplementation in preventing anemia during pregnancy 2018 · daily supplementation group · Non-anemic pregnant women at 14–22 weeks’ gestation | 60 mg | — | 143 |
| Periconceptional iron supplementation does not reduce anemia or improve iron status among pregnant women in rural Bangladesh 2009 · iron and folic acid (IFA) · Married, nulliparous women in rural Bangladesh, followed until pregnancy or the end of 9 months | 60 mg | 274 days | 134 |
| Intravenous ferric derisomaltose versus oral iron for persistent iron deficient pregnant women: a randomised controlled trial 2023 · Oral iron group · Pregnant women aged 18 years or older at 14–21 weeks’ gestation with persistent iron deficiency (ferritin <30 µg/L) after oral iron treatment | 100 mg | 18 weeks | 101 |
| Effects of 6-months of oral ferrous and ferric supplement therapy in patients who were hospitalized for decompensated chronic heart failure 2019 · Group I · Adults hospitalized for decompensated chronic heart failure with iron-deficiency anemia; mean age 73.3 years in this arm; men and women. | 700 mg | 26 weeks | 100 |
| Multimicronutrient supplementation for undernourished pregnant women and the birth size of their offspring: a double-blind, randomized, placebo-controlled trial 2007 · micronutrient supplementation group · Undernourished pregnant women enrolled at 24–32 weeks of gestation, with BMI <18.5 and/or hemoglobin 7–9 g/dL | 60 mg | 58 days | 99 |
| Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial 2000 · low-dose group · Adults undergoing primary hip arthroplasty with hemoglobin 98 to 137 g/L who did not predonate blood | 450 mg | 6 weeks | 79 |
| Weekly vs daily iron and folic acid supplementation in adolescent Nepalese girls 2002 · Group A · Healthy adolescent girls in Nepal; median age 15 years | 350 mg | 100 days | 70 |
| Weekly vs daily iron and folic acid supplementation in adolescent Nepalese girls 2002 · Group B · Healthy adolescent girls in Nepal; median age 15 years | 50 mg | 14 weeks | 67 |
| Dual fortification of salt with iron and iodine in women and children in rural Ghana 2007 · Iodised salt plus weekly 70 mg iron supplement (women) · Mildly anaemic or non-anaemic, non-pregnant, non-lactating women | 10 mg | 240 days | 65 |
| Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial 2000 · early group · Premature infants with birth weight <1250 g | 6 mg/kg | 8 weeks | 57 |
| Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial 2000 · late group · Premature infants with birth weight <1250 g | 6 mg/kg | 8 weeks | 57 |
| Effectiveness of Shuanghuang Yangxue Decoction for Treating Cancer-Related Anemia With Serum Iron Deficiency in Lung Cancer Patients: A Randomized Clinical Trial 2025 · Treatment group · Adults aged 18–80 with lung cancer, mild to moderate cancer-related anemia, serum iron deficiency, and qi and blood deficiency syndrome | 200 mg | 4 weeks | 50 |
| Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial 2000 · high-dose group · Adults undergoing primary hip arthroplasty with hemoglobin 98 to 137 g/L who did not predonate blood | 450 mg | 6 weeks | 44 |
| Lower rate of preeclampsia after antioxidant supplementation in pregnant women with low antioxidant status 2006 · control group · Pregnant women screened positive for low antioxidant status at 8 to 12 weeks of gestation | 30 mg | — | 31 |
| Elective coronary and valve surgery without blood transfusion in patients treated with recombinant human erythropoietin (epoetin-alpha) 2000 · group B · Patients undergoing elective open-heart surgery | 1.58 g | 3 weeks | 30 |
| Effect of Lipid-Based Multiple Micronutrients Supplementation in Underweight Primigravida Pre-Eclamptic Women on Maternal and Pregnancy Outcomes: Randomized Clinical Trial 2022 · Group 1 · Pregnant primigravida women aged 15–35 with pre-eclampsia and underweight for gestational age | 60 mg | 48 days | 30 |
| Recombinant human erythropoietin in the treatment of anemia of prematurity 1995 · Group A · Premature infants with birthweight ≤1.75 kg, gestational age ≤33 weeks, and anemia (hemoglobin <10 g/dL and hematocrit <30%) | 3 mg/kg | 4 weeks | 26 |
| Recombinant human erythropoietin in the treatment of anemia of prematurity 1995 · Group B · Premature infants with birthweight ≤1.75 kg, gestational age ≤33 weeks, and anemia (hemoglobin <10 g/dL and hematocrit <30%) | 3 mg/kg | 4 weeks | 25 |
| Recombinant human erythropoietin in the treatment of anemia of prematurity 1995 · Group C · Premature infants with birthweight ≤1.75 kg, gestational age ≤33 weeks, and anemia (hemoglobin <10 g/dL and hematocrit <30%) | 3 mg/kg | 4 weeks | 19 |
| Albendazole therapy and reduced decline in haemoglobin concentration during pregnancy (Sierra Leone) 2001 · albendazole plus iron-folate supplements · Pregnant women in Sierra Leone | 36 mg | — | — |
| Treatment of anemia with microencapsulated ferrous fumarate plus ascorbic acid supplied as sprinkles to complementary (weaning) foods 2001 · sprinkles group · Anemic children aged 6–18 months in rural Ghana | 80 mg | 60 days | — |
| Home-fortification with iron and zinc sprinkles or iron sprinkles alone successfully treats anemia in infants and young children 2003 · FeZn (combined supplementation group) · Anemic infants in rural Ghana; mean age 10.3 ± 2.5 months | 80 mg | 60 days | — |
| Simultaneous weekly supplementation of iron and zinc is associated with lower morbidity due to diarrhea and acute lower respiratory infection in Bangladeshi infants 2003 · 20 mg iron and 20 mg zinc with 1 mg riboflavin · Infants aged 6 months at enrollment, followed until 12 months | 2.86 mg | 183 days | — |
| Simultaneous weekly supplementation of iron and zinc is associated with lower morbidity due to diarrhea and acute lower respiratory infection in Bangladeshi infants 2003 · Micronutrient mix (MM) · Infants aged 6 months at enrollment, followed until 12 months | 2.86 mg | 183 days | — |
| Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal 2003 · Folic acid + iron · Pregnant women in rural Nepal | 60 mg | — | — |
| Dual fortification of salt with iodine and micronized ferric pyrophosphate: a randomized, double-blind, controlled trial 2004 · dual-fortified salt (DFS) group · Iodine-deficient children aged 6–15 years in rural northern Morocco, with a high prevalence of anemia | 18 mg | 304 days | — |
| Effect of routine prophylactic supplementation with iron and folic acid on preschool child mortality in southern Nepal: community-based, cluster-randomised, placebo-controlled trial 2006 · iron and folic acid · Children aged 1–36 months in southern Nepal | 12.5 mg | — | — |
| Effect of routine prophylactic supplementation with iron and folic acid on preschool child mortality in southern Nepal: community-based, cluster-randomised, placebo-controlled trial 2006 · iron and folic acid with zinc · Children aged 1–36 months in southern Nepal | 12.5 mg | — | — |
| Fortifying milk with ferrous gluconate and zinc oxide in a public nutrition program reduced the prevalence of anemia in toddlers 2006 · Fortified milk (FM) · Healthy, low-income children aged 10–30 months | 5.8 mg | 26 weeks | — |
| Treatment and prevention of anemia with ferrous sulfate plus folic acid in children attending daycare centers in Goiânia, Goiás State, Brazil: a randomized controlled trial 2008 · Treatment group receiving ferrous sulfate plus folic acid · Children aged 6–24 months with anemia attending municipal daycare centers in Goiânia, Brazil | 4.2 mg/kg | 90 days | — |
| Treatment and prevention of anemia with ferrous sulfate plus folic acid in children attending daycare centers in Goiânia, Goiás State, Brazil: a randomized controlled trial 2008 · Prevention group receiving ferrous sulfate plus folic acid · Non-anemic children aged 6–24 months attending municipal daycare centers in Goiânia, Brazil | 1.4 mg/kg | 90 days | — |
| Equity in adherence to and effect of prenatal food and micronutrient supplementation on child mortality: results from the MINIMat randomized trial, Bangladesh 2014 · EFe60F (early food invitation; 60 mg iron + 400 μg folic acid) · Pregnant women in rural Bangladesh, enrolled before 14 weeks’ gestation | 60 mg | — | — |
| Equity in adherence to and effect of prenatal food and micronutrient supplementation on child mortality: results from the MINIMat randomized trial, Bangladesh 2014 · UFe60F (usual food invitation; 60 mg iron + 400 μg folic acid) · Pregnant women in rural Bangladesh, enrolled before 14 weeks’ gestation | 60 mg | — | — |
| Reducing iron deficiency anemia in Bolivian school children: calcium and iron combined versus iron supplementation alone 2014 · Ca + Fe group · Children aged 6 to 10 years in Bolivia | 30 mg | 90 days | — |
| Prebiotic galacto-oligosaccharides mitigate the adverse effects of iron fortification on the gut microbiome: a randomised controlled study in Kenyan infants 2017 · FeGOS group · Kenyan infants aged 6.5–9.5 months | 5 mg | 120 days | — |
| Effects of long-term weekly iron and folic acid supplementation on lower genital tract infection - a double blind, randomised controlled trial in Burkina Faso 2017 · iron · Healthy nulliparous, non-pregnant women aged 15–24 years at enrolment; some became pregnant during follow-up | 8.57 mg | 548 days | — |
| Prenatal and Postnatal Supplementation with Lipid-Based Nutrient Supplements Reduces Anemia and Iron Deficiency in 18-Month-Old Bangladeshi Children: A Cluster-Randomized Effectiveness Trial 2018 · IFA-LNS · Pregnant women and their children in Bangladesh; children received supplementation from 6 to 24 months of age | 69 mg | — | — |
| Prenatal and Postnatal Supplementation with Lipid-Based Nutrient Supplements Reduces Anemia and Iron Deficiency in 18-Month-Old Bangladeshi Children: A Cluster-Randomized Effectiveness Trial 2018 · IFA-MNP · Pregnant women and their children in Bangladesh; children received supplementation from 6 to 24 months of age | 70 mg | — | — |
| Prenatal iron containing supplements provided to Chinese women with no or mild anemia had no effect on hemoglobin concentration in post-partum women or their infants at 6 and 12 months of age 2019 · IFA · Nulliparous pregnant women with hemoglobin concentration >100 g/L and no or mild anemia | 30 mg | — | — |
| Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study 1994 · rHuEpo group · Preterm infants up to 32 weeks’ gestation, 2 to 8 weeks postnatal age, with central hematocrit ≤35% and anemia of prematurity | 3 mg/kg | 6 weeks | — |
| Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study 1994 · Placebo group · Preterm infants up to 32 weeks’ gestation, 2 to 8 weeks postnatal age, with central hematocrit ≤35% and anemia of prematurity | 3 mg/kg | 6 weeks | — |
| Predictors of adherence to micronutrient supplementation before and during pregnancy in Vietnam 2017 · IFA (iron and folic acid) preconception group · Women of reproductive age in Vietnam intending to become pregnant | 8.57 mg | 400 days | 1,489 |
| Evaluation of multiple micronutrient supplementation and medium-quantity lipid-based nutrient supplementation in pregnancy on child development in rural Niger: A secondary analysis of a cluster randomized controlled trial 2022 · MMS · Pregnant women under 30 weeks’ gestation at enrollment, without the specified chronic health conditions or pregnancy complications | 30 mg | — | 1,083 |
| Effect of a randomised exclusive breastfeeding counselling intervention nested into the MINIMat prenatal nutrition trial in Bangladesh 2017 · Fe30 · Pregnant women in rural Bangladesh, enrolled before 14 weeks of gestation | 30 mg | — | 917 |
| Effect of a randomised exclusive breastfeeding counselling intervention nested into the MINIMat prenatal nutrition trial in Bangladesh 2017 · MMS · Pregnant women in rural Bangladesh, enrolled before 14 weeks of gestation | 30 mg | — | 914 |
| Effects of Daily Zinc, Daily Multiple Micronutrient Powder, or Therapeutic Zinc Supplementation for Diarrhea Prevention on Physical Growth, Anemia, and Micronutrient Status in Rural Laotian Children: A Randomized Controlled Trial 2019 · Micronutrient powder group · Children aged 6–23 months at enrollment in rural Laos; the study population included children with differing nutritional status, and enrollment was not restricted to a deficiency or diagnosis. | 6 mg | 36 weeks | 701 |
| Patients' perceptions of care in a Type 1 hybrid effectiveness-implementation trial on intravenous iron for anaemia in pregnancy in Nigeria 2026 · Oral FS group · Pregnant women aged 15–49 years, at 20–32 weeks’ gestation, with iron deficiency anaemia | 600 mg | — | 529 |
| Impact of preconceptional micronutrient supplementation on maternal mental health during pregnancy and postpartum: results from a randomized controlled trial in Vietnam 2017 · Iron and folic acid (IFA) · Women aged 18–40 planning pregnancy; reproductive-age women without a stated diagnosed condition | 8.57 mg | 56 weeks | 526 |
| Impact of preconceptional micronutrient supplementation on maternal mental health during pregnancy and postpartum: results from a randomized controlled trial in Vietnam 2017 · Multiple micronutrients (MM) · Women aged 18–40 planning pregnancy; reproductive-age women without a stated diagnosed condition | 8.57 mg | 56 weeks | 518 |
| Prenatal and postnatal lipid-based nutrient supplementation and cognitive, social-emotional, and motor function in preschool-aged children in Ghana: a follow-up of a randomized controlled trial 2019 · multiple micronutrients (MMN) group · Pregnant women aged 18 years or older, enrolled at up to 20 weeks of gestation; supplementation continued postpartum | 20 mg | — | 439 |
| Preconception micronutrient supplementation positively affects child intellectual functioning at 6 y of age: A randomized controlled trial in Vietnam 2021 · IFA (iron and folic acid) group · Women of reproductive age receiving preconception supplementation; offspring were assessed at ages 6–7 years | 8.57 mg | 194 days | 427 |
| Preconception micronutrient supplementation positively affects child intellectual functioning at 6 y of age: A randomized controlled trial in Vietnam 2021 · MM (multiple micronutrient) group · Women of reproductive age receiving preconception supplementation; offspring were assessed at ages 6–7 years | 8.57 mg | 200 days | 422 |
| Prenatal Intravenous Iron and Child Growth: A Secondary Analysis of a Randomized Clinical Trial 2025 · SOC group · Pregnant women aged 13–26 weeks with moderate to severe anemia | 400 mg | — | 367 |
| Improved gastrointestinal tolerance and iron status via probiotic use in iron deficiency anaemia patients initiating oral iron replacement: a randomised controlled trial 2024 · IRT-only group · Adults over 18 with newly diagnosed iron deficiency anaemia; 94.9% female | 100 mg | 90 days | 157 |
| Interventional impact of liposomal iron on iron-deficient children developmental outcome: randomized, double-blind, placebo-controlled trial 2025 · IDA group · Children aged 6–59 months with iron deficiency anemia | 1.4 mg/kg | 120 days | 124 |
| The Effect of Iron-Fortified Lentils on Blood and Cognitive Status among Adolescent Girls in Bangladesh 2023 · fortified lentil (FL) condition · Adolescent girls aged 10–17 years in Bangladesh; generally healthy and not pregnant or breastfeeding | 6.9 g | 85 days | 117 |
| Oral iron supplementation after blood donation: a randomized clinical trial 2015 · oral ferrous gluconate group · Adult male and female whole-blood donors aged 18 years or older, after a 500-mL donation; participants had low or higher baseline ferritin | 325 mg | 24 weeks | 111 |
| Side effects of oral iron prophylaxis in pregnancy--myth or reality? 2006 · 80 mg group · Healthy pregnant women; age and sex beyond pregnancy not specified | 80 mg | — | 103 |
| Side effects of oral iron prophylaxis in pregnancy--myth or reality? 2006 · 60 mg group · Healthy pregnant women; age and sex beyond pregnancy not specified | 60 mg | — | 102 |
| Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial 2012 · oral ferrous sulfate · Women aged 18–53 years with fatigue, ferritin below 50 μg/L, and hemoglobin above 12.0 g/dL | 80 mg | 12 weeks | 102 |
| The impact of different doses of oral iron supplementation during pregnancy: a pilot randomized trial 2024 · Alternate · Pregnant women aged 18 years or older, without anemia, enrolled at gestational age 13 weeks + 6 days or earlier | 100 mg | — | 99 |
| The impact of different doses of oral iron supplementation during pregnancy: a pilot randomized trial 2024 · Daily · Pregnant women aged 18 years or older, without anemia, enrolled at gestational age 13 weeks + 6 days or earlier | 200 mg | — | 98 |
| Do side-effects reduce compliance to iron supplementation? A study of daily- and weekly-dose regimens in pregnancy 2002 · daily-supplementation regimen · Pregnant women in Bangladesh | 60 mg | 90 days | 86 |
| Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial 2003 · oral ferrous sulphate · Women aged 18 to 55 with unexplained fatigue who were not anaemic | 80 mg | 4 weeks | 75 |
| Clinical evaluation of iron treatment efficiency among non-anemic but iron-deficient female blood donors: a randomized controlled trial 2012 · FeSO4 · Menstruating female blood donors aged 18–50 with iron deficiency without anemia (hemoglobin ≥120 g/L and ferritin ≤30 ng/mL) | 80 mg | 4 weeks | 74 |
| The effect of iron therapy on the growth of iron-replete and iron-deplete children 2003 · group II · Iron-deficient children aged 6–24 months | 6 mg/kg | 120 days | 50 |
| [Study on treatment of iron-deficiency anemia by shengxuening] 2004 · control group · Patients with iron-deficiency anemia | 300 mg | 30 days | 50 |
| Interventional impact of liposomal iron on iron-deficient children developmental outcome: randomized, double-blind, placebo-controlled trial 2025 · NAID interventional group · Children aged 6–59 months with non-anemic iron deficiency | 1.4 mg/kg | 120 days | 47 |
| Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls 1996 · oral ferrous sulphate · adolescent girls with non-anaemic iron deficiency | 1.3 g | 8 weeks | 41 |
| Effects of a Bovine Lactoferrin Formulation from Cow's Milk on Menstrual Distress in Volunteers: A Randomized, Crossover Study 2016 · FeLf · Healthy women aged 20–49 with regular menstrual cycles and pain during menstruation | 6.7 mg | — | 35 |
| Iron deficiency and child and maternal health 2009 · IDA-Fe · Iron-deficient anemic mothers recruited at 6–8 weeks postpartum | 125 mg | 213 days | 34 |
| Neurological development and iron supplementation in healthy late-preterm neonates: a randomized double-blind controlled trial 2022 · iron group · Healthy late-preterm infants born at 34–36 weeks’ gestation, beginning treatment at 14 days of life | 2 mg/kg | 26 weeks | 27 |
| Oral Ferrous Sulphate Improves Functional Capacity on Heart Failure Patients with Iron Deficiency Anemia 2022 · Ferrous sulphate group · Adults aged 18–75 with heart failure with reduced ejection fraction (HFREF), NYHA class II–III, and iron deficiency anemia | 600 mg | 12 weeks | 27 |
| Tolerability of Oral Supplementation with Microencapsulated Ferric Saccharate Compared to Ferrous Sulphate in Healthy Premenopausal Woman: A Crossover, Randomized, Double-Blind Clinical Trial 2022 · Microencapsulated ferric saccharate (MFS; AB-Fortis) · Healthy premenopausal women aged 18–50 years | 60 mg | 2 weeks | 26 |
| Tolerability of Oral Supplementation with Microencapsulated Ferric Saccharate Compared to Ferrous Sulphate in Healthy Premenopausal Woman: A Crossover, Randomized, Double-Blind Clinical Trial 2022 · Ferrous sulphate (FS) · Healthy premenopausal women aged 18–50 years | 60 mg | 2 weeks | 25 |
| Iron supplementation improves energetic efficiency in iron-depleted female rowers 2014 · Fe treatment group · Female rowers with depleted iron stores and no anemia | 100 mg | 6 weeks | 21 |
| Efficacy and Safety of 5-Aminolevulinic Acid Combined with Iron on Skeletal Muscle Mass Index and Physical Performance of Patients with Sarcopenia: A Multicenter, Double-Blinded, Randomized-Controlled Trial (ALADDIN Study) 2023 · ALA 100/SFC 57 group · Men and women aged 65 years or older with sarcopenia | 57 mg | 12 weeks | 21 |
| Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease 2005 · ferrous fumarate · Adults with iron deficiency anaemia and Crohn's disease or ulcerative colitis | 120 mg | 2 weeks | 19 |
| Effects of iron supplementation on attention deficit hyperactivity disorder in children 2008 · oral iron · Children aged 5–8 years with ADHD, nonanemic and with serum ferritin below 30 ng/mL | 80 mg | 12 weeks | 18 |
| Single versus Split Dose of Iron Optimizes Hemoglobin Mass Gains at 2106 m Altitude 2019 · SPLIT · Elite male and female middle- and long-distance runners attending an altitude training camp at 2106 m; baseline serum ferritin at least 30 μg/L | 200 mg | 3 weeks | 13 |
| Iron supplementation limits the deleterious effects of repeated blood donation on endurance sport performance but not on iron status 2020 · 80 mg iron group · Moderately trained, iron-replete young men | 80 mg | 4 weeks | 12 |
| Attenuation of angiotensin converting enzyme inhibitor induced cough by iron supplementation: role of nitric oxide 2011 · iron group · Patients with cough while receiving ACE-inhibitor therapy; age and sex not reported | 200 mg | 4 weeks | 11 |
| Single versus Split Dose of Iron Optimizes Hemoglobin Mass Gains at 2106 m Altitude 2019 · SINGLE · Elite male and female middle- and long-distance runners attending an altitude training camp at 2106 m; baseline serum ferritin at least 30 μg/L | 200 mg | 3 weeks | 11 |
| A rapid, simple questionnaire to assess gastrointestinal symptoms after oral ferrous sulphate supplementation 2014 · Iron group · Healthy adults aged 18–65 years, men and women, with no stated chronic disease | 130 mg | 7 days | 10 |
| A study of the effects of latent iron deficiency on measures of cognition: a pilot randomised controlled trial of iron supplementation in young women 2014 · 60 mg iron · Women aged 18–35 with latent iron deficiency (low ferritin and haemoglobin at least 120 g/L) | 60 mg | 16 weeks | 7 |
| A study of the effects of latent iron deficiency on measures of cognition: a pilot randomised controlled trial of iron supplementation in young women 2014 · 80 mg iron · Women aged 18–35 with latent iron deficiency (low ferritin and haemoglobin at least 120 g/L) | 80 mg | 16 weeks | 6 |
| Iron Supplementation After Blood Donation Expedites Hematological Recovery but Does Not Influence Exercise Performance 2025 · iron group · Moderately active men and women aged 34.0 ± 7.6 years who donated blood | 60 mg | 5 weeks | 5 |
| Long-term zinc and iron supplementation in children of short stature: effect of growth and on trace element content in tissues 1999 · iron plus zinc · Children aged 4–11 years with short stature; 16 male and 14 female participants across the study | 12 mg | 1 year | — |
| Iron supplementation improves endurance after training in iron-depleted, nonanemic women 2000 · iron (S) group · Women aged 18–33 with iron depletion without anemia | 100 mg | 6 weeks | — |
| Impact of iron supplementation and deworming on growth performance in preschool Beninese children 2001 · iron + albendazole-placebo · Children aged 3–5 years from low-income households in a rural area in southern Benin; many were stunted and 76% were anemic | 60 mg | 90 days | — |
| Impact of iron supplementation and deworming on growth performance in preschool Beninese children 2001 · iron + albendazole · Children aged 3–5 years from low-income households in a rural area in southern Benin; many were stunted and 76% were anemic | 60 mg | 90 days | — |
| Iron supplementation inhibits cough associated with ACE inhibitors 2001 · iron group · Patients with ACE inhibitor-induced cough; age and sex not reported | 256 mg | 4 weeks | — |
| Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women 2002 · iron group · Previously untrained, marginally iron-depleted, nonanemic women | 100 mg | 6 weeks | — |
| Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study 1992 · r-HuEPO group · premature infants with birth weight ≤1250 g, at high risk of transfusion for anemia of prematurity | 6 mg/kg | 6 weeks | — |
| Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study 1992 · control group · premature infants with birth weight ≤1250 g, at high risk of transfusion for anemia of prematurity | 6 mg/kg | 6 weeks | — |
| A community-based randomized controlled trial of iron and zinc supplementation in Indonesian infants: effects on growth and development 2004 · Fe+Zn group · Indonesian infants aged 6–12 months | 10 mg | 26 weeks | — |
| Once-weekly and 5-days a week iron supplementation differentially affect cognitive function but not school performance in Thai children 2004 · Daily iron supplementation group · Thai primary schoolchildren; age and sex not stated | 300 mg | 16 weeks | — |
| Once-weekly and 5-days a week iron supplementation differentially affect cognitive function but not school performance in Thai children 2004 · Weekly iron supplementation group · Thai primary schoolchildren; age and sex not stated | 300 mg | 16 weeks | — |
| Zinc-iron, but not zinc-alone supplementation, increased linear growth of stunted infants with low haemoglobin 2007 · zinc+iron · Infants aged 3–6 months in rural East Lombok; the study included infants with stunting and low haemoglobin | 10 mg | 26 weeks | — |
| Zinc supplementation improved length growth only in anemic infants in a multi-country trial of iron and zinc supplementation in South-East Asia 2008 · iron and zinc supplementation · Infants aged 4–6 months in Indonesia, Thailand, and Vietnam | 10 mg | 26 weeks | — |
| Effects of iron supplementation of LBW infants on cognition and behavior at 3 years 2013 · 1 mg/kg/day iron group · Marginally low-birth-weight infants (2000–2500 g), receiving supplementation from 6 weeks to 6 months of age | 1 mg/kg | — | — |
| Effects of iron supplementation of LBW infants on cognition and behavior at 3 years 2013 · 2 mg/kg/day iron group · Marginally low-birth-weight infants (2000–2500 g), receiving supplementation from 6 weeks to 6 months of age | 2 mg/kg | — | — |
| Effect of iron deficiency anemia in pregnancy on child mental development in rural China 2013 · multiple micronutrients · Pregnant women in rural western China | 30 mg | — | — |
| IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia 2013 · Ferrous sulfate p.o. · Anemic heart failure patients with preserved renal function, low transferrin saturation, and low-to-moderately elevated ferritin levels | 600 mg | 8 weeks | — |
| Effects of pre- and postnatal nutrition interventions on child growth and body composition: the MINIMat trial in rural Bangladesh 2013 · Fe30F · Pregnant women enrolled before 14 weeks’ gestation; age 14–50 years | 30 mg | — | — |
| Effects of pre- and postnatal nutrition interventions on child growth and body composition: the MINIMat trial in rural Bangladesh 2013 · MMS · Pregnant women enrolled before 14 weeks’ gestation; age 14–50 years | 30 mg | — | — |
| A randomized trial of intravenous and oral iron in chronic kidney disease 2015 · oral iron group · Adults aged 18 years or older with iron-deficiency anemia and moderate to severe chronic kidney disease not on dialysis | 975 mg | 8 weeks | — |
| Preconception Micronutrient Supplementation with Iron and Folic Acid Compared with Folic Acid Alone Affects Linear Growth and Fine Motor Development at 2 Years of Age: A Randomized Controlled Trial in Vietnam 2017 · IFA group · Women in Vietnam receiving preconception supplementation; age and health status not stated | 8.57 mg | — | — |
| Total dose iron dextran infusion versus oral iron for treating iron deficiency anemia in pregnant women: a randomized controlled trial 2019 · Group B (oral iron) · Pregnant women with iron-deficiency anemia and hemoglobin 7–10 g/dL | 180 mg | 4 weeks | — |
| Effects of iron supplementation of low-birth-weight infants on cognition and behavior at 7 years: a randomized controlled trial 2018 · 1 mg/kg/day iron group · Marginally low-birth-weight infants (2,000–2,500 g), enrolled at 6 weeks of age | 1 mg/kg | 137 days | — |
| Effects of iron supplementation of low-birth-weight infants on cognition and behavior at 7 years: a randomized controlled trial 2018 · 2 mg/kg/day iron group · Marginally low-birth-weight infants (2,000–2,500 g), enrolled at 6 weeks of age | 2 mg/kg | 137 days | — |
| Effects of antenatal micronutrient supplementation regimens on adolescent emotional and behavioral problems: A 14-year follow-up of a double-blind, cluster-randomized controlled trial 2023 · Multiple micronutrient (MMN) · Pregnant females in rural western China; age and health condition not reported | 30 mg | — | — |
| Prenatal and postnatal small-quantity lipid-based nutrient supplements and children's social-emotional difficulties at ages 9-11 y in Ghana: follow-up of a randomized controlled trial 2023 · multiple micronutrient (MMN) group · Pregnant women in Ghana; children were followed through infancy and assessed at ages 9–11 years | 20 mg | — | — |
| Prenatal iron supplementation adjusted to maternal iron stores reduces behavioural problems in 4-year-old children 2024 · Stratum 1, 80 mg/day iron group · Non-anaemic pregnant women with initial haemoglobin 110–130 g/L; dose was assigned before 12 gestational weeks and results were stratified by initial serum ferritin | 80 mg | — | — |
| Effect of Prenatal Iron Supplementation Adapted to Hemoglobin Levels in Early Pregnancy on Fetal and Neonatal Growth-ECLIPSES Study 2024 · Stratum 1: 80 mg/day iron group · Healthy non-anemic pregnant women aged over 18 years, with hemoglobin 110–130 g/L at early pregnancy | 80 mg | — | — |
| Low-Dose Prophylactic Oral Iron Supplementation (Ferrous Fumarate, Ferrous Bisglycinate, and Ferrous Sulphate) in Pregnancy Is Not Associated With Clinically Significant Gastrointestinal Complaints: Results From Two Randomized Studies 2024 · 60 mg ferrous fumarate group · Healthy ethnic Danish women over 18 with an uncomplicated singleton pregnancy | 60 mg | — | — |
| Low-Dose Prophylactic Oral Iron Supplementation (Ferrous Fumarate, Ferrous Bisglycinate, and Ferrous Sulphate) in Pregnancy Is Not Associated With Clinically Significant Gastrointestinal Complaints: Results From Two Randomized Studies 2024 · 80 mg ferrous fumarate group · Healthy ethnic Danish women over 18 with an uncomplicated singleton pregnancy | 80 mg | — | — |
| Adverse effect of iron supplementation on weight gain of iron-replete young children 1994 · ferrous sulphate group · Iron-sufficient children aged 12–18 months in Indonesia | 3 mg/kg | 120 days | — |
| Effects of iron repletion on VO2max, endurance, and blood lactate in women 1993 · iron supplement (IG) · Women aged 19–35 with low plasma ferritin (<20 ng/ml), who were active | 100 mg | 8 weeks | — |
| Functional consequences of iron supplementation in iron-deficient female cotton mill workers in Beijing, China 1994 · 60 mg Fe/d ferrous sulphate group · iron-deficient, nonpregnant female cotton mill workers | 60 mg | 12 weeks | — |
| Functional consequences of iron supplementation in iron-deficient female cotton mill workers in Beijing, China 1994 · 120 mg Fe/d ferrous sulphate group · iron-deficient, nonpregnant female cotton mill workers | 120 mg | 12 weeks | — |
| Iron supplementation improves appetite and growth in anemic Kenyan primary school children 1994 · iron supplementation · Anemic Kenyan primary school children | 150 mg | 14 weeks | — |
| Altered metabolic response of iron-depleted nonanemic women during a 15-km time trial 1998 · iron supplement · Women aged 19–36 with iron depletion without anemia | 135 mg | 8 weeks | — |
| Impact of iron fortification on anaemia and iron deficiency among pre-school children living in Rural Ghana 2021 · iron-MNP group · Children aged 6–35 months living in rural Ghana; children with severe anaemia, severe malnutrition, recent iron supplementation, or chronic disease were excluded. | 12.5 mg | 150 days | 967 |
| Effects of fortified milk on morbidity in young children in north India: community based, randomised, double masked placebo controlled trial 2007 · fortified milk · Children aged 1–3 years in a peri-urban settlement in north India | 9.6 mg | 1 year | 316 |
| Multivitamin and iron supplementation to prevent periconceptional anemia in rural tanzanian women: a randomized, controlled trial 2015 · Folic acid, iron, multivitamins · Non-pregnant women and adolescent girls aged 15–29 years in rural Tanzania | 30 mg | 26 weeks | 267 |
| Regular vitamin C supplementation during pregnancy reduces hospitalization: outcomes of a Ugandan rural cohort study 2010 · Vitamin C group · Pregnant women aged at least 18, enrolled at 4–12 gestational weeks in Uganda | 200 mg | — | 187 |
| Effect of supplementation with zinc and other micronutrients on malaria in Tanzanian children: a randomised trial 2011 · Multi-nutrients with Zinc · Children aged 6–60 months enrolled in a rural area of Tanzania; children with height-for-age z-scores above −1.5 SD were excluded. | 18 mg | 251 days | 151 |
| Cow's milk-based beverage consumption in 1- to 4-year-olds and allergic manifestations: an RCT 2016 · CMBB · Children aged 1 to 4 years attending daycare in Brazil; generally healthy, without a stated diagnosed condition | 9 mg | 28 weeks | 125 |
| Lower rate of preeclampsia after antioxidant supplementation in pregnant women with low antioxidant status 2006 · supplementation group · Pregnant women screened positive for low antioxidant status at 8 to 12 weeks of gestation | 30 mg | — | 29 |
| Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren 2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified | 18 mg | 335 days | — |
| Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal 2003 · Folic acid + iron + zinc · Pregnant women in rural Nepal | 60 mg | — | — |
| Randomized, double-blind, placebo-controlled trial of selenium supplements among HIV-infected pregnant women in Tanzania: effects on maternal and child outcomes 2008 · selenium group · Infants born to women with HIV in the selenium group; follow-up after birth | 200 mg | — | — |
| Effect of micronutrient supplementation on diarrhoeal disease among stunted children in rural South Africa 2009 · multiple micronutrients · children aged 6–24 months; three cohorts: HIV-infected children, HIV-uninfected children born to HIV-infected mothers, and HIV-uninfected children born to HIV-uninfected mothers | 10 mg | 548 days | — |
| Predictors of adherence to micronutrient supplementation before and during pregnancy in Vietnam 2017 · MM (multiple micronutrients) preconception group · Women of reproductive age in Vietnam intending to become pregnant | 8.57 mg | 54 weeks | 1,469 |
| Effects of therapeutic zinc supplementation for diarrhea and two preventive zinc supplementation regimens on the incidence and duration of diarrhea and acute respiratory tract infections in rural Laotian children: A randomized controlled trial 2020 · MNP group · Children aged 6–23 months in rural Laos | 6 mg | 40 weeks | 852 |
| Effects of antenatal multiple micronutrient supplementation on children's weight and size at 2 years of age in Nepal: follow-up of a double-blind randomised controlled trial 2008 · intervention group · Pregnant women enrolled at no earlier than 12 weeks’ gestation, with singleton pregnancies and gestation up to 20 completed weeks | 30 mg | — | 600 |
| Effect of antenatal multiple micronutrient supplementation on anthropometry and blood pressure in mid-childhood in Nepal: follow-up of a double-blind randomised controlled trial 2014 · intervention group (multiple micronutrient supplement) · Pregnant women attending antenatal care in Nepal; no specific age range or deficiency criterion stated | 30 mg | — | 600 |
| Assessing the adherence and acceptability to iron and folic acid compared with multiple micronutrient supplements during pregnancy: a cluster-randomized noninferiority trial in Cambodia 2025 · MMS-180 · Healthy pregnant individuals aged 18–45 years, in the first 14 weeks of a low-risk singleton pregnancy | 30 mg | 180 days | 516 |
| Assessing the adherence and acceptability to iron and folic acid compared with multiple micronutrient supplements during pregnancy: a cluster-randomized noninferiority trial in Cambodia 2025 · MMS-90 · Healthy pregnant individuals aged 18–45 years, in the first 14 weeks of a low-risk singleton pregnancy | 30 mg | 180 days | 515 |
| Adherence in a pragmatic randomized controlled trial on prophylactic iron supplementation during pregnancy in Maputo, Mozambique 2015 · routine Fe · Pregnant women aged 18 years or older with non-high-risk pregnancies, at least 12 weeks’ gestation, attending prenatal care in Maputo, Mozambique | 60 mg | — | 2,184 |
| Evaluation of multiple micronutrient supplementation and medium-quantity lipid-based nutrient supplementation in pregnancy on child development in rural Niger: A secondary analysis of a cluster randomized controlled trial 2022 · IFA (routine care) · Pregnant women under 30 weeks’ gestation at enrollment, without the specified chronic health conditions or pregnancy complications | 60 mg | — | 1,105 |
| Effect of a randomised exclusive breastfeeding counselling intervention nested into the MINIMat prenatal nutrition trial in Bangladesh 2017 · Fe60 · Pregnant women in rural Bangladesh, enrolled before 14 weeks of gestation | 60 mg | — | 958 |
| Prevalence of morbidity symptoms among pregnant and postpartum women receiving different nutrient supplements in Ghana and Malawi: A secondary outcome analysis of two randomised controlled trials 2023 · IFA supplement group · Pregnant women aged 18 years or older in Ghana and pregnant women aged 15 years or older in Malawi; supplementation began by 20 weeks of pregnancy, with follow-up through lactation | 60 mg | — | 904 |
| Iron supplementation given to nonanemic infants: neurocognitive functioning at 16 years 2023 · Iron-supplemented group (iron-fortified formula or, for primarily breastfed infants, liquid multivitamin preparation) · Nonanemic Chilean infants randomized at 6 months; term births with no stated diagnosed condition | 15 mg | 183 days | 656 |
| Effects of antenatal multiple micronutrient supplementation on children's weight and size at 2 years of age in Nepal: follow-up of a double-blind randomised controlled trial 2008 · control group · Pregnant women enrolled at no earlier than 12 weeks’ gestation, with singleton pregnancies and gestation up to 20 completed weeks | 60 mg | — | 600 |
| Assessing the adherence and acceptability to iron and folic acid compared with multiple micronutrient supplements during pregnancy: a cluster-randomized noninferiority trial in Cambodia 2025 · IFA-90 · Healthy pregnant individuals aged 18–45 years, in the first 14 weeks of a low-risk singleton pregnancy | 60 mg | 90 days | 515 |
| The effect of blister packaging Iron and Folate on adherence to medication and hemoglobin levels among pregnant women at National Referral Hospital antenatal clinics in a low to middle income country: a Randomised Controlled Trial (The IFAd Trial) 2022 · IFA in blister packaging · Pregnant women in their second trimester up to 28 weeks, aged 15–43 years, eligible for iron and folic acid supplementation | 60 mg | 8 weeks | 478 |
| The effect of blister packaging Iron and Folate on adherence to medication and hemoglobin levels among pregnant women at National Referral Hospital antenatal clinics in a low to middle income country: a Randomised Controlled Trial (The IFAd Trial) 2022 · IFA in loose packaging · Pregnant women in their second trimester up to 28 weeks, aged 15–43 years, eligible for iron and folic acid supplementation | 60 mg | 8 weeks | 474 |
| Small-quantity, lipid-based nutrient supplements provided to women during pregnancy and 6 mo postpartum and to their infants from 6 mo of age increase the mean attained length of 18-mo-old children in semi-urban Ghana: a randomized controlled trial 2016 · IFA · Pregnant women aged 18 years or older enrolled at up to 20 weeks of gestation; their infants received no supplement | 60 mg | — | 441 |
| Maternal Supplementation with Small-Quantity Lipid-Based Nutrient Supplements Compared with Multiple Micronutrients, but Not with Iron and Folic Acid, Reduces the Prevalence of Low Gestational Weight Gain in Semi-Urban Ghana: A Randomized Controlled Trial 2017 · IFA group · Pregnant women aged 18 years or older, enrolled at 20 weeks’ gestation or earlier; semi-urban Ghana | 60 mg | — | 441 |
| Prenatal and postnatal lipid-based nutrient supplementation and cognitive, social-emotional, and motor function in preschool-aged children in Ghana: a follow-up of a randomized controlled trial 2019 · iron and folic acid (IFA) group · Pregnant women aged 18 years or older, enrolled at up to 20 weeks of gestation | 60 mg | — | 441 |
| Supplementation with Small-Quantity Lipid-Based Nutrient Supplements Does Not Increase Child Morbidity in a Semiurban Setting in Ghana: A Secondary Outcome Noninferiority Analysis of the International Lipid-Based Nutrient Supplements (iLiNS)-DYAD Randomized Controlled Trial 2020 · IFA group · Pregnant women aged 18 years or older, enrolled by 20 weeks’ gestation; offspring received no supplement | 60 mg | — | 441 |
| Effect of prenatal micronutrient-fortified balanced energy-protein supplementation on maternal and newborn body composition: A sub-study from the MISAME-III randomized controlled efficacy trial in rural Burkina Faso 2023 · Intervention · Pregnant women aged 15–40 years, enrolled before 21 completed weeks of gestation; maternal and newborn body composition were assessed postpartum | 65 mg | — | 440 |
| Sustained effects of small-quantity lipid-based nutrient supplements provided during the first 1000 days on child growth at 9-11 y in a randomized controlled trial in Ghana 2024 · daily IFA tablets · Pregnant females aged 18 years or older enrolled at up to 20 weeks of gestation; their children received no infant supplementation | 60 mg | — | 440 |
| Associations of maternal nutrition during pregnancy and post-partum with maternal cognition and caregiving 2018 · IFA · Pregnant women enrolled at ≤20 weeks’ gestation in Malawi, followed through 6 months postpartum | 60 mg | 1 year | 238 |
| Association of prenatal lipid-based nutritional supplementation with fetal growth in rural Gambia 2017 · MMN · Pregnant women aged 18–45 years in rural Gambia, enrolled at 10–20 weeks’ gestation | 60 mg | — | 164 |
| Association of prenatal lipid-based nutritional supplementation with fetal growth in rural Gambia 2017 · PE · Pregnant women aged 18–45 years in rural Gambia, enrolled at 10–20 weeks’ gestation | 60 mg | — | 151 |
| Association of prenatal lipid-based nutritional supplementation with fetal growth in rural Gambia 2017 · FeFol · Pregnant women aged 18–45 years in rural Gambia, enrolled at 10–20 weeks’ gestation | 60 mg | — | 146 |
| Improved gastrointestinal tolerance and iron status via probiotic use in iron deficiency anaemia patients initiating oral iron replacement: a randomised controlled trial 2024 · IRT-Pro group · Adults over 18 with newly diagnosed iron deficiency anaemia; 97.8% female | 100 mg | 30 days | 138 |
| Effect of Picture-based health education and counselling on knowledge and adherence to preconception Iron-folic acid supplementation among women planning to be pregnant in Eastern Ethiopia: a randomized controlled trial 2022 · Intervention group · Women aged 18–45 planning pregnancy after stopping contraception or following spontaneous abortion | 60 mg | 90 days | 122 |
| Prenatal and preschool micronutrient supplementation and behavioral outcomes in school-aged children in Nepal-a cohort study 2025 · Maternal iron/folic acid · Pregnant women; their children were assessed at ages 7–9 years | 60 mg | — | 101 |
| Effect of iron content on the tolerability of prenatal multivitamins in pregnancy 2008 · 35 mg group (PregVit) · Pregnant women who had not started or had discontinued a multivitamin because of adverse events, enrolled before 20 weeks gestation | 35 mg | — | 92 |
| Effect of iron content on the tolerability of prenatal multivitamins in pregnancy 2008 · 60 mg group (Orifer F) · Pregnant women who had not started or had discontinued a multivitamin because of adverse events, enrolled before 20 weeks gestation | 60 mg | — | 75 |
| Daily consumption of ready-to-use peanut-based therapeutic food increased fat free mass, improved anemic status but has no impact on the zinc status of people living with HIV/AIDS: a randomized controlled trial 2016 · RUTF group · Adult men and women with HIV/AIDS hospitalized in Senegal, with malnutrition common in the study population | 600 mcg | 90 days | 32 |
| Management of iron deficiency in women of childbearing age with oral iron intolerance: a prospective, randomised, controlled trial of three doses of an iron-whey-protein formulation : Prospective RandomisEd study of women of Childbearing age with gastroInteStinal Intolerance to Oral iroN (PRECISION) 2024 · Standard dose group (IWP 25 mg) · Non-pregnant women aged 18–55 with low ferritin and self-reported intolerance to oral iron; stratified by anaemia status | 25 mg | 12 weeks | 21 |
| Management of iron deficiency in women of childbearing age with oral iron intolerance: a prospective, randomised, controlled trial of three doses of an iron-whey-protein formulation : Prospective RandomisEd study of women of Childbearing age with gastroInteStinal Intolerance to Oral iroN (PRECISION) 2024 · High dose group (IWP 50 mg) · Non-pregnant women aged 18–55 with low ferritin and self-reported intolerance to oral iron; stratified by anaemia status | 50 mg | 12 weeks | 20 |
| Management of iron deficiency in women of childbearing age with oral iron intolerance: a prospective, randomised, controlled trial of three doses of an iron-whey-protein formulation : Prospective RandomisEd study of women of Childbearing age with gastroInteStinal Intolerance to Oral iroN (PRECISION) 2024 · Low dose group (IWP 14 mg) · Non-pregnant women aged 18–55 with low ferritin and self-reported intolerance to oral iron; stratified by anaemia status | 14 mg | 12 weeks | 18 |
| Vitamin A and iron supplementation is as efficient as hormonal therapy in constitutionally delayed children 2004 · nutritional programme · Boys aged 13.6–15.5 years referred for short stature and delayed puberty, with subnormal vitamin A intake | 12 mg | 26 weeks | 17 |
| Integrating Calcium Into Antenatal Iron-Folic Acid Supplementation in Ethiopia: Women's Experiences, Perceptions of Acceptability, and Strategies to Support Calcium Supplement Adherence 2020 · 3-event regimen · Healthy pregnant women aged 16 years or older, 12–28 weeks’ gestation, in rural Ethiopia | 65 mg | 6 weeks | 17 |
| Integrating Calcium Into Antenatal Iron-Folic Acid Supplementation in Ethiopia: Women's Experiences, Perceptions of Acceptability, and Strategies to Support Calcium Supplement Adherence 2020 · 2-event regimen · Healthy pregnant women aged 16 years or older, 12–28 weeks’ gestation, in rural Ethiopia | 65 mg | 6 weeks | 16 |
| Vitamin A and iron supplementation is as efficient as hormonal therapy in constitutionally delayed children 2004 · oxandrolone and nutritional programme · Boys aged 13.6–15.5 years referred for short stature and delayed puberty, with subnormal vitamin A intake | 12 mg | 26 weeks | 15 |
| Integrating Calcium Into Antenatal Iron-Folic Acid Supplementation in Ethiopia: Women's Experiences, Perceptions of Acceptability, and Strategies to Support Calcium Supplement Adherence 2020 · 4-event regimen · Healthy pregnant women aged 16 years or older, 12–28 weeks’ gestation, in rural Ethiopia | 65 mg | 6 weeks | 15 |
| Effects of 5-aminolevulinic acid with iron supplementation on respiratory responses to graded cycling and interval walking training achievement in older women over 75 yrs 2021 · ALA+SFC · Women aged over 75 years (mean age approximately 78) with no exercise habits | 115 mg | 7 days | 15 |
| Iron and zinc supplementation promote motor development and exploratory behavior among Bangladeshi infants 2004 · iron+zinc · Infants from rural Bangladesh, 6–12 months old, at risk of micronutrient deficiencies | 2.86 mg | 26 weeks | — |
| Maternal iron deficiency anemia affects postpartum emotions and cognition 2005 · daily iron · Young postpartum mothers with iron-deficiency anemia; age range not stated | 125 mg | 26 weeks | — |
| Mother-infant interactions and infant development are altered by maternal iron deficiency anemia 2005 · daily iron treatment · Anemic mothers of full-term, normal-birth-weight infants; maternal age not stated | 125 mg | — | — |
| Combined iron and folic acid supplementation with or without zinc reduces time to walking unassisted among Zanzibari infants 5- to 11-mo old 2006 · iron+folic acid (FeFA) · Children aged 5–11 months at the start of supplementation, nutritionally at risk, in Pemba, Zanzibar | 12.5 mg | 1 year | — |
| Combined iron and folic acid supplementation with or without zinc reduces time to walking unassisted among Zanzibari infants 5- to 11-mo old 2006 · iron+folic acid+zinc (FeFA+Zn) · Children aged 5–11 months at the start of supplementation, nutritionally at risk, in Pemba, Zanzibar | 12.5 mg | 1 year | — |
| Zinc-iron, but not zinc-alone supplementation, increased linear growth of stunted infants with low haemoglobin 2007 · zinc+iron+vitamin-A · Infants aged 3–6 months in rural East Lombok; the study included infants with stunting and low haemoglobin | 10 mg | 26 weeks | — |
| Supplementation with iron and riboflavin enhances dark adaptation response to vitamin A-fortified rice in iron-deficient, pregnant, nightblind Nepali women 2007 · FeR + VA · Pregnant Nepali women with nightblindness; the reported pupillary-threshold subgroup was iron-deficient at baseline | 30 mg | 6 weeks | — |
| The effects of iron and/or zinc supplementation on maternal reports of sleep in infants from Nepal and Zanzibar 2009 · iron–folic acid · Infants aged 4–18 months in Pemba Island, Zanzibar, or Sarlahi District, Nepal | 12.5 mg | 1 year | — |
| The effects of iron and/or zinc supplementation on maternal reports of sleep in infants from Nepal and Zanzibar 2009 · iron–folic acid and zinc · Infants aged 4–18 months in Pemba Island, Zanzibar, or Sarlahi District, Nepal | 12.5 mg | 1 year | — |
| Physical work capacity of young underprivileged school girls impact of daily vs intermittent iron folic acid supplementation: a randomized controlled trial 2009 · daily IFA group · Schoolgirls aged 9–13 years from underprivileged communities | 100 mg | 1 year | — |
| Maternal zinc supplementation reduces diarrheal morbidity in peruvian infants 2010 · zinc · Pregnant women in a periurban slum of Lima, Peru | 60 mg | — | — |
| Daily supplementation with iron plus folic acid, zinc, and their combination is not associated with younger age at first walking unassisted in malnourished preschool children from a deficient population in rural Nepal 2010 · iron+folic acid · Malnourished children aged 1–36 months in a deficient population in rural Nepal | 12.5 mg | — | — |
| Daily supplementation with iron plus folic acid, zinc, and their combination is not associated with younger age at first walking unassisted in malnourished preschool children from a deficient population in rural Nepal 2010 · zinc+iron+folic acid · Malnourished children aged 1–36 months in a deficient population in rural Nepal | 12.5 mg | — | — |
| "Functional food" for acceleration of growth in short children born small for gestational age 2010 · nutritional program (NUT) · Children aged 6.4 ± 1.8 years, born small for gestational age, short stature and subnormal nutrient intake | 10 mg | 26 weeks | — |
| Effect of iron deficiency anemia in pregnancy on child mental development in rural China 2013 · iron/folic acid · Pregnant women in rural western China | 60 mg | — | — |
| Developmental effects of micronutrient supplementation and malaria in Zanzibari children 2013 · FeFA alone · Zanzibari children aged 5–14 months at baseline | 12.5 mg | — | — |
| Developmental effects of micronutrient supplementation and malaria in Zanzibari children 2013 · FeFA with zinc · Zanzibari children aged 5–14 months at baseline | 12.5 mg | — | — |
| Effects of pre- and postnatal nutrition interventions on child growth and body composition: the MINIMat trial in rural Bangladesh 2013 · Fe60F · Pregnant women enrolled before 14 weeks’ gestation; age 14–50 years | 60 mg | — | — |
| Zinc supplementation sustained normative neurodevelopment in a randomized, controlled trial of Peruvian infants aged 6-18 months 2014 · zinc, iron, and copper supplement · Infants aged 6–18 months | 10 mg | 1 year | — |
| Zinc supplementation sustained normative neurodevelopment in a randomized, controlled trial of Peruvian infants aged 6-18 months 2014 · iron and copper supplement · Infants aged 6–18 months | 10 mg | 1 year | — |
| Effects of antenatal micronutrient supplementation regimens on adolescent emotional and behavioral problems: A 14-year follow-up of a double-blind, cluster-randomized controlled trial 2023 · Iron-folic acid (IFA) · Pregnant females in rural western China; age and health condition not reported | 60 mg | — | — |
| Fortified balanced energy-protein supplementation during pregnancy and lactation and infant growth in rural Burkina Faso: A 2 × 2 factorial individually randomized controlled trial 2023 · Prenatal BEP and IFA supplementation · Pregnant women aged 15–40 years in rural Burkina Faso | 65 mg | — | — |
| Fortified balanced energy-protein supplementation during pregnancy and lactation and infant growth in rural Burkina Faso: A 2 × 2 factorial individually randomized controlled trial 2023 · Postnatal BEP and IFA supplementation · Women in rural Burkina Faso who had given birth; maternal ages 15–40 years at enrollment | 65 mg | 26 weeks | — |
| Fortified balanced energy-protein supplementation during pregnancy and lactation and infant growth in rural Burkina Faso: A 2 × 2 factorial individually randomized controlled trial 2023 · Prenatal and postnatal BEP and IFA supplementation · Pregnant women aged 15–40 years in rural Burkina Faso who continued into lactation | 65 mg | — | — |
| Prenatal and postnatal small-quantity lipid-based nutrient supplements and children's social-emotional difficulties at ages 9-11 y in Ghana: follow-up of a randomized controlled trial 2023 · iron and folic acid (IFA) group · Pregnant women in Ghana; children were followed through infancy and assessed at ages 9–11 years | 60 mg | — | — |
| Effect of Early-Life Lipid-Based Nutrient Supplement and Home Environment on Autonomic Nervous System Regulation at 9-11 Years: A Follow-Up of a Randomized Controlled Trial 2025 · Iron and folic acid (IFA) group · Pregnant women; their offspring received no supplementation | 60 mg | — | — |
| Biochemical indices and neuromuscular function tests in rural Gambian schoolchildren given a riboflavin, or multivitamin plus iron, supplement 1994 · multivitamin plus iron group · Rural Gambian children aged 8–14 years, preselected for the study; endemic riboflavin deficiency was reported | 28.6 mg | 1 year | — |
| Long-term oral supplementation with iron is not harmful for young children in a poor community of Bangladesh 1997 · Treatment group · Children aged 2–48 months living in a poor community of Bangladesh | 15 mg | 450 days | — |
| Adding zinc to prenatal iron and folate tablets improves fetal neurobehavioral development 1999 · iron and folate without zinc · Pregnant women in a Peruvian population; gestational age not otherwise specified | 60 mg | — | — |
| Adding zinc to prenatal iron and folate tablets improves fetal neurobehavioral development 1999 · iron, folate, and zinc · Pregnant women in a Peruvian population; gestational age not otherwise specified | 60 mg | — | — |
| Maternal Blood Pressure in Relation to Prenatal Lipid-Based Nutrient Supplementation and Adverse Birth Outcomes in a Ghanaian Cohort: A Randomized Controlled Trial and Cohort Analysis 2021 · MMN group · Pregnant Ghanaian women aged 18 years or older, enrolled by 20 weeks of gestation | 20 mg | — | 354 |
| Maternal Blood Pressure in Relation to Prenatal Lipid-Based Nutrient Supplementation and Adverse Birth Outcomes in a Ghanaian Cohort: A Randomized Controlled Trial and Cohort Analysis 2021 · LNS group · Pregnant Ghanaian women aged 18 years or older, enrolled by 20 weeks of gestation | 20 mg | — | 354 |
| Lower systolic blood pressure at age 7 y in low-birth-weight children who received iron supplements in infancy: results from a randomized controlled trial 2017 · 2 mg Fe · kg -1 · d -1 · Marginally low-birth-weight infants weighing 2000–2500 g; sex not specified | 2 mg/kg | 138 days | 65 |
| Lower systolic blood pressure at age 7 y in low-birth-weight children who received iron supplements in infancy: results from a randomized controlled trial 2017 · 1 mg Fe · kg -1 · d -1 · Marginally low-birth-weight infants weighing 2000–2500 g; sex not specified | 1 mg/kg | 138 days | 54 |
| Combined food and micronutrient supplements during pregnancy have limited impact on child blood pressure and kidney function in rural Bangladesh 2013 · Fe30F · Pregnant women in rural Bangladesh; age range not specified | 30 mg | — | — |
| Combined food and micronutrient supplements during pregnancy have limited impact on child blood pressure and kidney function in rural Bangladesh 2013 · MMS · Pregnant women in rural Bangladesh; age range not specified | 30 mg | — | — |
| The Effect of Iron Fortification on Iron (Fe) Status and Inflammation: A Randomized Controlled Trial 2016 · Meat group (MG) · Healthy infants and young children; enrolled at 3–5 months and given the intervention from 6 to 18 months of age | 1 mg | 1 year | 511 |
| The Effect of Iron Fortification on Iron (Fe) Status and Inflammation: A Randomized Controlled Trial 2016 · Fortified cereal group (FG) · Healthy infants and young children; enrolled at 3–5 months and given the intervention from 6 to 18 months of age | 1.1 mg | 1 year | 465 |
| Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial 2003 · iron-supplemented group · Pregnant women; age and other health conditions not specified | 20 mg | — | 215 |
| Ferritin-guided iron supplementation as an alternative or complement to prolonged blood donation intervals (FORTE): a double-blind, randomised, controlled trial 2025 · 30 mg alternate day group · Blood donors aged 18–80 years with ferritin levels ≤30 μg/L | 15 mg | 8 weeks | 112 |
| Weekly iron-folic acid supplements containing 2.8 mg folic acid are associated with a lower risk of neural tube defects than the current practice of 0.4 mg: a randomised controlled trial in Malaysia 2020 · 0 mg folic acid group · Women aged 18–45 years, predominantly 18–21, non-pregnant and not planning pregnancy | 8.57 mg | 16 weeks | 110 |
| Iron prophylaxis during pregnancy -- how much iron is needed? A randomized dose- response study of 20-80 mg ferrous iron daily in pregnant women 2005 · 20 mg group · Healthy pregnant women, from 18 weeks of gestation | 20 mg | — | 105 |
| Effect of daily versus once-weekly home fortification with micronutrient Sprinkles on hemoglobin and iron status among young children in rural Bangladesh 2007 · Sprinkles daily · Children aged 12–24 months with mild to moderate anemia | 12.5 mg | 8 weeks | 79 |
| Body iron and individual iron prophylaxis in pregnancy--should the iron dose be adjusted according to serum ferritin? 2006 · 20 mg group · Healthy pregnant women; age and sex beyond pregnancy not specified | 20 mg | — | 74 |
| Effect of daily versus once-weekly home fortification with micronutrient Sprinkles on hemoglobin and iron status among young children in rural Bangladesh 2007 · Sprinkles once weekly · Children aged 12–24 months with mild to moderate anemia | 4.29 mg | 8 weeks | 73 |
| Multiple micronutrient supplements improve micronutrient status and anemia but not growth and morbidity of Indonesian infants: a randomized, double-blind, placebo-controlled trial 2005 · Group 3 (DI) · Indonesian infants aged 6–12 months | 10 mg | 23 weeks | 69 |
| Efficacy of iron-supplement bars to reduce anemia in urban Indian women: a cluster-randomized controlled trial 2017 · intervention · Nonpregnant women aged 18–35 with anemia | 14 mg | 90 days | 65 |
| Efficacy of a microencapsulated iron pyrophosphate-fortified fruit juice: a randomised, double-blind, placebo-controlled study in Spanish iron-deficient women 2011 · F group · Menstruating iron-deficient women; ages not stated | 18 mg | 16 weeks | 64 |
| Changes in blood pressure and lipid levels in young women consuming a vitamin D-fortified skimmed milk: a randomised controlled trial 2013 · D-placebo · Women aged 18–35 with low iron stores; healthy, non-pregnant, and non-breast-feeding | 15 mg | 16 weeks | 54 |
| Early iron supplementation in exclusively breastfed Gambian infants: a randomized controlled trial 2024 · iron supplementation group · Exclusively breastfed, generally healthy Gambian infants aged 6 to 10 weeks | 7.5 mg | 14 weeks | 50 |
| Gold kiwifruit consumed with an iron-fortified breakfast cereal meal improves iron status in women with low iron stores: a 16-week randomised controlled trial 2011 · Banana group · Women aged 18–44 with low iron stores | 16 mg | 16 weeks | 36 |
| Gold kiwifruit consumed with an iron-fortified breakfast cereal meal improves iron status in women with low iron stores: a 16-week randomised controlled trial 2011 · Gold kiwifruit group · Women aged 18–44 with low iron stores | 16 mg | 16 weeks | 33 |
| Iron supplementation in pregnancy: is less enough? A randomized, placebo controlled trial of low dose iron supplementation with and without heme iron 1997 · Hemofer (heme and non-heme iron) · Pregnant women in the second half of pregnancy | 27 mg | — | 31 |
| Changes in Iron Status Are Related to Changes in Brain Activity and Behavior in Rwandan Female University Students: Results from a Randomized Controlled Efficacy Trial Involving Iron-Biofortified Beans 2019 · biofortified bean (BFB) group · women aged 18–27 attending the University of Rwanda, selected for low serum ferritin; some had iron deficiency or iron-deficiency anemia | 5.9 mg | 128 days | 27 |
| High Bioavailability from Ferric Pyrophosphate-Fortified Bouillon Cubes in Meals is Not Increased by Sodium Pyrophosphate: a Stable Iron Isotope Study in Young Nigerian Women 2019 · 0:1 NaPP:57Fe ratio · Women aged 18–35 with low iron status, recruited in Nigeria | 5.04 mg | 5 days | 23 |
| Iron bioavailability of a casein-based iron fortificant compared with that of ferrous sulfate in whole milk: a randomized trial with a crossover design in adult women 2019 · ferrous sulfate · Healthy, nonanemic women aged 19–40 with normal iron status | 5 mg | 1 day | 21 |
| Iron absorption from a breakfast cereal: effects of EDTA compounds and ascorbic acid 2001 · Hydrogen reduced iron · Non-anaemic female volunteers | 3.75 mg | 2 days | 20 |
| Iron absorption from a breakfast cereal: effects of EDTA compounds and ascorbic acid 2001 · Hydrogen reduced iron plus Na2EDTA (EDTA:Fe 1:2) · Non-anaemic female volunteers | 3.75 mg | 2 days | 20 |
| Iron absorption from a breakfast cereal: effects of EDTA compounds and ascorbic acid 2001 · Hydrogen reduced iron plus NaFe(III)EDTA (EDTA:total Fe 1:3) · Non-anaemic female volunteers | 3.75 mg | 2 days | 20 |
| Iron absorption from a breakfast cereal: effects of EDTA compounds and ascorbic acid 2001 · Hydrogen reduced iron plus NaFe(III)EDTA (EDTA:total Fe 1:2) · Non-anaemic female volunteers | 3.75 mg | 2 days | 20 |
| Cofortification of ferric pyrophosphate and citric acid/trisodium citrate into extruded rice grains doubles iron bioavailability through in situ generation of soluble ferric pyrophosphate citrate complexes 2016 · extruded FePP-fortified rice (No CA/TSC) · Iron-sufficient young women | 4 mg | 1 day | 20 |
| Cofortification of ferric pyrophosphate and citric acid/trisodium citrate into extruded rice grains doubles iron bioavailability through in situ generation of soluble ferric pyrophosphate citrate complexes 2016 · FeSO4 reference meal · Iron-sufficient young women | 4 mg | 1 day | 20 |
| Effects of different regimens of iron prophylaxis on maternal iron status and pregnancy outcome: a randomized control trial 2017 · liposomal iron 28 mg/daily (LI28) · pregnant women recruited at 11–13 weeks with a normal singleton pregnancy and no anemia | 28 mg | — | 20 |
| Iron Bioavailability from Ferrous Ammonium Phosphate, Ferrous Sulfate, and Ferric Pyrophosphate in an Instant Milk Drink-A Stable Isotope Study in Children 2022 · Arm 1: FeSO4 treatment · Apparently healthy children aged 3–6 years with normal BMI for age and no anemia or iron deficiency | 2 mg | 4 days | 20 |
| Iron Bioavailability from Ferrous Ammonium Phosphate, Ferrous Sulfate, and Ferric Pyrophosphate in an Instant Milk Drink-A Stable Isotope Study in Children 2022 · Arm 1: FAP treatment · Apparently healthy children aged 3–6 years with normal BMI for age and no anemia or iron deficiency | 2 mg | 4 days | 20 |
| Iron Bioavailability from Ferrous Ammonium Phosphate, Ferrous Sulfate, and Ferric Pyrophosphate in an Instant Milk Drink-A Stable Isotope Study in Children 2022 · Arm 2: FeSO4 treatment · Apparently healthy children aged 3–6 years with normal BMI for age and no anemia or iron deficiency | 2 mg | 4 days | 20 |
| Iron Bioavailability from Ferrous Ammonium Phosphate, Ferrous Sulfate, and Ferric Pyrophosphate in an Instant Milk Drink-A Stable Isotope Study in Children 2022 · Arm 2: FePP treatment · Apparently healthy children aged 3–6 years with normal BMI for age and no anemia or iron deficiency | 2 mg | 4 days | 20 |
| Effects of low-dose iron supplementation in women with low serum ferritin concentration 1994 · FE-27 group · Premenopausal, non-pregnant women with low serum ferritin and haemoglobin concentration at least 120 g/L | 27 mg | 26 weeks | 19 |
| Effects of low-dose iron supplementation in women with low serum ferritin concentration 1994 · FE-9 group · Premenopausal, non-pregnant women with low serum ferritin and haemoglobin concentration at least 120 g/L | 9 mg | 26 weeks | 18 |
| A short-term intervention of ingesting iron along with methionine and threonine leads to a higher hemoglobin level than that with iron alone in young healthy women: a randomized, double-blind, parallel-group, comparative study 2023 · FE group · Healthy women aged 20–39 years, without a stated diagnosis of iron deficiency anemia | 6 mg | 6 weeks | 15 |
| Alginate inhibits iron absorption from ferrous gluconate in a randomized controlled trial and reduces iron uptake into Caco-2 cells 2014 · Test meal 2 (Fe) · Young adults with ferritin 15–60 µg/L, predominantly women aged 19–27 years; one male aged 49 years | 21 mg | 1 day | 13 |
| Energy deficit increases hepcidin and exacerbates declines in dietary iron absorption following strenuous physical activity: a randomized-controlled cross-over trial 2021 · Energy matched (BAL) · Healthy iron-sufficient men, mean age 22.4 years | 3.8 mg | 1 day | 10 |
| Energy deficit increases hepcidin and exacerbates declines in dietary iron absorption following strenuous physical activity: a randomized-controlled cross-over trial 2021 · Energy deficit (DEF) · Healthy iron-sufficient men, mean age 22.4 years | 3.8 mg | 1 day | 10 |
| A double stable isotope technique for measuring iron absorption in infants 1994 · iron-labelled formula test meals (57Fe and 58Fe) · healthy infants aged 13–25 weeks | 2.5 mg | 4 days | 9 |
| Iron and zinc supplementation improves indicators of vitamin A status of Mexican preschoolers 2000 · iron · Rural Mexican children aged 18–36 months | 20 mg | 26 weeks | — |
| Redistribution of vitamin A after iron supplementation in Indonesian infants 2003 · 10 mg Fe · Indonesian infants aged 4 months | 10 mg | 26 weeks | — |
| A community-based randomized controlled trial of iron and zinc supplementation in Indonesian infants: interactions between iron and zinc 2003 · Fe group · Indonesian infants aged 6–12 months | 10 mg | 26 weeks | — |
| Iron status in exercising women: the effect of oral iron therapy vs increased consumption of muscle foods 1992 · 10 FE + EX · Previously sedentary women participating in a 12-week moderate aerobic-exercise program | 10 mg | 12 weeks | — |
| Effectiveness of nutrition education, iron supplementation or both on iron status in children 2003 · Group 2, supplementation · Children aged 9–36 months in an urban slum in Delhi | 2.86 mg | 8 weeks | — |
| Effectiveness of nutrition education, iron supplementation or both on iron status in children 2003 · Group 3, nutrition education with supplementation · Children aged 9–36 months in an urban slum in Delhi | 2.86 mg | 8 weeks | — |
| Low dose daily iron supplementation improves iron status and appetite but not anemia, whereas quarterly anthelminthic treatment improves growth, appetite and anemia in Zanzibari preschool children 2004 · iron alone · Children aged 6–71 months with baseline hemoglobin >70 g/L in Zanzibar | 10 mg | 1 year | — |
| Low dose daily iron supplementation improves iron status and appetite but not anemia, whereas quarterly anthelminthic treatment improves growth, appetite and anemia in Zanzibari preschool children 2004 · iron plus mebendazole · Children aged 6–71 months with baseline hemoglobin >70 g/L in Zanzibar | 10 mg | 1 year | — |
| Daily doses of 20 mg of elemental iron compensate for iron loss in regular blood donors: a randomized, double-blind, placebo-controlled study 2004 · 20 mg/day iron group · Regular male and female blood donors; sex-specific donation schedules are reported, but ages are not stated. | 20 mg | 26 weeks | — |
| Are we giving too much iron? Low-dose iron therapy is effective in octogenarians 2005 · 15 mg iron nonanemic control group · Adults over 80 years without anemia | 15 mg | 60 days | — |
| Efficacy of combined iron and zinc supplementation on micronutrient status and growth in Vietnamese infants 2006 · Fe-group · Breast-fed infants aged 4–7 months in rural Vietnam | 10 mg | 26 weeks | — |
| Iron-biofortified rice improves the iron stores of nonanemic Filipino women 2005 · high-iron rice · Women religious sisters living in convents in Metro Manila, Philippines; nonanemic subgroup results were reported | 1.79 mg | 274 days | — |
| Comparison of the efficacy of wheat-based snacks fortified with ferrous sulfate, electrolytic iron, or hydrogen-reduced elemental iron: randomized, double-blind, controlled trial in Thai women 2005 · Ferrous sulfate · Women aged 18–50 with low iron stores | 12 mg | 35 weeks | — |
| Comparison of the efficacy of wheat-based snacks fortified with ferrous sulfate, electrolytic iron, or hydrogen-reduced elemental iron: randomized, double-blind, controlled trial in Thai women 2005 · Electrolytic iron · Women aged 18–50 with low iron stores | 12 mg | 35 weeks | — |
| Comparison of the efficacy of wheat-based snacks fortified with ferrous sulfate, electrolytic iron, or hydrogen-reduced elemental iron: randomized, double-blind, controlled trial in Thai women 2005 · Hydrogen-reduced iron · Women aged 18–50 with low iron stores | 12 mg | 35 weeks | — |
| The efficacy of ferrous bisglycinate and electrolytic iron as fortificants in bread in iron-deficient school children 2006 · bread with electrolytic Fe as fortificant · Children aged 6–11 years with serum ferritin <20 microg/l | 3.66 mg | 137 days | — |
| The efficacy of ferrous bisglycinate and electrolytic iron as fortificants in bread in iron-deficient school children 2006 · bread with ferrous bisglycinate as fortificant · Children aged 6–11 years with serum ferritin <20 microg/l | 3.66 mg | 137 days | — |
| Extruded rice fortified with micronized ground ferric pyrophosphate reduces iron deficiency in Indian schoolchildren: a double-blind randomized controlled trial 2006 · iron group · Iron-depleted children aged 6–13 years in Bangalore, India | 20 mg | 213 days | — |
| Levels of serum transferrin receptor and its response to Fe-supplement in Fe-deficient children 2006 · Fe store depletion (IDs) group · Children aged 6–14 years with Fe store depletion | 8.57 mg | 9 weeks | — |
| Levels of serum transferrin receptor and its response to Fe-supplement in Fe-deficient children 2006 · Fe deficiency erythropoiesis (IDE) group · Children aged 6–14 years with Fe deficiency erythropoiesis | 8.57 mg | 9 weeks | — |
| Improved iron bioavailability in an oat-based beverage: the combined effect of citric acid addition, dephytinization and iron supplementation 2007 · Product A · Healthy men and women; the beverage was developed for children aged 1–3 years, but the study participants were healthy adults | 1.3 mg | 4 days | — |
| Improved iron bioavailability in an oat-based beverage: the combined effect of citric acid addition, dephytinization and iron supplementation 2007 · Product B · Healthy men and women; the beverage was developed for children aged 1–3 years, but the study participants were healthy adults | 1.3 mg | 4 days | — |
| Improved iron bioavailability in an oat-based beverage: the combined effect of citric acid addition, dephytinization and iron supplementation 2007 · Product C · Healthy men and women; the beverage was developed for children aged 1–3 years, but the study participants were healthy adults | 1.3 mg | 4 days | — |
| Improved iron bioavailability in an oat-based beverage: the combined effect of citric acid addition, dephytinization and iron supplementation 2007 · Product D · Healthy men and women; the beverage was developed for children aged 1–3 years, but the study participants were healthy adults | 1.3 mg | 4 days | — |
| Electrolytic iron or ferrous sulfate increase body iron in women with moderate to low iron stores 2007 · heme iron · Women with moderate to low iron stores | 5 mg | 12 weeks | — |
| Should we lower the dose of iron when treating anaemia in pregnancy? A randomized dose-response trial 2009 · 20 mg iron group · Pregnant women in mid-pregnancy with anaemia (haemoglobin <110 g/L) | 20 mg | 8 weeks | — |
| Effect of daily or weekly multiple-micronutrient and iron foodlike tablets on body iron stores of Indonesian infants aged 6-12 mo: a double-blind, randomized, placebo-controlled trial 2007 · Daily multiple-micronutrient (DMM) foodlike tablets (foodLETs) · Indonesian infants aged 6–12 months | 10 mg | 23 weeks | — |
| Effect of daily or weekly multiple-micronutrient and iron foodlike tablets on body iron stores of Indonesian infants aged 6-12 mo: a double-blind, randomized, placebo-controlled trial 2007 · Weekly multiple-micronutrient (WMM) foodlike tablets (foodLETs) · Indonesian infants aged 6–12 months | 2.86 mg | 23 weeks | — |
| Effect of daily or weekly multiple-micronutrient and iron foodlike tablets on body iron stores of Indonesian infants aged 6-12 mo: a double-blind, randomized, placebo-controlled trial 2007 · Daily iron (DI) foodlike tablets (foodLETs) · Indonesian infants aged 6–12 months | 10 mg | 23 weeks | — |
| Absorption of low and therapeutic doses of ferric maltol, a novel ferric iron compound, in iron deficient subjects using a single dose iron absorption test 1991 · 10 mg ferric maltol aqueous solution · Iron-deficient subjects; age and sex not reported | 10 mg | 1 day | — |
| Absorption of low and therapeutic doses of ferric maltol, a novel ferric iron compound, in iron deficient subjects using a single dose iron absorption test 1991 · 10 mg ferric maltol tablet · Iron-deficient subjects; age and sex not reported | 10 mg | 1 day | — |
| Efficacy of iron-fortified Ultra Rice in improving the iron status of women in Mexico 2008 · iron-fortified rice group · Nonpregnant, nonlactating women aged 18 to 49 years recruited from six factories | 13 mg | 26 weeks | — |
| Effect of zinc and iron supplementation on indicators of iron, zinc and vitamin A status of primary school children 2007 · iron · 11-year-old primary school children | 20 mg | 120 days | — |
| Random serial sampling to evaluate efficacy of iron fortification: a randomized controlled trial of margarine fortification with ferric pyrophosphate or sodium iron edetate 2010 · MGFePP group · Women aged 18–40 with serum ferritin concentrations below 25 μg/L | 14 mg | 32 weeks | — |
| Random serial sampling to evaluate efficacy of iron fortification: a randomized controlled trial of margarine fortification with ferric pyrophosphate or sodium iron edetate 2010 · NaFeEDTA group · Women aged 18–40 with serum ferritin concentrations below 25 μg/L | 14 mg | 32 weeks | — |
| Micronized ferric pyrophosphate supplied through extruded rice kernels improves body iron stores in children: a double-blind, randomized, placebo-controlled midday meal feeding trial in Indian schoolchildren 2011 · FR-MDM · Children aged 5–11 years participating in the midday meal scheme in India | 19 mg | 240 days | — |
| Iron fortification of whole wheat flour reduces iron deficiency and iron deficiency anemia and increases body iron stores in Indian school-aged children 2012 · daily wheat-based lunch meal fortified with 6 mg of Fe as NaFeEDTA · Fe-depleted children aged 6–15 years in India | 6 mg | 213 days | — |
| Bioavailability of daily low dose iron supplements in menstruating women with low iron stores 1990 · haem iron and non-haem iron supplement · Menstruating women aged 18–48 years with serum ferritin ≤20 micrograms/l and haemoglobin >120 g/l | 18 mg | 26 weeks | — |
| Bioavailability of daily low dose iron supplements in menstruating women with low iron stores 1990 · non-haem iron-only supplement 1 · Menstruating women aged 18–48 years with serum ferritin ≤20 micrograms/l and haemoglobin >120 g/l | 18 mg | 26 weeks | — |
| Bioavailability of daily low dose iron supplements in menstruating women with low iron stores 1990 · non-haem iron-only supplement 2 · Menstruating women aged 18–48 years with serum ferritin ≤20 micrograms/l and haemoglobin >120 g/l | 18 mg | 26 weeks | — |
| [Dietary supplement of iron for iron deficiency] 2013 · low-dose group · 76 women and men with iron deficiency and mild iron-deficiency anaemia; age not stated | 27.6 mg | 12 weeks | — |
| A randomized, blinded, placebo-controlled trial of education and iron supplementation for mitigation of iron deficiency in regular blood donors 2016 · 19 mg of iron group · Adult men with at least three, and women with at least two, red blood cell-equivalent donations in the prior 12 months; frequent blood donors | 19 mg | 60 days | — |
| Can Iron Treatments Aggravate Epistaxis in Some Patients With Hereditary Hemorrhagic Telangiectasia? 2016 · molasses dietary supplement group · healthy male and female volunteers aged 18 to 80 years | 2 mg | 2 days | — |
| Sodium pyrophosphate enhances iron bioavailability from bouillon cubes fortified with ferric pyrophosphate 2016 · FePP only · Iron-deficient women | 2.5 mg | 1 day | — |
| Sodium pyrophosphate enhances iron bioavailability from bouillon cubes fortified with ferric pyrophosphate 2016 · FeSO4 only · Iron-deficient women | 2.5 mg | 1 day | — |
| Mode of oral iron administration and the amount of iron habitually consumed do not affect iron absorption, systemic iron utilisation or zinc absorption in iron-sufficient infants: a randomised trial 2016 · low-Fe formula group · Fe-sufficient 6-month-old infants | 1.3 mg | 45 days | — |
| Effects of iron supplementation and nutrition education on haemoglobin, ferritin and oxidative stress in iron-deficient female adolescents in Palestine: randomized control trial 2018 · iron supplementation group (A) · Iron-deficient female adolescents in Gaza, Palestine | 28.6 mg | 90 days | — |
| Effects of iron supplementation and nutrition education on haemoglobin, ferritin and oxidative stress in iron-deficient female adolescents in Palestine: randomized control trial 2018 · iron supplementation with nutrition education group (B) · Iron-deficient female adolescents in Gaza, Palestine | 28.6 mg | 90 days | — |
| The Effect of Lactobacillus plantarum 299v on Iron Status and Physical Performance in Female Iron-Deficient Athletes: A Randomized Controlled Trial 2020 · CtrlFe · Female athletes aged 16–40 years with low iron stores, non-anemic, and regularly training at least 5 hours per week | 20 mg | 12 weeks | — |
| Is a Lower Dose of More Bioavailable Iron (18-mg Ferrous Bisglycinate) Noninferior to 60-mg Ferrous Sulfate in Increasing Ferritin Concentrations While Reducing Gut Inflammation and Enteropathogen Detection in Cambodian Women? A Randomized Controlled Noninferiority Trial 2023 · 18-mg ferrous bisglycinate · Nonpregnant women aged 18–45 years in Cambodia | 18 mg | 12 weeks | — |
| Consumption of Iron-Fortified Lentils Is Protective against Declining Iron Status among Adolescent Girls in Bangladesh: Evidence from a Community-Based Double-Blind, Cluster-Randomized Controlled Trial 2024 · 200 g cooked iron-fortified lentils (IFLs) · Girls aged 10–17 years in rural Bangladesh, selected as adolescent girls; iron deficiency status at enrollment is not specified | 8.63 mg | 85 days | — |
| Vitamin C-Rich Guava Consumed with Mungbean Dal Reduces Anemia and Increases Hemoglobin but not Iron Stores: A Randomized Controlled Trial of Food-to-Food Fortification in Indian Children 2024 · mungbean dal only · Children aged 6–10 years in rural Haryana, India; the group included children with and without anemia or iron deficiency | 3 mg | 213 days | — |
| Effectiveness of intermittent iron and high-dose vitamin A supplementation on hemoglobin, iron and vitamin A status of schoolchildren in southern Ethiopia: a randomized placebo controlled trial 2026 · iron · Schoolchildren aged 7–10 years in rural Ethiopia | 6 mg | 330 days | — |
| Zinc supplementation reduced morbidity, but neither zinc nor iron supplementation affected growth or body composition of Mexican preschoolers 1997 · iron · Mexican preschool children in a rural community | 20 mg | 1 year | — |
| Small-quantity, lipid-based nutrient supplements provided to women during pregnancy and 6 mo postpartum and to their infants from 6 mo of age increase the mean attained length of 18-mo-old children in semi-urban Ghana: a randomized controlled trial 2016 · LNS (women and infants) · Pregnant women aged 18 years or older enrolled at up to 20 weeks of gestation, and their infants from 6 to 18 months of age | 26 mg | 1 year | 440 |
| Prenatal and postnatal lipid-based nutrient supplementation and cognitive, social-emotional, and motor function in preschool-aged children in Ghana: a follow-up of a randomized controlled trial 2019 · LNS group · Pregnant women aged 18 years or older and their children, from pregnancy through the child's age of 18 months | 26 mg | — | 440 |
| Micronutrient fortified milk improves iron status, anemia and growth among children 1-4 years: a double masked, randomized, controlled trial 2010 · Micronutrient-fortified milk (MN group) · Children aged 1–4 years in India; many had anemia, iron deficiency, or growth faltering | 9.6 mg | 1 year | 316 |
| Effect of small-quantity lipid-based nutrient supplements on growth, psychomotor development, iron status, and morbidity among 6- to 12-mo-old infants in South Africa: a randomized controlled trial 2019 · SQ-LNS-plus · Infants enrolled at 6 months of age in a peri-urban South African setting; no specific disease or deficiency was required. | 5.8 mg | 26 weeks | 250 |
| Associations of maternal nutrition during pregnancy and post-partum with maternal cognition and caregiving 2018 · MMN · Pregnant women enrolled at ≤20 weeks’ gestation in Malawi, followed through 6 months postpartum | 20 mg | 1 year | 239 |
| Associations of maternal nutrition during pregnancy and post-partum with maternal cognition and caregiving 2018 · LNS · Pregnant women enrolled at ≤20 weeks’ gestation in Malawi, followed through 6 months postpartum | 20 mg | 1 year | 234 |
| Association of prenatal lipid-based nutritional supplementation with fetal growth in rural Gambia 2017 · PE + MMN · Pregnant women aged 18–45 years in rural Gambia, enrolled at 10–20 weeks’ gestation | 60 mg | — | 159 |
| Effect on longitudinal growth and anemia of zinc or multiple micronutrients added to vitamin A: a randomized controlled trial in children aged 6-24 months 2010 · Multiple micronutrients · Children enrolled at 6 months and followed to 24 months in rural South Africa; HIV-infected and HIV-uninfected children, both sexes | 10 mg | 548 days | 126 |
| Acceptability of multiple micronutrient powders and iron syrup in Bihar, India 2018 · multiple micronutrient powder (MNP) · Children aged 6–23 months in rural Bihar, not currently taking iron supplements | 12.5 mg | 30 days | 100 |
| A prospective randomized comparative trial evaluating postoperative nutritional intervention in patients with oral cancer 2022 · Intervention group · Adults with oral cancer after surgery; ages 18 and older, both sexes | 100 mg | 26 weeks | 22 |
| A micronutrient-fortified seasoning powder reduces morbidity and improves short-term cognitive function, but has no effect on anthropometric measures in primary school children in northeast Thailand: a randomized controlled trial 2008 · seasoning powder fortified with micronutrients · Children aged 5.5–13.4 years in primary schools in northeast Thailand | 5 mg | 31 weeks | — |
| Preconception Micronutrient Supplementation Affects Maternal BMI and Body Composition Postpartum: A Randomized Controlled Trial in Vietnam 2024 · Iron and folic acid (IFA) · Females in Vietnam receiving preconception supplementation who later delivered live offspring; age and health condition not specified | 8.57 mg | — | — |
| Impact of IgG response to malaria-specific antigens and immunity against malaria in pre-school children in Ghana. A cluster randomized, placebo-controlled trial 2021 · Iron group · Children aged 6–35 months in malaria-endemic communities in Ghana | 12.5 mg | 150 days | 435 |
| Impact of small-quantity lipid-based nutrient supplement on hemoglobin, iron status and biomarkers of inflammation in pregnant Ghanaian women 2017 · MMN · Pregnant women in a semi-urban setting in Ghana | 20 mg | — | 354 |
| Impact of small-quantity lipid-based nutrient supplement on hemoglobin, iron status and biomarkers of inflammation in pregnant Ghanaian women 2017 · LNS · Pregnant women in a semi-urban setting in Ghana | 20 mg | — | 354 |
| Effects of iron supplements and iron-containing micronutrient powders on the gut microbiome in Bangladeshi infants: a randomized controlled trial 2024 · Iron · Infants recruited at 8 months of age in rural Bangladesh | 12.5 mg | 13 weeks | 308 |
| The Effect of Oral Iron Supplementation on Gut Microbial Composition: a Secondary Analysis of a Double-Blind, Randomized Controlled Trial among Cambodian Women of Reproductive Age 2023 · 18 mg ferrous bisglycinate · Non-pregnant Cambodian women aged 18–45; generally healthy, with some participants anemic or iron deficient | 18 mg | 12 weeks | 160 |
| Effectiveness of daily and weekly iron supplementation in the prevention of anemia in infants 2008 · daily group · children aged 6–12 months | 12.5 mg | 24 weeks | 150 |
| Effectiveness of daily and weekly iron supplementation in the prevention of anemia in infants 2008 · weekly group · children aged 6–12 months | 3.57 mg | 24 weeks | 147 |
| Hepcidin-guided screen-and-treat interventions for young children with iron-deficiency anaemia in The Gambia: an individually randomised, three-arm, double-blind, controlled, proof-of-concept, non-inferiority trial 2023 · 12 mg screen-and-treat group · Children aged 6–23 months with anaemia in rural Gambia | 12 mg | 82 days | 136 |
| Hepcidin-guided screen-and-treat interventions for young children with iron-deficiency anaemia in The Gambia: an individually randomised, three-arm, double-blind, controlled, proof-of-concept, non-inferiority trial 2023 · 6 mg screen-and-treat group · Children aged 6–23 months with anaemia in rural Gambia | 6 mg | 82 days | 136 |
| Hepcidin-guided screen-and-treat interventions for young children with iron-deficiency anaemia in The Gambia: an individually randomised, three-arm, double-blind, controlled, proof-of-concept, non-inferiority trial 2023 · control group · Children aged 6–23 months with anaemia in rural Gambia | 12 mg | 82 days | 135 |
| Adherence to home fortification with micronutrient powders in Kenyan pre-school children: self-reporting and sachet counts compared to an electronic monitoring device 2018 · Iron, 12.5 mg as ferrous fumarate · Children aged 12–36 months in Kisumu West, Kenya | 12.5 mg | 30 days | 114 |
| Adherence to home fortification with micronutrient powders in Kenyan pre-school children: self-reporting and sachet counts compared to an electronic monitoring device 2018 · Iron, 3 mg as NaFeEDTA · Children aged 12–36 months in Kisumu West, Kenya | 3 mg | 30 days | 112 |
| Impact of weekly treatment with ferrous sulfate on hemoglobin level, morbidity and nutritional status of anemic infants 2006 · Mild anemia group · Infants aged 12–18 months with mild anemia | 6.43 mg | 26 weeks | 111 |
| [Use of daily and weekly ferrous sulfate to treat anemic childbearing-age women] 1999 · alternative weekly regimen · Menstruating women aged 15–45 years with anemia (Hb <12 mg/dl) in a low-income community | 8.57 mg | 12 weeks | 79 |
| Efficacy of iron fortification compared to iron supplementation among Vietnamese schoolchildren 2006 · Fe+MEB (iron-fortified noodles and mebendazole) · Anaemic Vietnamese grade 1–3 schoolchildren; mean age 87.3 months | 10.7 mg | 26 weeks | 72 |
| Effects of weekly iron supplementation on pregnant Indonesian women are similar to those of daily supplementation 1996 · weekly iron group · Pregnant women, 8–24 weeks’ gestation | 17.1 mg | 79 days | 71 |
| Impact of weekly treatment with ferrous sulfate on hemoglobin level, morbidity and nutritional status of anemic infants 2006 · Moderate/severe anemia group · Infants aged 12–18 months with moderate/severe anemia | 6.43 mg | 26 weeks | 69 |
| Daily versus intermittent iron supplementation in pregnant women: hematological and pregnancy outcome 2004 · weekly iron group · pregnant women; age and sex beyond pregnancy not reported; anemia status varied | 28.6 mg | 17 weeks | 56 |
| Low iron status as a factor of increased bone resorption and effects of an iron and vitamin D-fortified skimmed milk on bone remodelling in young Spanish women 2014 · Fe group · Young iron-deficient women | 15 mg | 16 weeks | 54 |
| [The effectiveness of three regimens using ferrous sulfate to treat anemia in pregnant women] 2004 · twice a week · Pregnant women with anemia | 8.57 mg | — | 53 |
| Iron Supplementation with Ferrous Sulfate or Ferrous Bisglycinate for 12 Weeks Does Not Influence Group B Streptococcus Colonization in Cambodian Women: A Secondary Analysis of a Randomized Controlled Trial 2025 · ferrous bisglycinate · Healthy, nonpregnant women aged 18–45 years in Kampong Thom, Cambodia | 18 mg | 12 weeks | 50 |
| [The effectiveness of three regimens using ferrous sulfate to treat anemia in pregnant women] 2004 · once a week · Pregnant women with anemia | 8.57 mg | — | 48 |
| Milk fortified with iron or iron supplementation to improve nutritional status of pregnant women: an intervention trial from rural Vietnam 2005 · iron-fortified milk group · Pregnant women in rural Vietnam; age and baseline condition not specified | 15 mg | 16 weeks | 44 |
| Bioavailability of a heme-iron concentrate product added to chocolate biscuit filling in adolescent girls living in a rural area of Mexico 2010 · heme-iron concentrate (HIC) · Adolescent girls living in a rural area of Mexico | 10.3 mg | 7 weeks | 40 |
| Efficacy of different strategies to treat anemia in children: a randomized clinical trial 2010 · Iron supplement (IS) · Children aged 6–42 months with anemia in rural communities in Mexico | 20 mg | 120 days | 40 |
| Bioavailability of a heme-iron concentrate product added to chocolate biscuit filling in adolescent girls living in a rural area of Mexico 2010 · iron sulfate (IS) · Adolescent girls living in a rural area of Mexico | 10.3 mg | 7 weeks | 37 |
| Circulating non-transferrin-bound iron after oral administration of supplemental and fortification doses of iron to healthy women: a randomized study 2014 · 6 mg iron with a standard test meal · Healthy women with replete or reduced iron stores | 6 mg | 1 day | 32 |
| Efficacy of daily vs. weekly supplementation of iron in schoolchildren with low iron status 2004 · weekly supplementation group · Children aged 5–10 years with iron deficiency anemia | 28.6 mg | 60 days | 30 |
| Consumption of Sinlek Rice Drink Improved Red Cell Indices in Anemic Elderly Subjects 2021 · Group D (high-dose iron-rice drink, IR) · Adults aged over 60 years, non-anemic | 27 mg | 30 days | 27 |
| Consumption of Sinlek Rice Drink Improved Red Cell Indices in Anemic Elderly Subjects 2021 · Group A (white-rice drink, WR) · Adults aged over 60 years, non-anemic | 2 mg | 30 days | 25 |
| Consumption of Sinlek Rice Drink Improved Red Cell Indices in Anemic Elderly Subjects 2021 · Group C (low-dose iron-rice drink, anemic group) · Adults aged over 60 years with anemia | 15 mg | 30 days | 23 |
| Iron nutritional status is improved in Brazilian preterm infants fed food cooked in iron pots 1998 · Control group (food cooked in aluminum pots) · Healthy preterm infants from low-socioeconomic-level families, followed from 4 to 12 months of age; sex not specified | 2 mg | 50 weeks | 23 |
| Measurement of long-term iron absorption and loss during iron supplementation using a stable isotope of iron ((57) Fe) 2021 · positive control arm · Anaemic Gambian toddlers | 12 mg | 12 weeks | 22 |
| The bioavailability of iron picolinate is comparable to iron sulfate when fortified into a complementary fruit yogurt: a stable iron isotope study in young women 2020 · iron sulfate-fortified yogurt · Healthy women aged 18–40 with weight below 65 kg and plasma ferritin below 50 µg/L; mean age 25.1 years | 5 mg | 1 day | 20 |
| The bioavailability of iron picolinate is comparable to iron sulfate when fortified into a complementary fruit yogurt: a stable iron isotope study in young women 2020 · iron picolinate-fortified yogurt · Healthy women aged 18–40 with weight below 65 kg and plasma ferritin below 50 µg/L; mean age 25.1 years | 5 mg | 1 day | 20 |
| Iron Absorption from Bouillon Fortified with Iron-Enriched Aspergillus oryzae Is Higher Than That Fortified with Ferric Pyrophosphate in Young Women 2020 · ASP-p (study II) · Women aged 18–35 with ferritin <40 μg/L who were not anemic | 4.2 mg | 3 days | 18 |
| Iron Absorption from Bouillon Fortified with Iron-Enriched Aspergillus oryzae Is Higher Than That Fortified with Ferric Pyrophosphate in Young Women 2020 · FeSO4 (study II) · Women aged 18–35 with ferritin <40 μg/L who were not anemic | 4.2 mg | 3 days | 18 |
| Iron Absorption from Bouillon Fortified with Iron-Enriched Aspergillus oryzae Is Higher Than That Fortified with Ferric Pyrophosphate in Young Women 2020 · ASP-p (study I) · Women aged 18–35 with ferritin <40 μg/L who were not anemic | 4.2 mg | 3 days | 17 |
| Iron Absorption from Bouillon Fortified with Iron-Enriched Aspergillus oryzae Is Higher Than That Fortified with Ferric Pyrophosphate in Young Women 2020 · FePP (study I) · Women aged 18–35 with ferritin <40 μg/L who were not anemic | 4.2 mg | 3 days | 17 |
| Mixture of ferric sodium ethylenediaminetetraacetate (NaFeEDTA) and ferrous sulfate: an effective iron fortificant for complementary foods for young Chinese children 2012 · Study 2: food fortified with 4 mg iron as FeSO₄ · Children aged 24 to 31 months | 4 mg | 1 day | 15 |
| Mixture of ferric sodium ethylenediaminetetraacetate (NaFeEDTA) and ferrous sulfate: an effective iron fortificant for complementary foods for young Chinese children 2012 · Study 1: food fortified with FeSO₄ · Children aged 24 to 31 months | 2 mg | 1 day | 14 |
| Mixture of ferric sodium ethylenediaminetetraacetate (NaFeEDTA) and ferrous sulfate: an effective iron fortificant for complementary foods for young Chinese children 2012 · Study 1: food fortified with NaFeEDTA · Children aged 24 to 31 months | 2 mg | 1 day | 14 |
| Iron Supplementation during Three Consecutive Days of Endurance Training Augmented Hepcidin Levels 2017 · iron-treatment (Fe condition) · Healthy male endurance athletes aged 19–22 years, including long-distance runners and triathletes | 24 mg | 3 days | 7 |
| The effect of different anthelmintic treatment regimens combined with iron supplementation on the nutritional status of schoolchildren in KwaZulu-Natal, South Africa: a randomized controlled trial 2001 · single-dose albendazole plus praziquantel with iron · Primary-school pupils in KwaZulu-Natal, South Africa; ages and sex not specified | 28.6 mg | 1 year | — |
| The effect of different anthelmintic treatment regimens combined with iron supplementation on the nutritional status of schoolchildren in KwaZulu-Natal, South Africa: a randomized controlled trial 2001 · triple-dose albendazole plus praziquantel with iron · Primary-school pupils in KwaZulu-Natal, South Africa; ages and sex not specified | 28.6 mg | 1 year | — |
| The effect of different anthelmintic treatment regimens combined with iron supplementation on the nutritional status of schoolchildren in KwaZulu-Natal, South Africa: a randomized controlled trial 2001 · placebo anthelmintic regimen with iron · Primary-school pupils in KwaZulu-Natal, South Africa; ages and sex not specified | 28.6 mg | 1 year | — |
| [Efficacy of daily and weekly iron supplementation for the control of iron deficiency anaemia in infants in rural Vietnam] 2002 · Group 2 · Infants aged 5–12 months with iron-deficiency anaemia | 15 mg | 90 days | — |
| [Efficacy of daily and weekly iron supplementation for the control of iron deficiency anaemia in infants in rural Vietnam] 2002 · Group 3 · Infants aged 5–12 months with iron-deficiency anaemia | 15 mg | 26 weeks | — |
| [Efficacy of daily and weekly iron supplementation for the control of iron deficiency anaemia in infants in rural Vietnam] 2002 · Group 4 · Infants aged 5–12 months with iron-deficiency anaemia | 2.14 mg | 26 weeks | — |
| Therapeutic effects of NaFeEDTA-fortified soy sauce in anaemic children in China 2002 · low-NaFeEDTA group · Iron-deficient anaemic schoolchildren aged 11–17 years | 5 mg | 90 days | — |
| Therapeutic effects of NaFeEDTA-fortified soy sauce in anaemic children in China 2002 · high-NaFeEDTA group · Iron-deficient anaemic schoolchildren aged 11–17 years | 20 mg | 90 days | — |
| Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat 2003 · 8-mg haem iron supplement · 21 healthy male volunteers | 8 mg | — | — |
| A double-masked, randomized control trial of iron supplementation in early infancy in healthy term breast-fed infants 2003 · Iron supplementation group · Healthy term breast-fed infants, from 1 to 6 months of age | 7.5 mg | 150 days | — |
| Weekly iron supplements given by teachers sustain the haemoglobin concentration of schoolchildren in the Philippines 2004 · Iron supplementation group · Children aged 7–12 years in rural primary schools in the Philippines | 15.4 mg | 10 weeks | — |
| Studies on the effectiveness of NaFeEDTA-fortified soy sauce in controlling iron deficiency: a population-based intervention trial 2005 · NaFeEDTA-fortified soy sauce group · Residents aged 3 years or older in Bijie City, China, described as a high-risk population for iron deficiency | 4.9 mg | 548 days | — |
| Are we giving too much iron? Low-dose iron therapy is effective in octogenarians 2005 · 15 mg elemental iron group · Hospitalized adults over 80 years with iron-deficiency anemia | 15 mg | 60 days | — |
| Iron fortification reduces blood lead levels in children in Bangalore, India 2006 · iron-fortified rice meal · Iron-deficient, lead-exposed children aged 5–9 years in Bangalore, India | 15 mg | 16 weeks | — |
| Multi-micronutrient Sprinkles including a low dose of iron provided as microencapsulated ferrous fumarate improves haematologic indices in anaemic children: a randomized clinical trial 2006 · 12.5 mg iron as ferrous fumarate Sprinkles · Anaemic Ghanaian children aged 6–18 months | 12.5 mg | 8 weeks | — |
| Multi-micronutrient Sprinkles including a low dose of iron provided as microencapsulated ferrous fumarate improves haematologic indices in anaemic children: a randomized clinical trial 2006 · 20 mg iron as ferrous fumarate Sprinkles · Anaemic Ghanaian children aged 6–18 months | 20 mg | 8 weeks | — |
| Multi-micronutrient Sprinkles including a low dose of iron provided as microencapsulated ferrous fumarate improves haematologic indices in anaemic children: a randomized clinical trial 2006 · 20 mg iron as ferric pyrophosphate Sprinkles · Anaemic Ghanaian children aged 6–18 months | 20 mg | 8 weeks | — |
| Multi-micronutrient Sprinkles including a low dose of iron provided as microencapsulated ferrous fumarate improves haematologic indices in anaemic children: a randomized clinical trial 2006 · 12.5 mg iron as liquid ferrous sulphate drops · Anaemic Ghanaian children aged 6–18 months | 12.5 mg | 8 weeks | — |
| Iron and zinc supplementation improved iron and zinc status, but not physical growth, of apparently healthy, breast-fed infants in rural communities of northeast Thailand 2006 · iron supplementation alone · Apparently healthy, breast-fed Thai infants aged 4–6 months | 10 mg | 26 weeks | — |
| Combined iron and zinc supplementation in infants improved iron and zinc status, but interactions reduced efficacy in a multicountry trial in southeast Asia 2007 · iron · Infants aged 4–6 months | 10 mg | 26 weeks | — |
| Low dose 'Sprinkles'-- an innovative approach to treat iron deficiency anemia in infants and young children 2007 · Sprinkles 12.5 mg ferrous fumarate · Children aged 6–18 months with hemoglobin 70–100 g/L | 12.5 mg | 8 weeks | — |
| Low dose 'Sprinkles'-- an innovative approach to treat iron deficiency anemia in infants and young children 2007 · Sprinkles 20 mg ferrous fumarate · Children aged 6–18 months with hemoglobin 70–100 g/L | 20 mg | 8 weeks | — |
| Low dose 'Sprinkles'-- an innovative approach to treat iron deficiency anemia in infants and young children 2007 · Sprinkles 20 mg micronized ferric pyrophosphate · Children aged 6–18 months with hemoglobin 70–100 g/L | 20 mg | 8 weeks | — |
| Low dose 'Sprinkles'-- an innovative approach to treat iron deficiency anemia in infants and young children 2007 · Drops 20 mg ferrous glycine sulphate (DROPS) · Children aged 6–18 months with hemoglobin 70–100 g/L | 20 mg | 8 weeks | — |
| The effect of weekly iron and vitamin A supplementation on hemoglobin levels and iron status in adolescent schoolgirls in western Kenya 2009 · Iron supplementation · Schoolgirls aged 12–18 years attending public primary schools in Kisumu, western Kenya | 17.1 mg | 150 days | — |
| Anemia reduction in preschool children with the addition of low doses of iron to school meals 2008 · group A (5 mg/daily) · preschool children with anemia | 5 mg | — | — |
| Anemia reduction in preschool children with the addition of low doses of iron to school meals 2008 · group B (10 mg/daily) · preschool children with anemia | 10 mg | — | — |
| A comparative intervention trial on fish sauce fortified with NaFe-EDTA and FeSO4+citrate in iron deficiency anemic school children in Kampot, Cambodia 2008 · NaFe-EDTA-fortified fish sauce · Schoolchildren and adolescents aged 6–21 years with iron-deficiency anemia in rural Cambodia | 10 mg | 21 weeks | — |
| A comparative intervention trial on fish sauce fortified with NaFe-EDTA and FeSO4+citrate in iron deficiency anemic school children in Kampot, Cambodia 2008 · FeSO4+citrate-fortified fish sauce · Schoolchildren and adolescents aged 6–21 years with iron-deficiency anemia in rural Cambodia | 10 mg | 21 weeks | — |
| Once weekly low-dose iron supplementation effectively improved iron status in adolescent girls 2010 · iron-supplemented group (ISG) · Female high school students aged 14–16 years | 21.4 mg | 16 weeks | — |
| Oral calcium supplementation reverses the biochemical pattern of parathyroid hormone resistance in underprivileged Indian toddlers 2009 · Placebo group (iron supplementation) · Toddlers aged 2.4 years on average from an urban slum in Pune, India, with low dietary calcium intake and vitamin D replete status | 20 mg | 8 weeks | — |
| In a randomized controlled trial of iron fortification, anthelmintic treatment, and intermittent preventive treatment of malaria for anemia control in Ivorian children, only anthelmintic treatment shows modest benefit 2010 · iron-fortified biscuits · Children aged 6–14 years attending school in Côte d'Ivoire | 20 mg | 26 weeks | — |
| Reduced erythrocyte superoxide dismutase activity in low birth weight infants given iron supplements 1991 · HiFe · Low birth weight infants | 13.8 mg | 16 weeks | — |
| Reduced erythrocyte superoxide dismutase activity in low birth weight infants given iron supplements 1991 · MidFe · Low birth weight infants | 7 mg | 16 weeks | — |
| The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d'Ivoire 2010 · iron-fortified biscuits · Ivorian children aged 6–14 years | 20 mg | 26 weeks | — |
| Weekly iron supplementation for the prevention of anemia in pre-school children: a randomized, double-blind, placebo-controlled trial 2011 · intervention participants · 5-year-old preschool children attending a public school in northeast Brazil | 7.14 mg | 14 weeks | — |
| Milk-based cornstarch porridge fortified with iron is effective in reducing anemia: a randomized, double-blind, placebo-controlled trial 2012 · Intervention group · 4-year-old preschoolers | 10 mg | 14 weeks | — |
| [Effect of iron supplementation on iron deficiency anemia of childbearing age women in Shanghai] 2012 · intervention group · Women aged 21 to 45 years with anemia | 8 mg | 26 weeks | — |
| Use of iron-fortified rice reduces anemia in infants 2012 · iron-fortified rice intervention center · Infants aged 10–23 months at a public child day care center in Brazil; sex and anemia status at enrollment not specified | 8.06 mg | 18 weeks | — |
| Daily and Weekly Iron Supplementations are Effective in Increasing Hemoglobin and Reducing Anemia in Infants 2013 · intervention-group A · Infants aged 12–24 months | 3.57 mg | 120 days | — |
| Daily and Weekly Iron Supplementations are Effective in Increasing Hemoglobin and Reducing Anemia in Infants 2013 · intervention-group B · Infants aged 12–24 months | 12.5 mg | 120 days | — |
| Multiple micronutrient supplementation reduces anemia and anxiety in rural China's elementary school children 2013 · intervention group · Mostly 10–12-year-old fourth-grade students in rural elementary schools | 5 mg | 150 days | — |
| Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants 2015 · MNP containing 2.5 mg iron as NaFeEDTA · Kenyan infants aged 6 months | 2.5 mg | 120 days | — |
| Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants 2015 · MNP containing 12.5 mg iron as ferrous fumarate · Kenyan infants aged 6 months | 12.5 mg | 120 days | — |
| Consuming Iron Biofortified Beans Increases Iron Status in Rwandan Women after 128 Days in a Randomized Controlled Feeding Trial 2016 · Fe-Beans group · Women aged 18–27 years in Rwanda with serum ferritin <20 μg/L | 14.5 mg | 128 days | — |
| Mode of oral iron administration and the amount of iron habitually consumed do not affect iron absorption, systemic iron utilisation or zinc absorption in iron-sufficient infants: a randomised trial 2016 · high-Fe formula group · Fe-sufficient 6-month-old infants | 6.6 mg | 45 days | — |
| Mode of oral iron administration and the amount of iron habitually consumed do not affect iron absorption, systemic iron utilisation or zinc absorption in iron-sufficient infants: a randomised trial 2016 · Fe drops group · Fe-sufficient 6-month-old infants | 6.6 mg | 45 days | — |
| Effects of wheat-flour biscuits fortified with iron and EDTA, alone and in combination, on blood lead concentration, iron status, and cognition in children: a double-blind randomized controlled trial 2016 · FeSO4-fortified biscuits · Lead-exposed Moroccan children | 8 mg | 28 weeks | — |
| A randomized clinical trial of the efficacy of single versus double-daily dose of oral iron for prevention of iron deficiency anemia in women with twin gestations 2017 · group I · Non-anemic women in the first trimester with twin gestations | 27 mg | 24 weeks | — |
| The operational implications of donor behaviors following enrollment in STRIDE (Strategies to Reduce Iron Deficiency in blood donors) 2017 · 19-mg iron pill group · Frequent whole-blood or double-red-cell donors who were not taking iron supplements at enrollment; adult age range and sex distribution not specified | 19 mg | 2 years | — |
| Iron Deficiency Anemia at Time of Vaccination Predicts Decreased Vaccine Response and Iron Supplementation at Time of Vaccination Increases Humoral Vaccine Response: A Birth Cohort Study and a Randomized Trial Follow-Up Study in Kenyan Infants 2020 · iron only group · Kenyan infants, mean age 7.5 months, mostly with iron deficiency anemia | 5 mg | 120 days | — |
| The Inclusion of Folic Acid in Weekly Iron-Folic Acid Supplements Confers no Additional Benefit on Anemia Reduction in Nonpregnant Women: A Randomized Controlled Trial in Malaysia 2021 · 60 mg Fe with 0 mg folic acid · Nonpregnant women aged 18–45 years in Malaysia | 8.57 mg | 16 weeks | — |
| Iron-Enriched Fish Powder Improved Haemoglobin Levels in Adolescent Girls of West Jaintia Hills District of Meghalaya, India 2022 · NaFeEDTA-enriched fish powder group · Girls aged 10–19 years with iron-deficiency anaemia | 25 mg | 60 days | — |
| Co-Administration of Iron and Bioavailable Curcumin Reduces Levels of Systemic Markers of Inflammation and Oxidative Stress in a Placebo-Controlled Randomised Study 2022 · FS18_Plac (ferrous sulphate—18 mg elemental iron + placebo) · Generally healthy adults aged 18–40 years with ferritin in the normal range; men and women | 18 mg | 6 weeks | — |
| Safety and efficacy of iron supplementation with 3 months of daily ferrous sulphate in children living with HIV and mild-to-moderate anaemia in Uganda: a double-blind, randomised, placebo-controlled trial 2024 · Iron group, children aged 6–23 months · Children aged 6–23 months living with HIV and mild-to-moderate anaemia, on stable ART | 12.5 mg | 12 weeks | — |
| Role of hepcidin on benefits and risks of supplementation with iron syrup and multiple micronutrient powders in Bangladeshi children: a substudy to a randomized controlled trial 2025 · iron syrup · 8-month-old children living in Bangladesh | 12.5 mg | 90 days | — |
| Role of hepcidin on benefits and risks of supplementation with iron syrup and multiple micronutrient powders in Bangladeshi children: a substudy to a randomized controlled trial 2025 · multiple micronutrient powders (MNPs) · 8-month-old children living in Bangladesh | 12.5 mg | 90 days | — |
| Heme iron compared with ferrous iron salts to treat iron deficiency anemia in Gambian children: a randomized controlled trial 2025 · heme iron polypeptide (HIP) group · Gambian anemic infants aged 6–12 months | 10 mg | 12 weeks | — |
| Heme iron compared with ferrous iron salts to treat iron deficiency anemia in Gambian children: a randomized controlled trial 2025 · ferrous sulfate group · Gambian anemic infants aged 6–12 months | 10 mg | 12 weeks | — |
| Low dose iron supplementation does not cover the need for iron during pregnancy 1993 · 18 mg iron group · Healthy nulliparous women with normal singleton pregnancies; normal hemoglobin concentration and intact iron stores at week 16 | 18 mg | — | — |
| Effective community intervention to improve hemoglobin status in preschoolers receiving once-weekly iron supplementation 1997 · Group 1: iron plus anthelminthic treatment · Children aged 2–5 years in a community field trial | 4.29 mg | — | — |
| Effective community intervention to improve hemoglobin status in preschoolers receiving once-weekly iron supplementation 1997 · Group 2: iron only · Children aged 2–5 years in a community field trial | 4.29 mg | — | — |
| Maternal Blood Pressure in Relation to Prenatal Lipid-Based Nutrient Supplementation and Adverse Birth Outcomes in a Ghanaian Cohort: A Randomized Controlled Trial and Cohort Analysis 2021 · IFA group · Pregnant Ghanaian women aged 18 years or older, enrolled by 20 weeks of gestation | 60 mg | — | 349 |
| Combined food and micronutrient supplements during pregnancy have limited impact on child blood pressure and kidney function in rural Bangladesh 2013 · Fe60F · Pregnant women in rural Bangladesh; age range not specified | 60 mg | — | — |
| Associations of antenatal micronutrient supplementation with adolescent blood pressure: evidence from a 14-year follow-up study of a randomized controlled trial 2025 · Folic acid plus iron (IFA) · Pregnant women less than 28 weeks of gestation; offspring were followed up at ages 10–14 years | 60 mg | — | — |
| Hepcidin-guided screen-and-treat interventions against iron-deficiency anaemia in pregnancy: a randomised controlled trial in The Gambia 2019 · 30 mg screen-and-treat approach · Pregnant women aged 18–45 years at 14–22 weeks’ gestation in The Gambia; anaemia was common in the study population, but women were not selected for a diagnosis or deficiency | 30 mg | 12 weeks | 165 |
| Ferritin-guided iron supplementation as an alternative or complement to prolonged blood donation intervals (FORTE): a double-blind, randomised, controlled trial 2025 · 60 mg alternate day group · Blood donors aged 18–80 years with ferritin levels ≤30 μg/L | 30 mg | 8 weeks | 110 |
| Iron prophylaxis during pregnancy -- how much iron is needed? A randomized dose- response study of 20-80 mg ferrous iron daily in pregnant women 2005 · 40 mg group · Healthy pregnant women, from 18 weeks of gestation | 40 mg | — | 108 |
| Ferritin-guided iron supplementation as an alternative or complement to prolonged blood donation intervals (FORTE): a double-blind, randomised, controlled trial 2025 · 30 mg daily group · Blood donors aged 18–80 years with ferritin levels ≤30 μg/L | 30 mg | 8 weeks | 107 |
| Supplementation during pregnancy with small-quantity lipid-based nutrient supplements or multiple micronutrients, compared with iron and folic acid, increases women's urinary iodine concentration in semiurban Ghana: A randomized controlled trial 2018 · MMN group · Pregnant women aged 18 years or older, enrolled at 20 weeks of gestation or earlier, in semiurban Ghana | 20 mg | — | 102 |
| Supplementation during pregnancy with small-quantity lipid-based nutrient supplements or multiple micronutrients, compared with iron and folic acid, increases women's urinary iodine concentration in semiurban Ghana: A randomized controlled trial 2018 · LNS group · Pregnant women aged 18 years or older, enrolled at 20 weeks of gestation or earlier, in semiurban Ghana | 20 mg | — | 101 |
| The benefits of iron supplementation following blood donation vary with baseline iron status 2020 · 37.5 mg elemental iron (ferrous gluconate) daily · Adult whole blood donors who had not donated in the previous 4 months; included donors across baseline ferritin groups (<12, 12–50, and ≥50 ng/mL) | 37.5 mg | 24 weeks | 96 |
| Body iron and individual iron prophylaxis in pregnancy--should the iron dose be adjusted according to serum ferritin? 2006 · 40 mg group · Healthy pregnant women; age and sex beyond pregnancy not specified | 40 mg | — | 76 |
| The influence and benefits of controlling for inflammation on plasma ferritin and hemoglobin responses following a multi-micronutrient supplement in apparently healthy, HIV+ Kenyan adults 2008 · Food plus micronutrient capsule (MN) · Apparently healthy adults who tested positive twice for HIV and had not reached stage IV or clinical AIDS; 10 men and 34 women | 30 mg | 90 days | 44 |
| Iron absorption and loss, and efficacy of iron supplementation with and without prebiotics in children with virally suppressed HIV: three prospective studies in South Africa 2025 · iron + placebo · children aged 10–15 years with virally suppressed HIV and iron deficiency | 50 mg | 12 weeks | 44 |
| Iron Absorption from Iron-Biofortified Sweetpotato Is Higher Than Regular Sweetpotato in Malawian Women while Iron Absorption from Regular and Iron-Biofortified Potatoes Is High in Peruvian Women 2020 · Regular yellow-fleshed potato test meal (Peru) · Women aged 18–25, weighing under 65 kg and not pregnant or lactating, in Peru; most had low iron stores | 500 mcg | 10 days | 35 |
| Iron Absorption from Iron-Biofortified Sweetpotato Is Higher Than Regular Sweetpotato in Malawian Women while Iron Absorption from Regular and Iron-Biofortified Potatoes Is High in Peruvian Women 2020 · Iron-biofortified purple-fleshed potato test meal (Peru) · Women aged 18–25, weighing under 65 kg and not pregnant or lactating, in Peru; most had low iron stores | 500 mcg | 10 days | 35 |
| Effect of daily supplementation with iron and zinc on iron status of childbearing age women 2015 · group 1 · Women aged 18–45 years of childbearing age | 30 mg | 90 days | 28 |
| Changes in iron status during competitive season in female collegiate swimmers 1993 · iron supplementation · Female varsity collegiate swimmers; 17 of the 25 had depleted iron stores at study entry | 39 mg | 5 weeks | 25 |
| Influence of an iron intervention on the zinc status of young adult New Zealand women with mild iron deficiency 2010 · supplement group (SG) · Women aged 18–40 years with mild iron deficiency and low iron stores | 50 mg | 120 days | 23 |
| Consumption of lettuce with seaweed extract biostimulant application improved iron homeostasis in a randomized interventional trial of healthy individuals 2025 · iron tablet group · Healthy adults aged 24–65 years, both sexes | 30 mg | 4 weeks | 21 |
| Total iron absorption by young women from iron-biofortified pearl millet composite meals is double that from regular millet meals but less than that from post-harvest iron-fortified millet meals 2013 · Regular-iron millet meal · Women aged 17–35 with marginal iron stores, nonpregnant and nonlactating | 800 mcg | 5 days | 20 |
| Total iron absorption by young women from iron-biofortified pearl millet composite meals is double that from regular millet meals but less than that from post-harvest iron-fortified millet meals 2013 · Iron-biofortified millet meal · Women aged 17–35 with marginal iron stores, nonpregnant and nonlactating | 800 mcg | 5 days | 20 |
| Comparison of Ferric Sodium EDTA in Combination with Vitamin C, Folic Acid, Copper Gluconate, Zinc Gluconate, and Selenomethionine as Therapeutic Option for Chronic Kidney Disease Patients with Improvement in Inflammatory Status 2022 · Group 3 (ferric liposomal formulation) · Adults over 18 with functional iron-deficiency anemia and moderate CKD stage 3a–3b | 30 mg | 26 weeks | 20 |
| Iron Absorption from an Intrinsically Labeled Lentil Meal Is Low but Upregulated in Women with Poor Iron Status 2015 · ferrous sulfate · 19 nonpregnant women, including 6 with anemia; ages not reported | 8 mg | 1 day | 19 |
| Relative bioavailability of iron and folic acid from a new powdered supplement compared to a traditional tablet in pregnant women 2009 · Tablet Supplement (Materna®) · Healthy pregnant women aged 18–45 years, at 24–32 weeks’ gestation | 27 mg | 1 day | 18 |
| Effects of long-term moderate exercise on iron status in young women 1995 · 50 mg.d-1 iron supplement, low iron diet · Previously sedentary college-age women with depleted iron stores | 50 mg | 24 weeks | 16 |
| Alginate inhibits iron absorption from ferrous gluconate in a randomized controlled trial and reduces iron uptake into Caco-2 cells 2014 · Test meal 1 (Beads +Fe) · Young adults with ferritin 15–60 µg/L, predominantly women aged 19–27 years; one male aged 49 years | 21 mg | 1 day | 13 |
| Heme iron-based dietary intervention for improvement of iron status in young women 2013 · Fe35 · Women of reproductive age, mean age 24 years | 35 mg | 12 weeks | 11 |
| A phase 1b randomised clinical trial evaluating BBI-001, a non-absorbed oral therapeutic for the treatment of iron overload 2025 · Cohort 3 BBI-001 (2000 mg) · Iron-deficient adults; all participants were female, mean age 22.2 years in Arm 1 and 25.4 years in Arm 2 | 10 mg | 1 day | 10 |
| A phase 1b randomised clinical trial evaluating BBI-001, a non-absorbed oral therapeutic for the treatment of iron overload 2025 · Cohort 2 BBI-001 (1000 mg) · Iron-deficient adults; all participants were female, mean age 30.4 years in Arm 1 and 27.5 years in Arm 2 | 10 mg | 1 day | 9 |
| Alginate inhibits iron absorption from ferrous gluconate in a randomized controlled trial and reduces iron uptake into Caco-2 cells 2014 · Test meal 3 (Beads + Fe + Ca) · Young adults with ferritin 15–60 µg/L, predominantly women aged 19–27 years; one male aged 49 years | 21 mg | 1 day | 7 |
| Alginate inhibits iron absorption from ferrous gluconate in a randomized controlled trial and reduces iron uptake into Caco-2 cells 2014 · Test meal 4 (Fe + Ca) · Young adults with ferritin 15–60 µg/L, predominantly women aged 19–27 years; one male aged 49 years | 21 mg | 1 day | 7 |
| A phase 1b randomised clinical trial evaluating BBI-001, a non-absorbed oral therapeutic for the treatment of iron overload 2025 · Cohort 1 BBI-001 (500 mg) · Iron-deficient adults; all participants were female, mean age 32.0 years in this arm | 10 mg | 1 day | 4 |
| Long-term weekly iron supplementation improves and sustains nonpregnant women's iron status as well or better than currently recommended short-term daily supplementation 1999 · Group 2 · Healthy fertile-age women | 8.57 mg | 213 days | — |
| Iron and zinc supplementation improves indicators of vitamin A status of Mexican preschoolers 2000 · zinc plus iron · Rural Mexican children aged 18–36 months | 20 mg | 26 weeks | — |
| Can dietary treatment of non-anemic iron deficiency improve iron status? 2001 · Supplement · Women aged 18 to 40 years with mild iron deficiency | 50 mg | 16 weeks | — |
| Selective iron supplementation based on serum ferritin values early in pregnancy: are the Norwegian recommendations satisfactory? 2003 · 3.6 mg heme iron plus 24 mg Fe2+ (Hemofer) · Pregnant women with serum ferritin <60 microg/L; supplementation began immediately for serum ferritin <20 microg/L or at 20 weeks for serum ferritin 20–60 microg/L | 27.6 mg | — | — |
| Iron status in exercising women: the effect of oral iron therapy vs increased consumption of muscle foods 1992 · 50 FE + EX · Previously sedentary women participating in a 12-week moderate aerobic-exercise program | 50 mg | 12 weeks | — |
| Daily doses of 20 mg of elemental iron compensate for iron loss in regular blood donors: a randomized, double-blind, placebo-controlled study 2004 · 40 mg/day iron group · Regular male and female blood donors; sex-specific donation schedules are reported, but ages are not stated. | 40 mg | 26 weeks | — |
| Effects of 4 weeks iron supplementation on haematological and immunological status in elite female soccer players 2004 · S group · Elite female soccer players aged 20–28 years | 40 mg | 4 weeks | — |
| Effect of daily versus twice weekly long-term iron supplementation on iron absorption and status in iron-deficient women: a stable isotope study 2006 · Group 1 · Young iron-deficient women | 50 mg | 90 days | — |
| Iron supplementation maintains ventilatory threshold and improves energetic efficiency in iron-deficient nonanemic athletes 2007 · iron supplementation · Men and women aged 18–41 years with iron deficiency but without anemia who were trained athletes | 30 mg | 6 weeks | — |
| Electrolytic iron or ferrous sulfate increase body iron in women with moderate to low iron stores 2007 · electrolytic iron · Women with moderate to low iron stores | 50 mg | 12 weeks | — |
| Electrolytic iron or ferrous sulfate increase body iron in women with moderate to low iron stores 2007 · reduced iron · Women with moderate to low iron stores | 50 mg | 12 weeks | — |
| Should we lower the dose of iron when treating anaemia in pregnancy? A randomized dose-response trial 2009 · 40 mg iron group · Pregnant women in mid-pregnancy with anaemia (haemoglobin <110 g/L) | 40 mg | 8 weeks | — |
| Effect of zinc and iron supplementation on indicators of iron, zinc and vitamin A status of primary school children 2007 · iron+ zinc · 11-year-old primary school children | 20 mg | 120 days | — |
| Improvement in iron deficiency anemia through therapy with ferric ammonium citrate and vitamin C and the effects of aerobic exercise 1991 · Group II · Female college-student volunteers with iron-deficiency anemia or severe latent iron deficiency | 6 mg | 9 weeks | — |
| Improvement in iron deficiency anemia through therapy with ferric ammonium citrate and vitamin C and the effects of aerobic exercise 1991 · Group IV · Female college-student volunteers with iron-deficiency anemia or severe latent iron deficiency | 6 mg | 9 weeks | — |
| Randomized, double-blind, placebo-controlled trial of an iron-fortified food product in female soldiers during military training: relations between iron status, serum hepcidin, and inflammation 2010 · iron-fortified food product · Female soldiers during basic combat training, including soldiers with normal iron status, iron deficiency, and iron-deficiency anemia | 56 mg | 9 weeks | — |
| An 8-week course of 45 mg of carbonyl iron daily reduces iron deficiency in female whole blood donors aged 18 to 45 years: results of a prospective randomized controlled trial 2014 · carbonyl iron · Female whole blood donors aged 18 to 45 years | 45 mg | 8 weeks | — |
| Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women 2015 · 40-mg iron dose · Nonanemic young women with plasma ferritin ≤20 µg/L | 40 mg | 2 days | — |
| A randomized, blinded, placebo-controlled trial of education and iron supplementation for mitigation of iron deficiency in regular blood donors 2016 · 38 mg of iron group · Adult men with at least three, and women with at least two, red blood cell-equivalent donations in the prior 12 months; frequent blood donors | 38 mg | 60 days | — |
| Efficacy of iron supplementation may be misinterpreted using conventional measures of iron status in iron-depleted, nonanemic women undergoing aerobic exercise training 2017 · iron supplement plus aerobic training · Iron-depleted, nonanemic Chinese women; age range not reported | 42 mg | 8 weeks | — |
| Efficacy of iron supplementation may be misinterpreted using conventional measures of iron status in iron-depleted, nonanemic women undergoing aerobic exercise training 2017 · iron supplement without aerobic training · Iron-depleted, nonanemic Chinese women; age range not reported | 42 mg | 8 weeks | — |
| The Effectiveness of Different Doses of Iron Supplementation and the Prenatal Determinants of Maternal Iron Status in Pregnant Spanish Women: ECLIPSES Study 2019 · Stratum 1, 40 mg/d iron · Pregnant women over 18 years old with initial hemoglobin 110–130 g/L at week 12 and no anemia | 40 mg | 24 weeks | — |
| Effects of consuming an iron supplement with a meal containing animal or plant-based meat on indicators of iron status and anemia in women of reproductive age with iron deficiency: a randomized, controlled study 2025 · Animal · Nonpregnant females of reproductive age with low iron stores (serum ferritin <25 μg/L) | 32 mg | 8 weeks | — |
| Effects of consuming an iron supplement with a meal containing animal or plant-based meat on indicators of iron status and anemia in women of reproductive age with iron deficiency: a randomized, controlled study 2025 · Plant · Nonpregnant females of reproductive age with low iron stores (serum ferritin <25 μg/L) | 32 mg | 8 weeks | — |
| Evaluation of a gastric delivery system for iron supplementation in pregnancy 1993 · one GDS capsule daily · Pregnant women aged 16–35 years at 14–22 weeks’ gestation with mild anemia (hemoglobin 80–110 g/L) | 50 mg | 12 weeks | — |
| Associations of antenatal micronutrient supplementation with adolescent blood pressure: evidence from a 14-year follow-up study of a randomized controlled trial 2025 · Multiple micronutrients (MMNs; UNIMMAP formulation) · Pregnant women less than 28 weeks of gestation; offspring were followed up at ages 10–14 years | 30 mg | — | — |
| Intravenous iron for non-anaemic iron deficiency in pregnancy: a multicentre, two-arm, randomised controlled trial 2026 · oral iron prophylaxis group · pregnant women aged 18 years or older with singleton pregnancy and non-anaemic iron deficiency | 30 mg | — | 305 |
| The effects of prophylactic iron given in prenatal supplements on iron status and birth outcomes: a randomized controlled trial 2006 · 30-mg group · Pregnant women who were initially iron-replete and nonanemic | 30 mg | — | 218 |
| Iron supplementation in singleton pregnancy: Is there a benefit to doubling the dose of elemental iron in iron-deficient pregnant women? a randomized controlled trial 2017 · One capsule daily · Pregnant women with iron deficiency anemia in singleton pregnancies, randomized during the second trimester | 34 mg | — | 160 |
| Is every other day iron supplementation effective for the treatment of the iron deficiency anemia in pregnancy? 2022 · every other day intake group · Pregnant women with iron-deficiency anemia; age and sex details beyond pregnancy not reported | 50 mg | 60 days | 140 |
| The effect of iron-fortified complementary food and intermittent preventive treatment of malaria on anaemia in 12- to 36-month-old children: a cluster-randomised controlled trial 2015 · Group 5: CF-FePP + IPT-placebo · Children aged 12–36 months living in rural Côte d’Ivoire; no major chronic illnesses and haemoglobin at least 7 g/dl | 5.8 mg | 270 days | 127 |
| Iron Fortified Complementary Foods Containing a Mixture of Sodium Iron EDTA with Either Ferrous Fumarate or Ferric Pyrophosphate Reduce Iron Deficiency Anemia in 12- to 36-Month-Old Children in a Malaria Endemic Setting: A Secondary Analysis of a Cluster-Randomized Controlled Trial 2017 · group 5, iron fortified CF containing FePP + NaFeEDTA (FePP) · Children aged 12–36 months in rural Côte d’Ivoire, with hemoglobin ≥7 g/dL and no major chronic illness | 5.8 mg | 39 weeks | 127 |
| The effect of iron-fortified complementary food and intermittent preventive treatment of malaria on anaemia in 12- to 36-month-old children: a cluster-randomised controlled trial 2015 · Group 2: CF-FeFum + IPT-placebo · Children aged 12–36 months living in rural Côte d’Ivoire; no major chronic illnesses and haemoglobin at least 7 g/dl | 5.8 mg | 270 days | 126 |
| Iron Fortified Complementary Foods Containing a Mixture of Sodium Iron EDTA with Either Ferrous Fumarate or Ferric Pyrophosphate Reduce Iron Deficiency Anemia in 12- to 36-Month-Old Children in a Malaria Endemic Setting: A Secondary Analysis of a Cluster-Randomized Controlled Trial 2017 · group 2, iron fortified CF containing FeFum + NaFeEDTA (FeFum) · Children aged 12–36 months in rural Côte d’Ivoire, with hemoglobin ≥7 g/dL and no major chronic illness | 5.8 mg | 39 weeks | 126 |
| The effect of iron-fortified complementary food and intermittent preventive treatment of malaria on anaemia in 12- to 36-month-old children: a cluster-randomised controlled trial 2015 · Group 4: CF-FeFum + IPT · Children aged 12–36 months living in rural Côte d’Ivoire; no major chronic illnesses and haemoglobin at least 7 g/dl | 5.8 mg | 270 days | 124 |
| Effect of iron supplementation on iron stores and total body iron after whole blood donation 2016 · ferrous gluconate · Repeat blood donors aged 18 years or older who had just donated whole blood; men and women, with both low- and higher-ferritin groups included. | 37.5 mg | 24 weeks | 111 |
| Consumption of Micronutrient Powder, Syrup or Fortified Food Significantly Improves Zinc and Iron Status in Young Mexican Children: A Cluster Randomized Trial 2022 · micronutrient powder (MNP) · Children aged 6–12 months in urban communities in southern Mexico, beneficiaries of the Prospera program | 10 mg | 120 days | 105 |
| Consumption of Micronutrient Powder, Syrup or Fortified Food Significantly Improves Zinc and Iron Status in Young Mexican Children: A Cluster Randomized Trial 2022 · micronutrient syrup · Children aged 6–12 months in urban communities in southern Mexico, beneficiaries of the Prospera program | 10 mg | 120 days | 105 |
| Iron Supplementation in Twin Pregnancy - The Benefit of Doubling the Iron Dose in Iron Deficient Pregnant Women: A Randomized Controlled Trial 2017 · group A · Iron-deficient women with twin gestations, from 16 weeks of pregnancy through 6 weeks postpartum | 34 mg | — | 85 |
| Consumption of Micronutrient Powder, Syrup or Fortified Food Significantly Improves Zinc and Iron Status in Young Mexican Children: A Cluster Randomized Trial 2022 · fortified food (FF) · Children aged 6–12 months in urban communities in southern Mexico, beneficiaries of the Prospera program | 10 mg | 120 days | 73 |
| Effect of daily vs twice weekly iron supplementation in Indonesian preschool children with low iron status 1995 · daily supplementation · Preschool children with low iron status | 30 mg | 8 weeks | 32 |
| Acute Administration of Bioavailable Curcumin Alongside Ferrous Sulphate Supplements Does Not Impair Iron Absorption in Healthy Adults in a Randomised Trial 2021 · FS18_Plac (ferrous sulphate–18 mg elemental iron + placebo) · Healthy adults aged 18–40 years with ferritin in the normal UK range | 55 mg | 1 day | 31 |
| Randomized trial of sucrosomial iron supplementation in patients with chemotherapy-related anemia treated with ESA 2022 · sucrosomial iron arm · Cancer patients with chemotherapy-induced anemia treated with ESAs | 30 mg | 12 weeks | 30 |
| Oral Versus Intravenous Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients on Maintenance Hemodialysis-Effect on Fibroblast Growth Factor-23 Metabolism 2018 · oral group · Patients on maintenance hemodialysis with severe iron deficiency | 50 mg | 10 weeks | 29 |
| Iron Supplementation Effects on Redox Status following Aseptic Skeletal Muscle Trauma in Adults and Children 2017 · iron supplement condition · Healthy recreationally active males: adults aged 18–45 years and preadolescent children aged 10–12 years, with normal iron status | 37 mg | 25 days | 25 |
| Maternal Human Milk Oligosaccharide Profile Modulates the Impact of an Intervention with Iron and Galacto-Oligosaccharides in Kenyan Infants 2019 · Fe group · Generally healthy infants aged 6.5–9.5 months; no stated diagnosed condition | 5 mg | 120 days | 24 |
| Iron supplementation decreases plasma zinc but has no effect on plasma fatty acids in non-anemic women 2013 · supplementation group (SG) · young non-anemic women | 37.4 mg | 12 weeks | 21 |
| Do iron and vitamin C co-supplementation influence platelet function or LDL oxidizability in healthy volunteers? 1999 · Group B · Healthy adult volunteers; sex and age range not stated | 14 mg | 12 weeks | 20 |
| A Prospective, Randomized, Interventional Study of Oral Iron Supplementation Comparing Daily Dose with Alternate Day Regimen Using Hepcidin as a Biomarker in Iron Deficiency Anemia 2020 · Group 1 (alternate day) · Adults with iron deficiency anemia; age and sex not reported | 30 mg | 3 weeks | 20 |
| Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial 2013 · Oral HIP group · Adults over 18 with non-dialysis chronic kidney disease, anemia, and iron indices below recommended targets; men and women | 33 mg | 26 weeks | 18 |
| Mixture of ferric sodium ethylenediaminetetraacetate (NaFeEDTA) and ferrous sulfate: an effective iron fortificant for complementary foods for young Chinese children 2012 · Study 2: food fortified with a mixture of FeSO₄ and NaFeEDTA · Children aged 24 to 31 months | 4 mg | 1 day | 15 |
| Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity 1993 · Control group · Very low birthweight infants, entered at 3 weeks of age, birth weights 900–1400 g; healthy and appropriate for gestational age | 18 mg | 5 weeks | 15 |
| Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity 1993 · r-HuEpo treated group · Very low birthweight infants, entered at 3 weeks of age, birth weights 900–1400 g; healthy and appropriate for gestational age | 18 mg | 5 weeks | 14 |
| Iron in Micronutrient Powder Promotes an Unfavorable Gut Microbiota in Kenyan Infants 2017 · MNP+Fe group · Breastfed Kenyan infants starting at 6 months of age, generally non- or mildly-anemic (hemoglobin ≥10 g/dL); sexes not specified | 12.5 mg | 90 days | 13 |
| Treatment of mild non-chemotherapy-induced iron deficiency anemia in cancer patients: comparison between oral ferrous bisglycinate chelate and ferrous sulfate 2012 · A group (ferrous bisglycinate chelate) · Adults aged 45–75 with solid tumors and mild iron deficiency anemia, after tumor surgery and not receiving chemotherapy | 42 mg | 60 days | 12 |
| Adaptation in iron absorption: iron supplementation reduces nonheme-iron but not heme-iron absorption from food 2000 · iron supplementation · healthy men and women | 50 mg | 12 weeks | — |
| Potential problems of ascorbate and iron supplementation: pro-oxidant effect in vivo? 2000 · 260 mg/d ascorbate plus 14 mg/d iron · 20 healthy subjects | 14 mg | 6 weeks | — |
| Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat 2003 · 35-mg ferrous iron supplement · 21 healthy male volunteers | 35 mg | — | — |
| Are we giving too much iron? Low-dose iron therapy is effective in octogenarians 2005 · 50 mg elemental iron group · Hospitalized adults over 80 years with iron-deficiency anemia | 50 mg | 60 days | — |
| Comparative assessment of the bioavailability, efficacy and safety of a modified-release (MR) carbonyl iron tablet and oral conventional iron preparation in adult Indian patients with nutritional iron deficiency anaemia 2005 · MR carbonyl iron · Adult Indian patients with clinical and laboratory diagnosis of nutritional iron deficiency anaemia | 45 mg | 12 weeks | — |
| Multi-micronutrient Sprinkles including a low dose of iron provided as microencapsulated ferrous fumarate improves haematologic indices in anaemic children: a randomized clinical trial 2006 · 30 mg iron as ferrous fumarate Sprinkles · Anaemic Ghanaian children aged 6–18 months | 30 mg | 8 weeks | — |
| Iron and/or zinc supplementation did not reduce blood lead concentrations in children in a randomized, placebo-controlled trial 2006 · Iron · First-grade children attending schools within 3.5 km of a metal foundry; lead-exposed | 30 mg | 26 weeks | — |
| Low dose 'Sprinkles'-- an innovative approach to treat iron deficiency anemia in infants and young children 2007 · Sprinkles 30 mg ferrous fumarate · Children aged 6–18 months with hemoglobin 70–100 g/L | 30 mg | 8 weeks | — |
| The efficacy of micronutrient supplementation in reducing the prevalence of anaemia and deficiencies of zinc and iron among adolescents in Sri Lanka 2008 · iron-only group · Schoolchildren aged 12–16 years; the study reports a high prevalence of low iron stores and anaemia at baseline. | 50 mg | 24 weeks | — |
| The effects of iron supplementation on serum copper and zinc levels in pregnant women with high-normal hemoglobin 2008 · case group · Pregnant women with hemoglobin 13.2 g/dL or greater, enrolled between the 13th and 18th week of pregnancy | 50 mg | — | — |
| Multiple micronutrients including iron are not more effective than iron alone for improving hemoglobin and iron status of Malian school children 2009 · Multiple micronutrient supplement (MM) · Malian anemic schoolchildren infected with Schistosoma haematobium | 18 mg | 12 weeks | — |
| The effect of iron-vitamin C co-supplementation on biomarkers of oxidative stress in iron-deficient female youth 2013 · 50 mg/day elemental iron · Iron-deficient, non-anemic girls | 50 mg | 12 weeks | — |
| 5-aminolevulinic acid, a precursor of heme, reduces both fasting and postprandial glucose levels in mildly hyperglycemic subjects 2013 · 5 mg ALA-P and 1.8 mg iron · Adults aged 35–70 years with mild hyperglycemia (fasting plasma glucose 105–125 mg/dL or HbA1c 6.1%–7.1%) | 1.8 mg | 12 weeks | — |
| 5-aminolevulinic acid, a precursor of heme, reduces both fasting and postprandial glucose levels in mildly hyperglycemic subjects 2013 · 15 mg ALA-P and 1.8 mg iron · Adults aged 35–70 years with mild hyperglycemia (fasting plasma glucose 105–125 mg/dL or HbA1c 6.1%–7.1%) | 1.8 mg | 12 weeks | — |
| Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial 2015 · Group OS · Adults with stage 3–5 non-dialysis chronic kidney disease and iron deficiency anaemia | 30 mg | 90 days | — |
| Antiretroviral Treatment Is Associated With Iron Deficiency in HIV-Infected Malawian Women That Is Mitigated With Supplementation, but Is Not Associated With Infant Iron Deficiency During 24 Weeks of Exclusive Breastfeeding 2015 · maternal LNS only (mLNS) · HIV-1-infected breastfeeding women in Malawi, postpartum; age range not stated | 15 mg | 28 weeks | — |
| Antiretroviral Treatment Is Associated With Iron Deficiency in HIV-Infected Malawian Women That Is Mitigated With Supplementation, but Is Not Associated With Infant Iron Deficiency During 24 Weeks of Exclusive Breastfeeding 2015 · maternal LNS/infant ARV (mLNS-iARV) · HIV-1-infected breastfeeding women in Malawi, postpartum; age range not stated | 15 mg | 28 weeks | — |
| Antiretroviral Treatment Is Associated With Iron Deficiency in HIV-Infected Malawian Women That Is Mitigated With Supplementation, but Is Not Associated With Infant Iron Deficiency During 24 Weeks of Exclusive Breastfeeding 2015 · maternal LNS/maternal ARV (mLNS-mARV) · HIV-1-infected breastfeeding women in Malawi, postpartum; age range not stated | 15 mg | 28 weeks | — |
| Effects of wheat-flour biscuits fortified with iron and EDTA, alone and in combination, on blood lead concentration, iron status, and cognition in children: a double-blind randomized controlled trial 2016 · NaFeEDTA-fortified biscuits · Lead-exposed Moroccan children | 8 mg | 28 weeks | — |
| A randomized clinical trial of the efficacy of single versus double-daily dose of oral iron for prevention of iron deficiency anemia in women with twin gestations 2017 · group II · Non-anemic women in the first trimester with twin gestations | 54 mg | 24 weeks | — |
| Effect of iron supplementation during lactation on maternal iron status and oxidative stress: A randomized controlled trial 2017 · Fe-W (iron taken with meals) · Lactating women; age and diagnosed condition not specified | 27 mg | 106 days | — |
| Effect of iron supplementation during lactation on maternal iron status and oxidative stress: A randomized controlled trial 2017 · Fe-B (iron taken between meals) · Lactating women; age and diagnosed condition not specified | 27 mg | 106 days | — |
| Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease 2017 · 240 mg once-daily vadadustat group; all subjects received supplemental iron · Adults with anemia secondary to stage 3 or 4 chronic kidney disease | 50 mg | 6 weeks | — |
| Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease 2017 · 370 mg once-daily vadadustat group; all subjects received supplemental iron · Adults with anemia secondary to stage 3 or 4 chronic kidney disease | 50 mg | 6 weeks | — |
| Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease 2017 · 500 mg once-daily vadadustat group; all subjects received supplemental iron · Adults with anemia secondary to stage 3 or 4 chronic kidney disease | 50 mg | 6 weeks | — |
| Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease 2017 · 630 mg once-daily vadadustat group; all subjects received supplemental iron · Adults with anemia secondary to stage 3 or 4 chronic kidney disease | 50 mg | 6 weeks | — |
| Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease 2017 · Placebo group; all subjects received supplemental iron · Adults with anemia secondary to stage 3 or 4 chronic kidney disease | 50 mg | 6 weeks | — |
| The operational implications of donor behaviors following enrollment in STRIDE (Strategies to Reduce Iron Deficiency in blood donors) 2017 · 38-mg iron pill group · Frequent whole-blood or double-red-cell donors who were not taking iron supplements at enrollment; adult age range and sex distribution not specified | 38 mg | 2 years | — |
| Vitamin D3 supplementation for 8 weeks leads to improved haematological status following the consumption of an iron-fortified breakfast cereal: a double-blind randomised controlled trial in iron-deficient women 2019 · vitamin D3 group · Fe-deficient women; mean age 27.4 years | 9 mg | 8 weeks | — |
| Is Iron Supplementation Influenced by Sub-Clinical Inflammation?: A Randomized Controlled Trial Among Adolescent Schoolgirls in Myanmar 2019 · IFA group · Post-menarcheal adolescent schoolgirls in grades 8–10 with anemia, aged approximately 13–16 years | 8.57 mg | 12 weeks | — |
| Iron Deficiency Anemia at Time of Vaccination Predicts Decreased Vaccine Response and Iron Supplementation at Time of Vaccination Increases Humoral Vaccine Response: A Birth Cohort Study and a Randomized Trial Follow-Up Study in Kenyan Infants 2020 · iron and GOS group · Kenyan infants, mean age 7.5 months, mostly with iron deficiency anemia | 5 mg | 120 days | — |
| Co-Administration of Iron and Bioavailable Curcumin Reduces Levels of Systemic Markers of Inflammation and Oxidative Stress in a Placebo-Controlled Randomised Study 2022 · FS18_Curc (ferrous sulphate—18 mg elemental iron + 500 mg curcumin) · Generally healthy adults aged 18–40 years with ferritin in the normal range; men and women | 18 mg | 6 weeks | — |
| Safety and efficacy of iron supplementation with 3 months of daily ferrous sulphate in children living with HIV and mild-to-moderate anaemia in Uganda: a double-blind, randomised, placebo-controlled trial 2024 · Iron group, children aged 24 months or older · Children aged 24 months to 12 years living with HIV and mild-to-moderate anaemia, on stable ART | 30 mg | 12 weeks | — |
| Growth performance in anemia and following iron supplementation 1993 · Anemic children receiving iron · Children aged 3–5 years with anemia (Hb 7–10 g/dl) | 40 mg | 26 weeks | — |
| Growth performance in anemia and following iron supplementation 1993 · Normal children receiving iron · Children aged 3–5 years with normal hemoglobin (H ≥ 11 g/dl) | 40 mg | 26 weeks | — |
| Antenatal Multiple Micronutrient Supplementation Compared to Iron-Folic Acid Affects Micronutrient Status but Does Not Eliminate Deficiencies in a Randomized Controlled Trial Among Pregnant Women of Rural Bangladesh 2019 · IFA · Pregnant women aged 12–45 years in rural Bangladesh | 27 mg | 165 days | 777 |
| Iron protein succinylate in the treatment of iron deficiency: controlled, double-blind, multicenter clinical trial on over 1,000 patients 1993 · ITF 282 · Patients with iron deficiency or overt iron-deficiency anemia; age and sex not specified | 120 mg | 60 days | 549 |
| Iron protein succinylate in the treatment of iron deficiency: controlled, double-blind, multicenter clinical trial on over 1,000 patients 1993 · Ferrous sulphate · Patients with iron deficiency or overt iron-deficiency anemia; age and sex not specified | 105 mg | 60 days | 546 |
| Impact of Preconception Micronutrient Supplementation on Anemia and Iron Status during Pregnancy and Postpartum: A Randomized Controlled Trial in Rural Vietnam 2016 · IFA (iron and folic acid) · Women aged 18–40 planning pregnancy in rural Vietnam; no specific diagnosed condition required | 8.57 mg | 56 weeks | 518 |
| A Prenatal Multiple Micronutrient Supplement Produces Higher Maternal Vitamin B-12 Concentrations and Similar Folate, Ferritin, and Zinc Concentrations as the Standard 60-mg Iron Plus 400-μg Folic Acid Supplement in Rural Bangladeshi Women 2016 · Fe30F · Pregnant women in rural Bangladesh enrolled before 14 weeks of pregnancy | 30 mg | 114 days | 213 |
| Including 60 mg Elemental Iron in a Multiple Micronutrient Supplement Blunts the Increase in Serum Zinc after 12 Weeks of Daily Supplementation in Predominantly Anemic, Nonpregnant Cambodian Women of Reproductive Age 2019 · Fe · Predominantly anemic, nonpregnant women aged 18–45 years | 60 mg | 12 weeks | 201 |
| Hepcidin-guided screen-and-treat interventions against iron-deficiency anaemia in pregnancy: a randomised controlled trial in The Gambia 2019 · 60 mg screen-and-treat approach · Pregnant women aged 18–45 years at 14–22 weeks’ gestation in The Gambia; anaemia was common in the study population, but women were not selected for a diagnosis or deficiency | 60 mg | 12 weeks | 166 |
| Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh 2020 · IFA · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified | 27 mg | — | 157 |
| Ferritin-guided iron supplementation as an alternative or complement to prolonged blood donation intervals (FORTE): a double-blind, randomised, controlled trial 2025 · 60 mg daily group · Blood donors aged 18–80 years with ferritin levels ≤30 μg/L | 60 mg | 8 weeks | 114 |
| Weekly iron-folic acid supplements containing 2.8 mg folic acid are associated with a lower risk of neural tube defects than the current practice of 0.4 mg: a randomised controlled trial in Malaysia 2020 · 2.8 mg folic acid group · Women aged 18–45 years, predominantly 18–21, non-pregnant and not planning pregnancy | 8.57 mg | 16 weeks | 111 |
| Iron prophylaxis during pregnancy -- how much iron is needed? A randomized dose- response study of 20-80 mg ferrous iron daily in pregnant women 2005 · 80 mg group · Healthy pregnant women, from 18 weeks of gestation | 80 mg | — | 108 |
| Iron prophylaxis during pregnancy -- how much iron is needed? A randomized dose- response study of 20-80 mg ferrous iron daily in pregnant women 2005 · 60 mg group · Healthy pregnant women, from 18 weeks of gestation | 60 mg | — | 106 |
| Consumption of multiple micronutrients or small-quantity lipid-based nutrient supplements containing iodine at the recommended dose during pregnancy, compared with iron and folic acid, does not affect women's urinary iodine concentration in rural Malawi: a secondary outcome analysis of the iLiNS DYAD trial 2021 · MMN group · Pregnant women enrolled at no more than 20 completed weeks of pregnancy in rural Malawi | 20 mg | — | 106 |
| Effect of supplementation with ferrous sulfate or iron bis-glycinate chelate on ferritin concentration in Mexican schoolchildren: a randomized controlled trial 2014 · Bis-glycinate chelate iron · Children aged 5–13 years with low iron stores but no anemia | 30 mg | 90 days | 101 |
| Effect of supplementation with ferrous sulfate or iron bis-glycinate chelate on ferritin concentration in Mexican schoolchildren: a randomized controlled trial 2014 · Ferrous sulfate · Children aged 5–13 years with low iron stores but no anemia | 30 mg | 90 days | 99 |
| A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy 2018 · oral ferrous sulphate · Pregnant women with iron deficiency anaemia; median age 28 years and median gestation 27 weeks | 325 mg | — | 81 |
| Body iron and individual iron prophylaxis in pregnancy--should the iron dose be adjusted according to serum ferritin? 2006 · 60 mg group · Healthy pregnant women; age and sex beyond pregnancy not specified | 60 mg | — | 77 |
| Body iron and individual iron prophylaxis in pregnancy--should the iron dose be adjusted according to serum ferritin? 2006 · 80 mg group · Healthy pregnant women; age and sex beyond pregnancy not specified | 80 mg | — | 75 |
| Iron status markers and serum erythropoietin in 120 mothers and newborn infants. Effect of iron supplementation in normal pregnancy 1994 · iron treated group · Healthy pregnant women assessed at 14–16 weeks of gestation | 66 mg | — | 63 |
| Iron supplementation in pregnant Danish women revisited: Effects on prepartum and postpartum iron deficiency, anemia, serum erythropoietin; including iron status, erythropoietin and anthropometrics in newborns. A randomized, placebo-controlled study 2022 · iron-treated · Pregnant women with normal pregnancies; age and iron-status eligibility are not reported | 66 mg | — | 62 |
| Neonatal outcomes from a randomized controlled trial of maternal treatment of iron deficiency anemia with intravenous ferumoxytol vs oral ferrous sulfate 2023 · oral ferrous sulfate · Pregnant participants with anemia by World Health Organization criteria | 650 mg | — | 62 |
| Milk versus medicine for the treatment of iron deficiency anaemia in hospitalised infants 2005 · iron medicine · Infants aged 9–23 months with iron deficiency anaemia, hospitalised with an acute illness | 3 mg/kg | 90 days | 59 |
| [Clinical experience with iron supplementation in pregnancy] 1998 · Ferrous sulfate group · Pregnant women with Hb <110 g/L, enrolled before 36 gestational weeks | 900 mg | — | 50 |
| Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial 2013 · Group A · Pregnant women with iron deficiency anemia (hemoglobin 7–9 g/dL, MCV <85 fL, and serum ferritin <15 ng/mL) | 180 mg | 4 weeks | 50 |
| Effect of iron supplementation from neonatal period on the iron status of6-month-old infants at-risk for early iron deficiency: a randomized interventional trial 2021 · Iron supplementation, infants of anemic mothers · Term infants (37–41 weeks) of anemic mothers; at risk for early iron deficiency | 2 mg/kg | 26 weeks | 50 |
| Effect of iron supplementation from neonatal period on the iron status of6-month-old infants at-risk for early iron deficiency: a randomized interventional trial 2021 · Iron supplementation, infants of non-anemic mothers · Term infants (37–41 weeks) of non-anemic mothers; at risk for early iron deficiency | 2 mg/kg | 26 weeks | 50 |
| A randomized placebo-controlled trial of iron supplementation in breastfed young infants initiated on complementary feeding: effect on haematological status 2004 · IS group · Healthy, non-low-birth-weight, predominantly breastfed infants aged 4–6 months, starting complementary feeding | 2 mg/kg | 8 weeks | 49 |
| Early versus late enteral prophylactic iron supplementation in preterm very low birth weight infants: a randomised controlled trial 2014 · Late iron (LI) group · Preterm very low birth weight infants, randomised at 2 weeks postnatal age | 2 mg/kg | 6 weeks | 47 |
| Early versus late enteral prophylactic iron supplementation in preterm very low birth weight infants: a randomised controlled trial 2014 · Early iron (EI) group · Preterm very low birth weight infants, randomised at 2 weeks postnatal age | 2 mg/kg | 10 weeks | 46 |
| A randomized controlled trial comparing oral and intravenous iron supplementation after Roux-en-Y gastric bypass surgery 2020 · Ferrous fumarate (FF) · Women with iron deficiency (serum ferritin <20 μg/l) after Roux-en-Y gastric bypass | 600 mg | 90 days | 41 |
| A randomized controlled trial comparing oral and intravenous iron supplementation after Roux-en-Y gastric bypass surgery 2020 · Ferrous gluconate (FG) · Women with iron deficiency (serum ferritin <20 μg/l) after Roux-en-Y gastric bypass | 1.39 g | 90 days | 39 |
| Effect of ferric citrate hydrate on fibroblast growth factor 23 and platelets in non-dialysis-dependent chronic kidney disease and non-chronic kidney disease patients with iron deficiency anemia 2024 · FC-high group · Japanese adults aged 20 years or older, women and men, with iron deficiency anemia, with or without non-dialysis-dependent chronic kidney disease | 1 g | 24 weeks | 37 |
| The efficacy and safety of early supplementation of iron polymaltose complex in preterm infants 2007 · 4-week group · Preterm infants with gestational age ≤32 weeks fed enriched human milk | 5 mg/kg | 4 weeks | 36 |
| Effect of ferric citrate hydrate on fibroblast growth factor 23 and platelets in non-dialysis-dependent chronic kidney disease and non-chronic kidney disease patients with iron deficiency anemia 2024 · FC-low group · Japanese adults aged 20 years or older, women and men, with iron deficiency anemia, with or without non-dialysis-dependent chronic kidney disease | 500 mg | 24 weeks | 36 |
| Iron concentration in breast milk normalised within one week of a single high-dose infusion of iron isomaltoside in randomised controlled trial 2017 · oral iron group · Postpartum women treated for postpartum haemorrhage; age and sex details beyond women not reported | 70.5 mg | 7 days | 35 |
| The efficacy and safety of early supplementation of iron polymaltose complex in preterm infants 2007 · 2-week group · Preterm infants with gestational age ≤32 weeks fed enriched human milk | 5 mg/kg | 6 weeks | 32 |
| Acupuncture Improves Intestinal Absorption of Iron in Iron-deficient Obese Patients: A Randomized Controlled Preliminary Trial 2017 · Acupuncture group · Adults aged 20–55 years with obesity and iron deficiency or iron-deficiency anemia | 5 mg/kg | 6 weeks | 30 |
| Acupuncture Improves Intestinal Absorption of Iron in Iron-deficient Obese Patients: A Randomized Controlled Preliminary Trial 2017 · Control group · Adults aged 20–55 years with obesity and iron deficiency or iron-deficiency anemia | 5 mg/kg | 6 weeks | 30 |
| Effect of Ferric Citrate versus Ferrous Sulfate on Iron and Phosphate Parameters in Patients with Iron Deficiency and CKD: A Randomized Trial 2020 · ferric citrate · Adults with moderate to severe chronic kidney disease and iron deficiency | 6 g | 12 weeks | 30 |
| Effect of Ferric Citrate versus Ferrous Sulfate on Iron and Phosphate Parameters in Patients with Iron Deficiency and CKD: A Randomized Trial 2020 · ferrous sulfate · Adults with moderate to severe chronic kidney disease and iron deficiency | 975 mg | 12 weeks | 30 |
| Prophylactic iron supplementation after Roux-en-Y gastric bypass: a prospective, double-blind, randomized study 1998 · oral iron · Menstruating women after Roux-en-Y gastric bypass | 640 mg | 2 years | 29 |
| Total infusion of low molecular weight iron-dextran for treating postpartum anemia 2011 · Group B · Postpartum women with iron-deficiency anemia | 800 mg | 30 days | 26 |
| Effect of daily supplementation with iron and zinc on iron status of childbearing age women 2015 · group 2 · Women aged 18–45 years of childbearing age | 30 mg | 90 days | 26 |
| Iron Absorption from Iron-Biofortified Sweetpotato Is Higher Than Regular Sweetpotato in Malawian Women while Iron Absorption from Regular and Iron-Biofortified Potatoes Is High in Peruvian Women 2020 · Regular orange-fleshed sweetpotato test meal (Malawi) · Women aged 18–35 with low iron stores, weighing under 65 kg and not pregnant or lactating, in Malawi | 330 mcg | 10 days | 24 |
| Iron Absorption from Iron-Biofortified Sweetpotato Is Higher Than Regular Sweetpotato in Malawian Women while Iron Absorption from Regular and Iron-Biofortified Potatoes Is High in Peruvian Women 2020 · Iron-biofortified orange-fleshed sweetpotato test meal (Malawi) · Women aged 18–35 with low iron stores, weighing under 65 kg and not pregnant or lactating, in Malawi | 330 mcg | 10 days | 24 |
| Effect of phosphate binders on supplemental iron absorption in healthy subjects 2002 · iron alone · healthy subjects; age and sex not stated | 65 mg | 1 day | 23 |
| Effect of phosphate binders on supplemental iron absorption in healthy subjects 2002 · iron with sevelamer HCl · healthy subjects; age and sex not stated | 65 mg | 1 day | 23 |
| Effect of Vitamin E With Therapeutic Iron Supplementation on Iron Repletion and Gut Microbiome in US Iron Deficient Infants and Toddlers 2016 · iron + placebo (Fe group) · Infants and toddlers aged 9–24 months with iron deficiency or iron deficiency anemia | 6 mg/kg | 8 weeks | 22 |
| Total iron absorption by young women from iron-biofortified pearl millet composite meals is double that from regular millet meals but less than that from post-harvest iron-fortified millet meals 2013 · Post-harvest iron-fortified millet meal · Women aged 17–35 with marginal iron stores, nonpregnant and nonlactating | 8.2 mg | 5 days | 20 |
| Iron absorption following a single oral dose of ferrous sulfate or ferric gluconate in patients with gastrectomy 2013 · Ferrous sulfate (FeS) · Gastrectomized patients with iron deficiency anemia; age and sex not reported | 105 mg | 1 day | 20 |
| Iron absorption following a single oral dose of ferrous sulfate or ferric gluconate in patients with gastrectomy 2013 · Ferric gluconate (FeG) · Gastrectomized patients with iron deficiency anemia; age and sex not reported | 105 mg | 1 day | 20 |
| Comparison of Ferric Sodium EDTA in Combination with Vitamin C, Folic Acid, Copper Gluconate, Zinc Gluconate, and Selenomethionine as Therapeutic Option for Chronic Kidney Disease Patients with Improvement in Inflammatory Status 2022 · Group 1 (ferrous sulfate prolonged-release tablets) · Adults over 18 with functional iron-deficiency anemia and moderate CKD stage 3a–3b | 105 mg | 26 weeks | 20 |
| Relative bioavailability of iron and folic acid from a new powdered supplement compared to a traditional tablet in pregnant women 2009 · Powdered Supplement · Healthy pregnant women aged 18–45 years, at 24–32 weeks’ gestation | 30 mg | 1 day | 18 |
| Iron absorption from soybean ferritin in nonanemic women 2006 · soybean ferritin · Healthy, nonanemic women | 140 mcg | 1 day | 16 |
| Heme iron-based dietary intervention for improvement of iron status in young women 2013 · Fe60 · Women of reproductive age, mean age 24 years | 60 mg | 12 weeks | 13 |
| Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women 2015 · Three 60-mg iron doses within 24 hours · Nonanemic young women with plasma ferritin ≤20 µg/L | 180 mg | 1 day | 13 |
| Oral iron absorption test in patients on CAPD: comparison of ferrous sulfate and a polysaccharide ferric complex 1996 · ferrous sulfate · 5 healthy controls and 7 stable patients on continuous ambulatory peritoneal dialysis (CAPD) | 150 mg | 1 day | 12 |
| Oral iron absorption test in patients on CAPD: comparison of ferrous sulfate and a polysaccharide ferric complex 1996 · polysaccharide ferric complex (Niferex) · 5 healthy controls and 7 stable patients on continuous ambulatory peritoneal dialysis (CAPD) | 150 mg | 1 day | 12 |
| Iron supplementation prevents a decline in iron stores and enhances strength performance in elite female volleyball players during the competitive season 2015 · iron treatment group (ITG) · Elite female volleyball players, mean age 27.0 ± 5.6 years; selected and grouped based on iron status | 325 mg | 11 weeks | 11 |
| Iron Bisglycinate Chelate and Polymaltose Iron for the Treatment of Iron Deficiency Anemia: A Pilot Randomized Trial 2018 · FeP group · Children aged 1–13 years with iron deficiency anemia | 3 mg/kg | 45 days | 11 |
| Iron Bisglycinate Chelate and Polymaltose Iron for the Treatment of Iron Deficiency Anemia: A Pilot Randomized Trial 2018 · FeBC group · Children aged 1–13 years with iron deficiency anemia | 3 mg/kg | 45 days | 9 |
| Iron supplementation in children after cardiopulmonary bypass for surgical repair of congenital heart disease 1994 · iron supplementation group · anemic boys and girls (mean age 6.5 years) after cardiopulmonary bypass for elective closure of a secundum atrial septal defect | 5 mg/kg | 47 days | 8 |
| Comparison of two doses of elemental iron in the treatment of latent iron deficiency: efficacy, side effects and blinding capabilities 2014 · 60 mg iron · Women aged 18–35 with latent iron deficiency | 60 mg | 16 weeks | 7 |
| Effect of high-dose iron supplements on fractional zinc absorption and status in pregnant women 2007 · iron-supplemented group · Pregnant women, iron-replete and consuming a Western diet; gestational ages 16 weeks to term | 100 mg | — | 6 |
| Comparison of two doses of elemental iron in the treatment of latent iron deficiency: efficacy, side effects and blinding capabilities 2014 · 80 mg iron · Women aged 18–35 with latent iron deficiency | 80 mg | 16 weeks | 6 |
| Comparison of Oral Iron Supplement Formulations for Normalization of Iron Status Following Roux-EN-y Gastric Bypass Surgery: a Randomized Trial 2018 · FeSO4 group · Iron-deficient women after Roux-en-Y gastric bypass surgery | 195 mg | 8 weeks | 6 |
| School-administered weekly iron-folate supplements improve hemoglobin and ferritin concentrations in Malaysian adolescent girls 1999 · 60 mg Fe plus 3.5 mg folic acid weekly · Adolescent girls with hemoglobin 80–119.9 g/L (group A, mild-to-moderate anemia) and 120–130 g/L (group B, borderline anemia); otherwise healthy | 8.57 mg | 22 weeks | — |
| School-administered weekly iron-folate supplements improve hemoglobin and ferritin concentrations in Malaysian adolescent girls 1999 · 120 mg Fe plus 3.5 mg folic acid weekly · Adolescent girls with hemoglobin 80–119.9 g/L (group A, mild-to-moderate anemia) and 120–130 g/L (group B, borderline anemia); otherwise healthy | 17.1 mg | 22 weeks | — |
| Effect of daily and intermittent iron supplementation on iron status of high school girls 2000 · Group 1 (daily dose) · High school girls, including anemic and non-anemic students; ages not reported | 150 mg | 90 days | — |
| Effects of iron repletion on blood volume and performance capacity in young athletes 2001 · iron-treated group · Young elite athletes aged 13–25 years, male and female, with low serum ferritin and normal hemoglobin concentration | 200 mg | 12 weeks | — |
| Dietary treatment of iron deficiency in women of childbearing age 2001 · iron supplementation (supplement group) · Iron-deficient women of childbearing age | 105 mg | 12 weeks | — |
| Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route 2002 · PO group · Pregnant patients at 6 months of pregnancy with iron-deficiency anemia, hemoglobin 8–10 g/dL and ferritin <50 microg/L; ages and sex beyond pregnancy not stated | 240 mg | 4 weeks | — |
| Iron absorption in breast-fed infants: effects of age, iron status, iron supplements, and complementary foods 2002 · iron supplements from 4 to 9 months · Healthy, term, breast-fed infants | 1 mg/kg | 150 days | — |
| Iron absorption in breast-fed infants: effects of age, iron status, iron supplements, and complementary foods 2002 · iron supplements from 6 to 9 months · Healthy, term, breast-fed infants | 1 mg/kg | 90 days | — |
| Cofortification of iron-fortified flour with zinc sulfate, but not zinc oxide, decreases iron absorption in Indonesian children 2002 · Iron-fortified flour only · Children aged 4–8 years in Indonesia | 60 mg/kg | 1 day | — |
| Iron supplementation improves iron status and reduces morbidity in children with or without upper respiratory tract infections: a randomized controlled study in Colombo, Sri Lanka 2003 · Iron supplementation, infection group · Children aged 5–10 years with recurrent upper respiratory tract infections and a current upper respiratory tract infection | 60 mg | 8 weeks | — |
| Iron supplementation improves iron status and reduces morbidity in children with or without upper respiratory tract infections: a randomized controlled study in Colombo, Sri Lanka 2003 · Iron supplementation, control group · Children aged 5–10 years without infection | 60 mg | 8 weeks | — |
| A community-based randomized controlled trial of iron and zinc supplementation in Indonesian infants: interactions between iron and zinc 2003 · Fe+Zn group · Indonesian infants aged 6–12 months | 10 mg | 26 weeks | — |
| Selective iron supplementation based on serum ferritin values early in pregnancy: are the Norwegian recommendations satisfactory? 2003 · 60 mg Fe2+ (Ferromax) · Pregnant women with serum ferritin <60 microg/L; supplementation began immediately for serum ferritin <20 microg/L or at 20 weeks for serum ferritin 20–60 microg/L | 60 mg | — | — |
| Iron supplementation and 2-unit red blood cell apheresis: a randomized, double-blind, placebo-controlled study 2004 · Group A (iron phase) · Regular blood donors; age and sex not stated | 100 mg | — | — |
| Iron supplementation and 2-unit red blood cell apheresis: a randomized, double-blind, placebo-controlled study 2004 · Group B (iron phase) · Regular blood donors; age and sex not stated | 100 mg | — | — |
| The effects of short-term iron supplementation on iron status in infants in malaria-endemic areas 2004 · Iron supplementation · Tanzanian infants aged 2–6 months in a malaria-endemic area | 2 mg/kg | 122 days | — |
| Zinc plus beta-carotene supplementation of pregnant women is superior to beta-carotene supplementation alone in improving vitamin A status in both mothers and infants 2004 · zinc · Pregnant women; age and specific condition not stated | 30 mg | — | — |
| Effect of postpartum iron supplementation on red cell and iron parameters in non-anaemic iron-deficient women: a randomised placebo-controlled study 2005 · oral iron sulphate · postpartum women with antenatal iron deficiency who were non-anaemic around delivery | 80 mg | 12 weeks | — |
| Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis 2005 · oral FeSO4 · Patients with anemia and chronic kidney disease not on dialysis, receiving erythropoietin; age and sex not reported | 975 mg | 29 days | — |
| Efficacy of combined iron and zinc supplementation on micronutrient status and growth in Vietnamese infants 2006 · Fe-Zn group · Breast-fed infants aged 4–7 months in rural Vietnam | 10 mg | 26 weeks | — |
| Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy 2006 · Group 1 · Patients participating in an autologous blood donation program before elective surgery; age and sex not reported | 200 mg | — | — |
| Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy 2006 · Group 2 · Patients participating in an autologous blood donation program before elective surgery; age and sex not reported | 200 mg | — | — |
| Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy 2006 · Group 3 · Patients participating in an autologous blood donation program before elective surgery; age and sex not reported | 200 mg | — | — |
| Effect of oral aluminium hydroxide on iron absorption from iron(III)-hydroxide polymaltose complex in patients with iron deficiency anemia / a single-centre randomized controlled isotope study 2007 · Treatment A · Patients with iron-deficiency anemia | 100 mg | 15 days | — |
| Should we lower the dose of iron when treating anaemia in pregnancy? A randomized dose-response trial 2009 · 80 mg iron group · Pregnant women in mid-pregnancy with anaemia (haemoglobin <110 g/L) | 80 mg | 8 weeks | — |
| Absorption of low and therapeutic doses of ferric maltol, a novel ferric iron compound, in iron deficient subjects using a single dose iron absorption test 1991 · 60 mg elemental iron as ferric maltol tablets · Iron-deficient subjects; age and sex not reported | 60 mg | 1 day | — |
| Assessment of iron availability using stable 54Fe 1991 · Iron preparation with dosage of 150 mg Fe2+ daily · Healthy male volunteers with experimentally induced iron deficiency | 150 mg | 90 days | — |
| Assessment of iron availability using stable 54Fe 1991 · Iron preparation with dosage of 160 mg Fe2+ daily · Healthy male volunteers with experimentally induced iron deficiency | 160 mg | 90 days | — |
| A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy 2010 · daily oral iron only · Pregnant women with moderate iron deficiency anaemia | 80 mg | — | — |
| Prevention of iron deficiency with carbonyl iron in female blood donors 1990 · low-dose carbonyl iron · Women aged 18 to 40 who had donated blood and undergone phlebotomy | 100 mg | 8 weeks | — |
| [Dietary supplement of iron for iron deficiency] 2013 · high-dose group · 76 women and men with iron deficiency and mild iron-deficiency anaemia; age not stated | 100 mg | 12 weeks | — |
| Iron-containing micronutrient supplementation of Chinese women with no or mild anemia during pregnancy improved iron status but did not affect perinatal anemia 2014 · IFA group · Pregnant nulliparous women aged 20 years or older, enrolled by 20 weeks’ gestation, with hemoglobin at least 100 g/L and no or mild anemia | 30 mg | — | — |
| Iron-containing micronutrient supplementation of Chinese women with no or mild anemia during pregnancy improved iron status but did not affect perinatal anemia 2014 · MM group · Pregnant nulliparous women aged 20 years or older, enrolled by 20 weeks’ gestation, with hemoglobin at least 100 g/L and no or mild anemia | 30 mg | — | — |
| Iron supplementation until 6 months protects marginally low-birth-weight infants from iron deficiency during their first year of life 2015 · 1 mg/kg/day iron group · Healthy marginally low-birth-weight infants weighing 2000–2500 g | 1 mg/kg | 20 weeks | — |
| Iron supplementation until 6 months protects marginally low-birth-weight infants from iron deficiency during their first year of life 2015 · 2 mg/kg/day iron group · Healthy marginally low-birth-weight infants weighing 2000–2500 g | 2 mg/kg | 20 weeks | — |
| Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women 2015 · 60-mg iron dose · Nonanemic young women with plasma ferritin ≤20 µg/L | 60 mg | 2 days | — |
| Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women 2015 · 80-mg iron dose · Nonanemic young women with plasma ferritin ≤20 µg/L | 80 mg | 2 days | — |
| Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women 2015 · 160-mg iron dose · Nonanemic young women with plasma ferritin ≤20 µg/L | 160 mg | 2 days | — |
| Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women 2015 · 240-mg iron dose · Nonanemic young women with plasma ferritin ≤20 µg/L | 240 mg | 2 days | — |
| Can Iron Treatments Aggravate Epistaxis in Some Patients With Hereditary Hemorrhagic Telangiectasia? 2016 · ferrous sulfate tablet group · healthy male and female volunteers aged 18 to 80 years | 65 mg | 2 days | — |
| The Effectiveness of Different Doses of Iron Supplementation and the Prenatal Determinants of Maternal Iron Status in Pregnant Spanish Women: ECLIPSES Study 2019 · Stratum 1, 80 mg/d iron · Pregnant women over 18 years old with initial hemoglobin 110–130 g/L at week 12 and no anemia | 80 mg | 24 weeks | — |
| Is a Lower Dose of More Bioavailable Iron (18-mg Ferrous Bisglycinate) Noninferior to 60-mg Ferrous Sulfate in Increasing Ferritin Concentrations While Reducing Gut Inflammation and Enteropathogen Detection in Cambodian Women? A Randomized Controlled Noninferiority Trial 2023 · 60-mg ferrous sulfate · Nonpregnant women aged 18–45 years in Cambodia | 60 mg | 12 weeks | — |
| Vitamin C-Rich Guava Consumed with Mungbean Dal Reduces Anemia and Increases Hemoglobin but not Iron Stores: A Randomized Controlled Trial of Food-to-Food Fortification in Indian Children 2024 · mungbean dal with fresh guava · Children aged 6–10 years in rural Haryana, India; the group included children with and without anemia or iron deficiency | 3.2 mg | 213 days | — |
| Evaluation of a gastric delivery system for iron supplementation in pregnancy 1993 · two FeSO4 tablets daily · Pregnant women aged 16–35 years at 14–22 weeks’ gestation with mild anemia (hemoglobin 80–110 g/L) | 100 mg | 12 weeks | — |
| [Evaluation of the bioequivalence of two fast-releasing iron(II) sulfate formulations] 1993 · A: Eryfer 100 · 16 normal female volunteers | 100 mg | 1 day | — |
| An evaluation of the effectiveness of oral iron therapy in hemodialysis patients receiving recombinant human erythropoietin 1997 · Oral iron, iron-replete patients · Hemodialysis patients receiving recombinant human erythropoietin with adequate iron stores | 300 mg | 90 days | — |
| An evaluation of the effectiveness of oral iron therapy in hemodialysis patients receiving recombinant human erythropoietin 1997 · Oral iron, iron-deficient patients · Hemodialysis patients receiving recombinant human erythropoietin with deficient iron stores | 300 mg | 90 days | — |
| The effect of a micronutrient powder home fortification program on anemia and cognitive outcomes among young children in rural China: a cluster randomized trial 2017 · Free MNP Group · Children aged 6–11 months at enrollment in rural southern Shaanxi, China; no specific diagnosed condition stated | 6 mg | 548 days | 1,192 |
| Iron status and inherited haemoglobin disorders modify the effects of micronutrient powders on linear growth and morbidity among young Lao children in a double-blind randomised trial 2019 · MNP group · Children aged 6–23 months in rural Lao PDR; young children, including children with anaemia and inherited haemoglobin disorders | 6 mg | 36 weeks | 852 |
| Effects of iron supplements and iron-containing micronutrient powders on the gut microbiome in Bangladeshi infants: a randomized controlled trial 2024 · MNPs · Infants recruited at 8 months of age in rural Bangladesh | 12.5 mg | 13 weeks | 307 |
| Effect of low-iron micronutrient powder (MNP) on the composition of gut microbiota of Bangladeshi children in a high-iron groundwater setting: a randomized controlled trial 2021 · Low-iron MNP · Children aged 2–5 years living in Belkuchi, Bangladesh, exposed to high-iron groundwater | 5 mg | 60 days | 27 |
| Effect of low-iron micronutrient powder (MNP) on the composition of gut microbiota of Bangladeshi children in a high-iron groundwater setting: a randomized controlled trial 2021 · Standard MNP · Children aged 2–5 years living in Belkuchi, Bangladesh, exposed to high-iron groundwater | 12.5 mg | 60 days | 26 |
| Effect of Micronutrient Powder (MNP) with a Low-Dose of Iron on Hemoglobin and Iron Biomarkers, and Its Effect on Morbidities in Rural Bangladeshi Children Drinking Groundwater with a High-Level of Iron: A Randomized Controlled Trial 2019 · low-dose-iron MNP · Bangladeshi children aged 2–5 years drinking groundwater with a high level of iron | 5 mg | 60 days | — |
| Effect of Micronutrient Powder (MNP) with a Low-Dose of Iron on Hemoglobin and Iron Biomarkers, and Its Effect on Morbidities in Rural Bangladeshi Children Drinking Groundwater with a High-Level of Iron: A Randomized Controlled Trial 2019 · standard MNP · Bangladeshi children aged 2–5 years drinking groundwater with a high level of iron | 12.5 mg | 60 days | — |
| Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients 2016 · SFOH · Dialysis patients with chronic kidney disease; analyzed subpopulations included patients taking stable oral VDRAs, no concomitant VDRAs, or stable intravenous paricalcitol | 1 g | 52 weeks | 710 |
| A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients 2014 · PA21 group (stage 1) · Adults aged 18 years or older with hyperphosphatemia receiving maintenance hemodialysis or peritoneal dialysis | 1 g | 24 weeks | 694 |
| Impact of Preconception Micronutrient Supplementation on Anemia and Iron Status during Pregnancy and Postpartum: A Randomized Controlled Trial in Rural Vietnam 2016 · Multiple micronutrients (MM) · Women aged 18–40 planning pregnancy in rural Vietnam; no specific diagnosed condition required | 8.57 mg | 56 weeks | 508 |
| Reticulocyte haemoglobin equivalent (RET-He) as an early marker of responsiveness to oral iron supplementation 2023 · daily iron supplementation · Cambodian women aged 18–45 years | 60 mg | 12 weeks | 356 |
| Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial
2017 · Oral iron · Adults with nondialysis-dependent chronic kidney disease, anemia, and iron deficiency; no ESA therapy at enrollment | 304 mg | 52 weeks | 317 |
| Benefits of pre-operative oral Sucrosomial® iron supplementation in cardiac surgery: influence of patient's baseline hemoglobin and gender 2023 · Iron group · Adults of unspecified age and sex undergoing elective cardiac surgery | 60 mg | 30 days | 309 |
| Provision of Lipid-Based Nutrient Supplements to Mothers During Pregnancy and 6 Months Postpartum and to Their Infants from 6 to 18 Months Promotes Infant Gut Microbiota Diversity at 18 Months of Age but Not Microbiota Maturation in a Rural Malawian Setting: Secondary Outcomes of a Randomized Trial 2020 · MMN group · Pregnant women aged 15 years or older, enrolled at 20 or more weeks of gestation; mothers and infants in the MMN group, with no direct infant supplementation | 20 mg | 548 days | 291 |
| Antenatal iron supplementation, FGF23, and bone metabolism in Kenyan women and their offspring: secondary analysis of a randomized controlled trial 2021 · Iron · Pregnant women aged 15–45 years with singleton pregnancies, 13–23 weeks’ gestation and hemoglobin concentration ≥90 g/L; offspring biomarkers were also assessed at birth. | 60 mg | 150 days | 235 |
| Prenatal nutrition supplementation and growth biomarkers in preadolescent Bangladeshi children: A birth cohort study 2022 · Fe30F · Pregnant women in rural Bangladesh; age and sex beyond pregnancy not specified | 30 mg | — | 189 |
| Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial 2007 · oral ferrous sulfate · Anemic postpartum women with hemoglobin ≤10 g/dL, enrolled within 10 days postpartum | 975 mg | 6 weeks | 178 |
| Comparison of intravenous ferrous sucrose and oral ferrous sulphate in treatment of postpartum iron deficiency anemia 2017 · oral ferrous sulphate · Women with postpartum iron deficiency anemia, two days after delivery | 300 mg | 6 weeks | 176 |
| Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study 2021 · FC-low group · Japanese adults aged 20 years or older with iron deficiency anemia; almost all participants were premenopausal women | 500 mg | 7 weeks | 174 |
| Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study 2021 · FC-high group · Japanese adults aged 20 years or older with iron deficiency anemia; almost all participants were premenopausal women | 1 g | 7 weeks | 172 |
| Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study 2021 · SF group · Japanese adults aged 20 years or older with iron deficiency anemia; almost all participants were premenopausal women | 100 mg | 7 weeks | 172 |
| [Comparison of the efficacy and safety between high-dose intravenous iron and oral iron in treating iron deficiency anemia: a multicenter, prospective, open-label, randomized controlled study] 2024 · 口服组(oral group) · Adults aged 18 years or older with iron deficiency anemia and low iron stores (serum ferritin <100 µg/L and transferrin saturation <20%) | 300 mg | — | 169 |
| Iron supplementation in singleton pregnancy: Is there a benefit to doubling the dose of elemental iron in iron-deficient pregnant women? a randomized controlled trial 2017 · Two capsules daily · Pregnant women with iron deficiency anemia in singleton pregnancies, randomized during the second trimester | 68 mg | — | 164 |
| Prenatal nutrition supplementation and growth biomarkers in preadolescent Bangladeshi children: A birth cohort study 2022 · MM · Pregnant women in rural Bangladesh; age and sex beyond pregnancy not specified | 30 mg | — | 162 |
| The Effect of Oral Iron Supplementation on Gut Microbial Composition: a Secondary Analysis of a Double-Blind, Randomized Controlled Trial among Cambodian Women of Reproductive Age 2023 · 60 mg ferrous sulfate · Non-pregnant Cambodian women aged 18–45; generally healthy, with some participants anemic or iron deficient | 60 mg | 12 weeks | 160 |
| Iron prophylaxis in pregnancy: intravenous route versus oral route 2009 · Oral iron group · Pregnant women with singleton pregnancies, enrolled at 21–24 weeks’ gestation, receiving iron prophylaxis | 80 mg | — | 130 |
| Is every other day iron supplementation effective for the treatment of the iron deficiency anemia in pregnancy? 2022 · daily intake group · Pregnant women with iron-deficiency anemia; age and sex details beyond pregnancy not reported | 100 mg | 60 days | 124 |
| A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial 2016 · Oral iron sulfate · Adults aged 18 years or older with nonmyeloid malignancies, anemia, and receiving chemotherapy | 200 mg | 12 weeks | 119 |
| A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia 2016 · Group B (oral iron sulphate) · Adults aged 18 years or older with non-dialysis-dependent chronic kidney disease, renal-related anaemia and iron deficiency | 200 mg | 8 weeks | 118 |
| Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia 2008 · ferrous sulfate · postpartum patients with iron deficiency anemia | 200 mg | 12 weeks | 117 |
| Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses 2019 · Ferric citrate · Adults with nondialysis-dependent chronic kidney disease and iron-deficiency anemia | 3 g | 16 weeks | 117 |
| Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients 2009 · Oral iron · Anemic adults with stage 5D chronic kidney disease receiving hemodialysis and a stable erythropoiesis-stimulating agent regimen | 200 mg | 3 weeks | 116 |
| A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED) 2013 · B · Adults aged 18 years or older with inflammatory bowel disease and iron-deficiency anemia | 200 mg | 8 weeks | 113 |
| Oral Ferric Maltol for the Treatment of Iron-Deficiency Anemia in Patients With CKD: A Randomized Trial and Open-Label Extension 2021 · Ferric maltol · Adults with stage 3 or 4 chronic kidney disease and iron-deficiency anemia | 60 mg | 52 weeks | 111 |
| Consumption of multiple micronutrients or small-quantity lipid-based nutrient supplements containing iodine at the recommended dose during pregnancy, compared with iron and folic acid, does not affect women's urinary iodine concentration in rural Malawi: a secondary outcome analysis of the iLiNS DYAD trial 2021 · LNS group · Pregnant women enrolled at no more than 20 completed weeks of pregnancy in rural Malawi | 20 mg | — | 107 |
| Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): a multicentre, open-label, randomised, controlled trial 2023 · oral iron treatment · Adults aged 18 years or older with iron deficiency anaemia and M0 stage colorectal cancer scheduled for elective curative resection | 600 mg | — | 106 |
| A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients 2011 · Oral iron · Adults and adolescents aged 12 years or older with iron-deficiency anaemia and non-dialysis-dependent chronic kidney disease | 975 mg | 8 weeks | 103 |
| Iron supplementation during pregnancy. Effect on iron status markers, serum erythropoietin and human placental lactogen. A placebo controlled study in 207 Danish women 1991 · iron treated group · Healthy pregnant women with uncomplicated pregnancies, from the 16th week of gestation until delivery | 66 mg | — | 100 |
| Compliance with home-based fortification strategies for delivery of iron and zinc: its effect on haematological and growth markers among 6-24 months old children in north India 2014 · Sprinkle and nutrition education (Mp) · Children aged 6–24 months in North Delhi, India; children were not selected for a diagnosed condition or documented nutrient deficiency. | 12.5 mg | 26 weeks | 97 |
| [Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study] 2009 · Oral medication group · Adults on maintenance dialysis with renal anemia (Hb 60–100 g/L and Hct 18%–30%); age and sex not specified | 600 mg | 12 weeks | 92 |
| Iron Supplementation in Twin Pregnancy - The Benefit of Doubling the Iron Dose in Iron Deficient Pregnant Women: A Randomized Controlled Trial 2017 · group B · Iron-deficient women with twin gestations, from 16 weeks of pregnancy through 6 weeks postpartum | 68 mg | — | 87 |
| Daily versus twice daily dose of ferrous sulphate supplementation in pregnant women: A randomized clinical trial 2019 · once daily dose · Pregnant women at 14–24 weeks’ gestation with haemoglobin ≥10 g/dl and ≤14.5 g/dl | 65 mg | — | 84 |
| Daily versus twice daily dose of ferrous sulphate supplementation in pregnant women: A randomized clinical trial 2019 · twice daily dose · Pregnant women at 14–24 weeks’ gestation with haemoglobin ≥10 g/dl and ≤14.5 g/dl | 130 mg | — | 80 |
| Multivitamin-mineral supplementation is not as efficacious as is iron supplementation in improving hemoglobin concentrations in nonpregnant anemic women living in Mexico 2004 · Fe group · Nonpregnant women recruited from a semirural community in Mexico, including anemic and nonanemic women | 60 mg | 12 weeks | 77 |
| Role of oral iron supplementation for anemia secondary to acute nonvariceal upper gastrointestinal bleeding: a randomized controlled trial 2023 · treatment group · Patients with anemia at discharge after nonvariceal upper gastrointestinal bleeding; age and sex not specified | 600 mg | 6 weeks | 77 |
| Efficacy of iron fortification compared to iron supplementation among Vietnamese schoolchildren 2006 · Fe tablet+MEB (iron supplementation and mebendazole) · Anaemic Vietnamese grade 1–3 schoolchildren; mean age 87.3 months | 200 mg | 26 weeks | 76 |
| [Use of daily and weekly ferrous sulfate to treat anemic childbearing-age women] 1999 · conventional daily regimen · Menstruating women aged 15–45 years with anemia (Hb <12 mg/dl) in a low-income community | 60 mg | 12 weeks | 71 |
| A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia 2008 · Control group · Postpartum women with hemorrhagic anemia (Hb 6.5–8.5 g/100 ml) | 200 mg | 12 weeks | 70 |
| Effects of weekly iron supplementation on pregnant Indonesian women are similar to those of daily supplementation 1996 · daily iron group · Pregnant women, 8–24 weeks’ gestation | 60 mg | 79 days | 68 |
| Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia 2008 · oral ferrous succinate group · Chinese patients on maintenance hemodialysis with renal anemia | 600 mg | 12 weeks | 66 |
| Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program 2015 · ferric maltol · Adults aged 18 years or older with Crohn's disease or ulcerative colitis and mild-to-moderate iron deficiency anemia, previously intolerant of or unresponsive to oral ferrous iron preparations | 463 mg | 85 days | 64 |
| A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial 2008 · FeSulf group · Adults with inflammatory bowel disease and iron deficiency anemia; age and sex not specified | 200 mg | 12 weeks | 63 |
| Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty 2014 · FS · Adults with postoperative anaemia after total knee arthroplasty | 100 mg | 24 days | 62 |
| Intravenous infusions of ferumoxytol compared to oral ferrous sulfate for the treatment of anemia in pregnancy: a randomized controlled trial 2023 · oral iron group · Pregnant participants with anemia (hemoglobin <11 g/dL and hematocrit <33%) | 650 mg | — | 62 |
| Serum erythropoietin during normal pregnancy: relationship to hemoglobin and iron status markers and impact of iron supplementation in a longitudinal, placebo-controlled study on 118 women 1997 · iron-treated women · Women with normal pregnancy, from the second trimester until delivery | 66 mg | — | 61 |
| Ferrous sulfate versus iron polymaltose complex for treatment of iron deficiency anemia in children 2009 · Group A (oral IPC) · Children with iron deficiency anemia; age and sex not reported | 6 mg/kg | — | 59 |
| Ferrous sulfate versus iron polymaltose complex for treatment of iron deficiency anemia in children 2009 · Group B (oral FS) · Children with iron deficiency anemia; age and sex not reported | 6 mg/kg | — | 59 |
| Oral Ferric Maltol for the Treatment of Iron-Deficiency Anemia in Patients With CKD: A Randomized Trial and Open-Label Extension 2021 · Open-label ferric maltol after placebo · Adults with stage 3 or 4 chronic kidney disease and iron-deficiency anemia who received placebo during the randomized phase | 60 mg | 36 weeks | 56 |
| Daily versus intermittent iron supplementation in pregnant women: hematological and pregnancy outcome 2004 · daily iron group · pregnant women; age and sex beyond pregnancy not reported; anemia status varied | 100 mg | 17 weeks | 55 |
| Comparative bioavailability of ferric polymaltose and ferrous sulphate in iron-deficient blood donors 1993 · Group 3 · Otherwise healthy blood donors with absolute iron deficiency anaemia | 200 mg | 12 weeks | 55 |
| Comparative bioavailability of ferric polymaltose and ferrous sulphate in iron-deficient blood donors 1993 · Group 2 · Otherwise healthy blood donors with absolute iron deficiency anaemia | 100 mg | 12 weeks | 53 |
| Moderate NaFeEDTA and ferrous sulfate supplementation can improve both hematologic status and oxidative stress in anemic pregnant women 2011 · group I · Anemic pregnant women with Hb 80 to <110 g/L | 60 mg | 60 days | 51 |
| Moderate NaFeEDTA and ferrous sulfate supplementation can improve both hematologic status and oxidative stress in anemic pregnant women 2011 · group IE · Anemic pregnant women with Hb 80 to <110 g/L | 60 mg | 60 days | 51 |
| Comparative bioavailability of ferric polymaltose and ferrous sulphate in iron-deficient blood donors 1993 · Group 1 · Otherwise healthy blood donors with absolute iron deficiency anaemia | 120 mg | 12 weeks | 51 |
| Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study 2016 · continued group · Adult men and women with ulcerative colitis or Crohn's disease, mild-to-moderate iron deficiency anaemia, and previous failure of oral iron therapy | 60 mg | 446 days | 50 |
| Efficacy and Mechanism of Buxue Yimu Pills on Gynecological Anemia: A Combination of Clinical and Network Pharmacology Study 2022 · Oral iron group · Patients with gynecological anemia due to gynecological conditions, hemoglobin 70–110 g/L | 900 mg | 4 weeks | 50 |
| Comparative study of tolerability and efficacy of iron protein succinylate versus iron hydroxide polymaltose complex in the treatment of iron deficiency in children 1998 · group A · Children aged 12–113 months, male and female, with sideropenia or sideropenic anemia | 4 mg/kg | 60 days | 50 |
| Comparative study of tolerability and efficacy of iron protein succinylate versus iron hydroxide polymaltose complex in the treatment of iron deficiency in children 1998 · group B · Children aged 12–113 months, male and female, with sideropenia or sideropenic anemia | 4 mg/kg | 60 days | 50 |
| [The effectiveness of three regimens using ferrous sulfate to treat anemia in pregnant women] 2004 · once a day · Pregnant women with anemia | 60 mg | — | 49 |
| A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients 2014 · Low-dose PA21 group (stage 2) · Adults on hemodialysis with hyperphosphatemia who had received PA21 in stage 1 | 250 mg | 3 weeks | 49 |
| Efficacy and tolerability of oral bovine lactoferrin compared to ferrous sulfate in pregnant women with iron deficiency anemia: a prospective controlled randomized study 2009 · Group B · Pregnant women with iron deficiency anemia | 520 mg | 30 days | 48 |
| Association of fibroblast growth factor 23 and α-klotho in hemodialysis patients during administration of ferric citrate hydrate: post hoc analysis of ASTRIO study 2021 · FC group · Adults aged 20 years or older with chronic kidney disease undergoing hemodialysis, hyperphosphatemia, and renal anemia | 750 mg | 24 weeks | 48 |
| Ferric citrate hydrate is associated with a reduced cost of drugs and a smaller change in red blood cell distribution width 2022 · FC group · Japanese adults aged 20 years or older with hyperphosphataemia and renal anaemia, receiving maintenance haemodialysis and ESA therapy | 750 mg | 24 weeks | 48 |
| A combination of iron and retinol supplementation benefits iron status, IL-2 level and lymphocyte proliferation in anemic pregnant women 2010 · Group I · Anemic pregnant women with hemoglobin 80 to less than 110 g/L | 60 mg | 60 days | 47 |
| Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study 2016 · switch group · Adult men and women with ulcerative colitis or Crohn's disease, mild-to-moderate iron deficiency anaemia, and previous failure of oral iron therapy | 60 mg | 1 year | 47 |
| Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study 2019 · FC group · Adults aged 20 years or older with hyperphosphataemia and renal anaemia who were receiving maintenance haemodialysis and erythropoiesis-stimulating agent therapy | 1.5 g | 24 weeks | 46 |
| An open-label, crossover study of a new phosphate-binding agent in haemodialysis patients: ferric citrate 2002 · ferric citrate · Adults with end-stage renal disease receiving haemodialysis; 23 women and 22 men in the study sample, average age 52.5 years | 3 g | 4 weeks | 45 |
| Oral Iron Treatment Response and Predictors in Anaemic Adolescents and Adults with IBD: A Prospective Controlled Open-Label Trial 2017 · adolescents · Adolescents aged 13–18 years with IBD and anaemia | 400 mg | 6 weeks | 45 |
| Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study 2021 · Group A (Sucrosomial iron) · Adults over 18 with iron deficiency anemia, iron sulfate intolerance or inadequate response, and no significant comorbidities | 60 mg | 30 days | 45 |
| Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy 2007 · Oral iron · Adults with chemotherapy-related anemia and cancer receiving chemotherapy and epoetin alfa | 975 mg | 8 weeks | 44 |
| Iron Supplementation with Ferrous Sulfate or Ferrous Bisglycinate for 12 Weeks Does Not Influence Group B Streptococcus Colonization in Cambodian Women: A Secondary Analysis of a Randomized Controlled Trial 2025 · ferrous sulfate · Healthy, nonpregnant women aged 18–45 years in Kampong Thom, Cambodia | 60 mg | 12 weeks | 44 |
| Oral Iron Treatment Response and Predictors in Anaemic Adolescents and Adults with IBD: A Prospective Controlled Open-Label Trial 2017 · adults · Adults older than 18 years with IBD and anaemia | 400 mg | 6 weeks | 43 |
| Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study 2011 · iron(III) polymaltose complex · Pregnant women with iron-deficiency anemia | 200 mg | 90 days | 41 |
| Milk fortified with iron or iron supplementation to improve nutritional status of pregnant women: an intervention trial from rural Vietnam 2005 · iron supplement group · Pregnant women in rural Vietnam; age and baseline condition not specified | 60 mg | 16 weeks | 40 |
| Iron supplementation in premature infants using the zinc protoporphyrin to heme ratio: short- and long-term outcomes 2013 · control group · Premature infants born at 27–30 completed weeks of gestation, older than 1 week, tolerating enteral feedings, and at risk for iron deficiency | 2.2 mg/kg | — | 40 |
| Effect of Low-Dose Ferrous Sulfate vs Iron Polysaccharide Complex on Hemoglobin Concentration in Young Children With Nutritional Iron-Deficiency Anemia: A Randomized Clinical Trial 2017 · ferrous sulfate group · Infants and children aged 9 to 48 months with nutritional iron-deficiency anemia | 3 mg/kg | 12 weeks | 40 |
| Effect of Low-Dose Ferrous Sulfate vs Iron Polysaccharide Complex on Hemoglobin Concentration in Young Children With Nutritional Iron-Deficiency Anemia: A Randomized Clinical Trial 2017 · iron polysaccharide complex group · Infants and children aged 9 to 48 months with nutritional iron-deficiency anemia | 3 mg/kg | 12 weeks | 40 |
| Lactoferrin for iron-deficiency anemia in children with inflammatory bowel disease: a clinical trial 2022 · Ferrous sulfate group · Children aged 5–18 years with inflammatory bowel disease in remission and iron-deficiency anemia | 6 mg/kg | 90 days | 40 |
| A randomized controlled trial of oral versus intravenous iron in chronic kidney disease 2006 · oral iron · Adults with anemia and iron deficiency, non-dialysis chronic kidney disease stage 3 or higher, not receiving erythropoiesis-stimulating agents | 975 mg | 6 weeks | 39 |
| Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study 2011 · ferrous sulfate · Pregnant women with iron-deficiency anemia | 200 mg | 90 days | 39 |
| Haematological effect of iron supplementation in breast fed term low birth weight infants 2005 · iron supplemented (IS) group · Predominantly breast-fed term low-birth-weight infants aged 50–80 days | 3 mg/kg | 8 weeks | 37 |
| Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD 2017 · PO (oral) iron therapy · Adults older than 18 years with iron deficiency, including patients with Crohn’s disease or ulcerative colitis and non-IBD anaemic controls; both sexes | 600 mg | 12 weeks | 36 |
| Post-operative anaemia in femoral neck fracture patients: does it need treatment? A single blinded prospective randomised controlled trial 2009 · treatment group · Elderly patients with anaemia after surgical treatment for fractured neck of femur | 600 mg | 4 weeks | 34 |
| Ferrous sulfate (Fe2+) had a faster effect than did ferric polymaltose (Fe3+) on increased oxidant status in children with iron-deficiency anemia 2014 · Fe(2+) group · Children with iron-deficiency anemia; age and sex not specified | 5 mg/kg | 30 days | 33 |
| Randomised clinical trial: intravenous vs oral iron for the treatment of anaemia after acute gastrointestinal bleeding 2019 · oral FeSulf · Adults aged over 18 with anaemia (haemoglobin <10 g/dL) after non-variceal acute gastrointestinal bleeding | 650 mg | 6 weeks | 33 |
| Ferrous sulfate (Fe2+) had a faster effect than did ferric polymaltose (Fe3+) on increased oxidant status in children with iron-deficiency anemia 2014 · Fe(3+) group · Children with iron-deficiency anemia; age and sex not specified | 5 mg/kg | 30 days | 32 |
| Rapid recovery time of hemoglobin level in female regular blood donors with ferrous fumarate and high dose of ascorbic acid supplement 2013 · Group I · Female regular blood donors; age range and health conditions beyond regular blood donation not specified | 200 mg | 30 days | 32 |
| Circulating non-transferrin-bound iron after oral administration of supplemental and fortification doses of iron to healthy women: a randomized study 2014 · 60 mg iron with water · Healthy women with replete or reduced iron stores | 60 mg | 1 day | 32 |
| Circulating non-transferrin-bound iron after oral administration of supplemental and fortification doses of iron to healthy women: a randomized study 2014 · 60 mg iron with a standard test meal · Healthy women with replete or reduced iron stores | 60 mg | 1 day | 32 |
| A randomized controlled trial of thrice-weekly versus thrice-daily oral ferrous fumarate treatment in adult patients with iron-deficiency anemia 2023 · TID arm · Adults older than 18 years with iron-deficiency anemia | 600 mg | 12 weeks | 32 |
| Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia 2020 · BD arm · Patients with iron-deficiency anemia; age and sex not specified | 120 mg | 6 weeks | 31 |
| Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia 2020 · AD arm · Patients with iron-deficiency anemia; age and sex not specified | 60 mg | 6 weeks | 31 |
| Acute Administration of Bioavailable Curcumin Alongside Ferrous Sulphate Supplements Does Not Impair Iron Absorption in Healthy Adults in a Randomised Trial 2021 · FS18_Curc (ferrous sulphate–18 mg elemental iron + 500 mg curcumin) · Healthy adults aged 18–40 years with ferritin in the normal UK range | 55 mg | 1 day | 31 |
| Acute Administration of Bioavailable Curcumin Alongside Ferrous Sulphate Supplements Does Not Impair Iron Absorption in Healthy Adults in a Randomised Trial 2021 · FS65_Plac (ferrous sulphate–65 mg elemental iron + placebo) · Healthy adults aged 18–40 years with ferritin in the normal UK range | 200 mg | 1 day | 31 |
| [Preoperative autologous blood collection under erythropoietin stimulation. Preliminary results in patient selection, erythropoietin dosage and administration] 1992 · Group B (100 IE EPO) · Patients undergoing elective total hip replacement; age and sex not reported | 750 mg | 3 weeks | 30 |
| Efficacy of daily vs. weekly supplementation of iron in schoolchildren with low iron status 2004 · daily supplementation group · Children aged 5–10 years with iron deficiency anemia | 200 mg | 60 days | 30 |
| A randomized controlled trial comparing the efficacy, tolerability, and cost of oral iron preparations in iron-deficiency anemia in pregnancy 2021 · ferrous sulfate (FS) · pregnant women with iron-deficiency anemia | 200 mg | — | 30 |
| A randomized controlled trial comparing the efficacy, tolerability, and cost of oral iron preparations in iron-deficiency anemia in pregnancy 2021 · ferrous fumarate (FF) · pregnant women with iron-deficiency anemia | 200 mg | — | 30 |
| A randomized controlled trial comparing the efficacy, tolerability, and cost of oral iron preparations in iron-deficiency anemia in pregnancy 2021 · ferrous ascorbate (FA) · pregnant women with iron-deficiency anemia | 200 mg | — | 30 |
| A randomized controlled trial comparing the efficacy, tolerability, and cost of oral iron preparations in iron-deficiency anemia in pregnancy 2021 · carbonyl iron (CI) · pregnant women with iron-deficiency anemia | 200 mg | — | 30 |
| An active new formulation of iron carried by aspartyl casein for iron-deficiency anemia: results of the ACCESS trial 2023 · FeSO4 · Adults with iron-deficiency anemia, either sex; mean age approximately 62.5 years | 94 mg | 12 weeks | 30 |
| Low-dose ferric carboxymaltose vs. oral iron for improving hemoglobin levels in postpartum East Asian women: A randomized controlled trial 2025 · Ferrous sulfate group · Postpartum East Asian women aged 20 or older with iron-deficiency anemia (hemoglobin <10 g/dL and serum ferritin ≤30 ng/mL) | 210 mg | 4 weeks | 30 |
| Daily oral iron supplementation produced greater improvements in hematological parameters than alternate day doses - A pilot double-blind randomized control trial in iron-deficient young women 2026 · 60 mg elemental iron daily · Non-pregnant iron-deficient women aged 18–45 years | 60 mg | 2 weeks | 30 |
| Daily oral iron supplementation produced greater improvements in hematological parameters than alternate day doses - A pilot double-blind randomized control trial in iron-deficient young women 2026 · 120 mg elemental iron on alternate days · Non-pregnant iron-deficient women aged 18–45 years | 60 mg | 2 weeks | 30 |
| The impact of intensive serial plasmapheresis and iron supplementation on iron metabolism and Hb concentration in menstruating women: a prospective randomized placebo-controlled double-blind study 2003 · Fe arm · Menstruating women undergoing regular plasmapheresis | 100 mg | 24 weeks | 29 |
| Iron deficiency anaemia: continuous versus intermittent treatment in anaemic children 1998 · Group B · Children aged 1–6 years with iron deficiency anaemia | 6 mg/kg | 60 days | 28 |
| A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients 2001 · daily oral iron supplements · Adults with end-stage renal failure receiving peritoneal dialysis and a stable erythropoietin dose, with normal iron stores and no other identified cause of impaired haemopoiesis | 210 mg | 122 days | 28 |
| Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial 2016 · oral iron group · Adults aged 18 or older with non-dialysis-dependent CKD, anemia and iron deficiency; not receiving ESA therapy | 200 mg | 56 weeks | 28 |
| Intravenous iron sucrose versus oral iron administration for the postoperative treatment of post-bariatric abdominoplasty anaemia: an open-label, randomised, superiority trial in Brazil 2018 · oral group · Women aged 18–55 undergoing post-bariatric abdominoplasty after Roux-en-Y gastric bypass, with stabilised weight loss and BMI below 32 kg/m² | 200 mg | 8 weeks | 28 |
| Iron deficiency anaemia: continuous versus intermittent treatment in anaemic children 1998 · Group A · Children aged 1–6 years with iron deficiency anaemia | 6 mg/kg | 60 days | 27 |
| [Preoperative autologous blood collection under erythropoietin stimulation. Preliminary results in patient selection, erythropoietin dosage and administration] 1992 · Group A (placebo EPO) · Patients undergoing elective total hip replacement; age and sex not reported | 750 mg | 3 weeks | 27 |
| [Preoperative autologous blood collection under erythropoietin stimulation. Preliminary results in patient selection, erythropoietin dosage and administration] 1992 · Group C (200 IE EPO/kg) · Patients undergoing elective total hip replacement; age and sex not reported | 750 mg | 3 weeks | 25 |
| Efficacy and safety of adjuvant recombinant human erythropoietin and ferrous sulfate as treatment for iron deficiency anemia during the third trimester of pregnancy 2016 · Group 2 (iron sulfate) · Pregnant women in the third trimester with iron deficiency anemia and hemoglobin below 11 g/dL | 600 mg | 4 weeks | 25 |
| Efficacy and safety of adjuvant recombinant human erythropoietin and ferrous sulfate as treatment for iron deficiency anemia during the third trimester of pregnancy 2016 · Group 3 (iron sulfate plus adjuvant rHuEPO) · Pregnant women in the third trimester with iron deficiency anemia and hemoglobin below 11 g/dL | 600 mg | 4 weeks | 25 |
| Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron 2018 · Oral iron · Adults with gastrointestinal-related iron-deficiency anemia; mean age 58.0 years, 8 men and 17 women | 975 mg | 2 weeks | 25 |
| Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis 2014 · ferrous sulfate · Adults aged 18 years or older with cystic fibrosis, low transferrin saturation and low hemoglobin | 325 mg | 6 weeks | 24 |
| Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial 1998 · treatment arm · Adults with anaemia and carcinoma of the lung, uterine cervix, prostate or breast receiving radiotherapy | 975 mg | 7 weeks | 24 |
| Pre-operative oral iron supplementation reduces blood transfusion in colorectal surgery - a prospective, randomised, controlled trial 2007 · iron-supplemented group · Adults with colorectal cancer undergoing colorectal resection; age and sex not specified | 600 mg | 2 weeks | 22 |
| Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials 2017 · consecutive-day group · Women aged 18–40 years with iron depletion (serum ferritin ≤25 μg/L) | 60 mg | 2 weeks | 21 |
| Intravenous iron sucrose in peritoneal dialysis patients with renal anemia 2008 · Oral ferrous succinate · Patients on maintenance peritoneal dialysis with renal anemia; age and sex not specified | 600 mg | 8 weeks | 20 |
| A Prospective, Randomized, Interventional Study of Oral Iron Supplementation Comparing Daily Dose with Alternate Day Regimen Using Hepcidin as a Biomarker in Iron Deficiency Anemia 2020 · Group 2 (daily) · Adults with iron deficiency anemia; age and sex not reported | 60 mg | 3 weeks | 20 |
| Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials 2017 · alternate-day group · Women aged 18–40 years with iron depletion (serum ferritin ≤25 μg/L) | 60 mg | 4 weeks | 19 |
| Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease 1996 · oral iron and subcutaneous erythropoietin · Patients with ulcerative colitis or Crohn's disease and anemia refractory to iron therapy | 100 mg | 12 weeks | 17 |
| Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease 1996 · oral iron and placebo · Patients with ulcerative colitis or Crohn's disease and anemia refractory to iron therapy | 100 mg | 12 weeks | 17 |
| The role of high-dose oral iron supplementation during erythropoietin therapy for anemia of prematurity 2001 · low-dose iron group · Preterm infants, gestational age 29±1.8 weeks and age 28±10 days, receiving rHuEPO therapy for anemia of prematurity | 8 mg/kg | 4 weeks | 15 |
| The role of high-dose oral iron supplementation during erythropoietin therapy for anemia of prematurity 2001 · high-dose iron group · Preterm infants, gestational age 29±1.8 weeks and age 28±10 days, receiving rHuEPO therapy for anemia of prematurity | 16 mg/kg | 4 weeks | 15 |
| Safety and efficacy of Ninjin'yoeito along with iron supplementation therapy for preoperative anemia, fatigue, and anxiety in patients with gynecological disease: an open-label, single-center, randomized phase-II trial 2022 · Iron supplementation group · Women aged 20 or older with preoperative iron deficiency anemia scheduled for gynecological surgery | 100 mg | 40 days | 15 |
| Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity 1996 · rHuEPO plus iron · Preterm infants, mean age 34 ± 14 days, receiving treatment for anaemia of prematurity | 6 mg/kg | 4 weeks | 15 |
| Oral iron is sufficient for erythropoietin treatment of very low birth-weight infants 1999 · rHuEPO and oral iron · Very low birth-weight infants | 6 mg/kg | 3 weeks | 14 |
| Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: preliminary results of a randomized, open-labeled, phase II trial 1993 · treatment arm · Cancer patients with lung cancer, cervical carcinoma, prostatic adenocarcinoma, or breast adenocarcinoma receiving radiotherapy, with or without chemotherapy | 975 mg | — | 14 |
| Efficacy and safety of SBR759, a novel calcium-free, iron (III)-based phosphate binder, versus placebo in chronic kidney disease stage V Japanese patients on maintenance renal replacement therapy 2014 · SBR759 3-g/day group · Japanese patients with hyperphosphataemia and chronic kidney disease stage V receiving maintenance renal replacement therapy | 3 g | 4 weeks | 13 |
| Efficacy and safety of SBR759, a novel calcium-free, iron (III)-based phosphate binder, versus placebo in chronic kidney disease stage V Japanese patients on maintenance renal replacement therapy 2014 · SBR759 6-g/day group · Japanese patients with hyperphosphataemia and chronic kidney disease stage V receiving maintenance renal replacement therapy | 6 g | 4 weeks | 13 |
| Efficacy and safety of SBR759, a novel calcium-free, iron (III)-based phosphate binder, versus placebo in chronic kidney disease stage V Japanese patients on maintenance renal replacement therapy 2014 · SBR759 9-g/day group · Japanese patients with hyperphosphataemia and chronic kidney disease stage V receiving maintenance renal replacement therapy | 9 g | 4 weeks | 13 |
| Roxadustat and Oral Iron Absorption in Chinese Patients with Anemia of Chronic Kidney Disease: A Randomized, Open-Label, Phase 4 Study (ALTAI) 2024 · Roxadustat · Adults aged 18 years or older with anemia of stage 4 or 5 chronic kidney disease | 100 mg | 2 weeks | 13 |
| A randomized controlled study of iron supplementation in patients treated with erythropoietin 1996 · Group 2 · Iron-replete renal failure patients commencing erythropoietin, with hemoglobin <8.5 g/dl and initial serum ferritin 100–800 micrograms/liter | 600 mg | 16 weeks | 13 |
| Supplemental zinc lowers measures of iron status in young women with low iron reserves 2002 · iron-supplemented group · Women aged 20–28 years who were nonanemic and had low iron stores (plasma ferritin <20 microg/L) | 100 mg | 6 weeks | 12 |
| Treatment of mild non-chemotherapy-induced iron deficiency anemia in cancer patients: comparison between oral ferrous bisglycinate chelate and ferrous sulfate 2012 · B group (ferrous sulphate) · Adults aged 45–75 with solid tumors and mild iron deficiency anemia, after tumor surgery and not receiving chemotherapy | 105 mg | 60 days | 12 |
| Efficacy and safety of SBR759, a novel calcium-free, iron (III)-based phosphate binder, versus placebo in chronic kidney disease stage V Japanese patients on maintenance renal replacement therapy 2014 · SBR759 12-g/day group · Japanese patients with hyperphosphataemia and chronic kidney disease stage V receiving maintenance renal replacement therapy | 12 g | 4 weeks | 12 |
| Roxadustat and Oral Iron Absorption in Chinese Patients with Anemia of Chronic Kidney Disease: A Randomized, Open-Label, Phase 4 Study (ALTAI) 2024 · rHuEPO · Adults aged 18 years or older with anemia of stage 4 or 5 chronic kidney disease | 100 mg | 2 weeks | 12 |
| [Erythropoietin therapy during frequent autologous blood donations. Dose-finding study] 1995 · 300 U/kg rHuEPO group · Adults scheduled for orthopaedic or vascular surgery who were donating autologous blood | 200 mg | 3 weeks | 11 |
| Effect of an iron mouthrinse on enamel and dentine erosion subjected or not to abrasion: an in situ/ex vivo study 2007 · iron solution rinse phase · 10 volunteers; age, sex, and health status not specified | 40 mL | 5 days | 10 |
| Equivalent effects on fecal reactive oxygen species generation with oral supplementation of three iron compounds: ferrous sulfate, sodium iron EDTA and iron polymaltose 2012 · Ferrous sulfate · Healthy, iron-repleted adult males | 100 mg | 6 days | 10 |
| Equivalent effects on fecal reactive oxygen species generation with oral supplementation of three iron compounds: ferrous sulfate, sodium iron EDTA and iron polymaltose 2012 · Sodium iron EDTA · Healthy, iron-repleted adult males | 100 mg | 6 days | 10 |
| Equivalent effects on fecal reactive oxygen species generation with oral supplementation of three iron compounds: ferrous sulfate, sodium iron EDTA and iron polymaltose 2012 · Iron polymaltose · Healthy, iron-repleted adult males | 100 mg | 6 days | 10 |
| Effects of iron on the pharmacokinetics of paracetamol in saliva 2013 · Ferrous sulphate with paracetamol · Healthy male volunteers; age not reported | 300 mg | 1 day | 10 |
| Randomized Controlled Trial of Darbepoetin α Versus Continuous Erythropoietin Receptor Activator Injected Subcutaneously Once Every Four Weeks in Patients with Chronic Kidney Disease at the Pre-Dialysis Stage 2015 · DA continuation group · Adults over 20 with predialysis chronic kidney disease and anemia, previously treated with darbepoetin alfa | 100 mg | 48 weeks | 10 |
| Randomized Controlled Trial of Darbepoetin α Versus Continuous Erythropoietin Receptor Activator Injected Subcutaneously Once Every Four Weeks in Patients with Chronic Kidney Disease at the Pre-Dialysis Stage 2015 · CERA changeover group · Adults over 20 with predialysis chronic kidney disease and anemia, previously treated with darbepoetin alfa | 100 mg | 48 weeks | 10 |
| Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials 2017 · once-daily dosing · Women aged 18–40 years with iron depletion (serum ferritin ≤25 μg/L) | 120 mg | 3 days | 10 |
| Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials 2017 · twice-daily divided dosing · Women aged 18–40 years with iron depletion (serum ferritin ≤25 μg/L) | 120 mg | 3 days | 10 |
| [Erythropoietin therapy during frequent autologous blood donations. Dose-finding study] 1995 · 200 U/kg rHuEPO group · Adults scheduled for orthopaedic or vascular surgery who were donating autologous blood | 200 mg | 3 weeks | 10 |
| [Erythropoietin therapy during frequent autologous blood donations. Dose-finding study] 1995 · 400 U/kg rHuEPO group · Adults scheduled for orthopaedic or vascular surgery who were donating autologous blood | 200 mg | 3 weeks | 10 |
| A single high dose of ascorbic acid and iron is not correlated with oxidative stress in healthy volunteers 2008 · 150 mg of iron carbonyl · Healthy, nonsmoking men aged 20–31 years | 150 mg | 1 day | 9 |
| [Erythropoietin therapy during frequent autologous blood donations. Dose-finding study] 1995 · 0 U/kg rHuEPO control group · Adults scheduled for orthopaedic or vascular surgery who were donating autologous blood | 200 mg | 3 weeks | 9 |
| [Erythropoietin therapy during frequent autologous blood donations. Dose-finding study] 1995 · 500 U/kg rHuEPO group · Adults scheduled for orthopaedic or vascular surgery who were donating autologous blood | 200 mg | 3 weeks | 9 |
| Iron supplementation does not affect copper and zinc absorption in breastfed infants 2009 · Iron supplementation from 6 to 9 months · Healthy breastfed term infants, supplemented from 6 to 9 months of age | 1 mg/kg | 13 weeks | 8 |
| The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin and ofloxacin 1994 · Norfloxacin with ferrous sulphate · Healthy volunteers; age and sex not reported | 100 mg | 1 day | 8 |
| The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin and ofloxacin 1994 · Ciprofloxacin with ferrous sulphate · Healthy volunteers; age and sex not reported | 100 mg | 1 day | 8 |
| The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin and ofloxacin 1994 · Ofloxacin with ferrous sulphate · Healthy volunteers; age and sex not reported | 100 mg | 1 day | 8 |
| Erythrocyte incorporation and absorption of 58Fe in premature infants treated with erythropoietin 1997 · epo group · Premature infants with birth weights ≤1.25 kg and gestational ages <31 weeks | 6 mg/kg | 6 weeks | 7 |
| Erythrocyte incorporation and absorption of 58Fe in premature infants treated with erythropoietin 1997 · placebo group · Premature infants with birth weights ≤1.25 kg and gestational ages <31 weeks | 6 mg/kg | 6 weeks | 7 |
| Ferrous sulphate interacts with captopril 1998 · ferrous sulphate with captopril · healthy adult volunteers | 300 mg | 1 day | 7 |
| Iron supplementation does not affect copper and zinc absorption in breastfed infants 2009 · Iron supplementation from 4 to 9 months · Healthy breastfed term infants, supplemented from 4 to 9 months of age | 1 mg/kg | 152 days | 6 |
| [Recombinant erythropoietin in autologous blood donation] 1991 · rHuEPO group · Adults of both sexes scheduled for hip arthroplasty | 100 mg | 23 days | 5 |
| [Recombinant erythropoietin in autologous blood donation] 1991 · Control group · Adults of both sexes scheduled for hip arthroplasty | 100 mg | 23 days | 5 |
| Treatment for iron deficiency anaemia with a combined supplementation of iron, vitamin A and zinc in women of Dinajpur, Bangladesh 1999 · Group A (iron alone) · Non-pregnant women aged 15–45 years with anaemia and haemoglobin ≤100 g/L | 60 mg | 60 days | — |
| [Effect of iron supplementation and its frequency during pregnancy] 1999 · G1 · Healthy pregnant women; age and sex beyond pregnancy not reported | 60 mg | — | — |
| Efficacy and acceptability of two iron supplementation schedules in adolescent school girls in Lima, Peru 2000 · Daily iron group · Adolescent girls aged 12–18 years in a public school in periurban Lima, Peru | 60 mg | 17 weeks | — |
| Efficacy and acceptability of two iron supplementation schedules in adolescent school girls in Lima, Peru 2000 · Intermittent iron group · Adolescent girls aged 12–18 years in a public school in periurban Lima, Peru | 60 mg | 17 weeks | — |
| Intravenous versus oral iron supplementation for preoperative stimulation of hemoglobin synthesis using recombinant human erythropoietin 2000 · Oral iron sulfate · Adults with normal hemoglobin and iron status due for elective surgery | 160 mg | 3 weeks | — |
| Daily iron supplementation is more effective than twice weekly iron supplementation in pregnant women in Pakistan in a randomized double-blind clinical trial 2000 · daily · Anemic pregnant women in Pakistan | 200 mg | 12 weeks | — |
| Changes in markers of anemia and iron metabolism and how they are influenced by antianemics in postpartum period 2001 · first group · Women after spontaneous delivery; age and postpartum condition details not reported | 80 mg | 60 days | — |
| A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin 2001 · oral iron · Anaemic patients with progressive renal insufficiency treated with erythropoietin | 600 mg | 158 days | — |
| Iron supplementation of breast-fed Honduran and Swedish infants from 4 to 9 months of age 2001 · iron supplements, group 1 · Term Swedish infants, breast-fed, from 4 to 9 months of age | 1 mg/kg | 152 days | — |
| Iron supplementation of breast-fed Honduran and Swedish infants from 4 to 9 months of age 2001 · iron supplements, group 1 · Term Honduran infants, breast-fed, from 4 to 9 months of age | 1 mg/kg | 152 days | — |
| Iron supplementation of breast-fed Honduran and Swedish infants from 4 to 9 months of age 2001 · iron supplements, group 2 · Term Swedish infants, breast-fed, from 4 to 9 months of age; iron was given from 6 to 9 months | 1 mg/kg | 13 weeks | — |
| Iron supplementation of breast-fed Honduran and Swedish infants from 4 to 9 months of age 2001 · iron supplements, group 2 · Term Honduran infants, breast-fed, from 4 to 9 months of age; iron was given from 6 to 9 months | 1 mg/kg | 13 weeks | — |
| Effectiveness of treatment of iron-deficiency anemia in infants and young children with ferrous bis-glycinate chelate 2001 · ferrous bis-glycinate chelate group · Infants and young children aged 6 to 36 months with iron-deficiency anemia | 5 mg/kg | 4 weeks | — |
| Concomitant supplemental vitamin A enhances the response to weekly supplemental iron and folic acid in anemic teenagers in urban Bangladesh 2001 · iron + folic acid · Teenage women in urban Bangladesh with hemoglobin concentrations of 80–120 g/L | 17.1 mg | 12 weeks | — |
| Impact of vitamin A supplementation on anaemia and plasma erythropoietin concentrations in pregnant women: a controlled clinical trial 2001 · Vitamin A group · Pregnant women in Malawi; mean gestational age 23 weeks at enrollment, with a high prevalence of anaemia | 30 mg | — | — |
| Impact of vitamin A supplementation on anaemia and plasma erythropoietin concentrations in pregnant women: a controlled clinical trial 2001 · Control group · Pregnant women in Malawi; mean gestational age 23 weeks at enrollment, with a high prevalence of anaemia | 30 mg | — | — |
| Prophylactic iron supplementation in pregnant women in Norway 2001 · 100 mg iron daily · Non-anaemic pregnant women, allocated at about 10 weeks of pregnancy | 100 mg | — | — |
| Once weekly is superior to daily iron supplementation on height gain but not on hematological improvement among schoolchildren in Thailand 2002 · daily iron group · Primary schoolchildren in rural southern Thailand; ages and health status not specified | 300 mg | 16 weeks | — |
| Treatment of iron deficiency in goitrous children improves the efficacy of iodized salt in Côte d'Ivoire 2002 · iron · Children aged 5–14 years with goiter and iron deficiency, consuming iodized salt | 60 mg | 16 weeks | — |
| Iron plus folate is more effective than iron alone in the treatment of iron deficiency anaemia in pregnancy: a randomised, double blind clinical trial 2002 · Iron alone · Pregnant women between 14 and 27 weeks with iron deficiency anaemia | 80 mg | 60 days | — |
| Effects of three different iron supplementations in term healthy infants after 5 months of life 2002 · 1 mg/kg/day iron group · Term, healthy, breastfed infants starting at 5 months of age | 1 mg/kg | — | — |
| Effects of three different iron supplementations in term healthy infants after 5 months of life 2002 · 2 mg/kg/day iron group · Term, healthy, breastfed infants starting at 5 months of age | 2 mg/kg | — | — |
| Effects of three different iron supplementations in term healthy infants after 5 months of life 2002 · 2 mg/kg/every other day iron group · Term, healthy, breastfed infants starting at 5 months of age | 1 mg/kg | — | — |
| Oral versus high dose parenteral iron supplementation in pregnancy 2005 · Group A (oral iron) · Pregnant women with singleton pregnancies, hemoglobin 8–11 g% at 16–24 weeks’ gestation | 100 mg | — | — |
| Preoperative epoetin alfa in colorectal surgery: a randomized, controlled study 2005 · Epoetin alfa 150 IU/kg/day group · Colorectal cancer patients with anemia scheduled for surgery | 200 mg | 10 days | — |
| Preoperative epoetin alfa in colorectal surgery: a randomized, controlled study 2005 · Epoetin alfa 300 IU/kg/day group · Colorectal cancer patients with anemia scheduled for surgery | 200 mg | 10 days | — |
| Preoperative epoetin alfa in colorectal surgery: a randomized, controlled study 2005 · Control group · Colorectal cancer patients with anemia scheduled for surgery | 200 mg | 10 days | — |
| Evaluation of epoetin supplemented with oral iron in patients with solid malignancies and chronic anemia not receiving anticancer treatment 2005 · oral iron · Patients with solid malignancies and chronic anemia of chronic disease, not receiving chemotherapy and/or radiotherapy | 200 mg | 24 weeks | — |
| Are we giving too much iron? Low-dose iron therapy is effective in octogenarians 2005 · 150 mg ferrous calcium citrate group · Hospitalized adults over 80 years with iron-deficiency anemia | 150 mg | 60 days | — |
| Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease 2005 · ferrous sulphate · Patients with inflammatory bowel disease and iron deficiency; age and sex not reported | 200 mg | 2 weeks | — |
| Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease 2005 · iron-polymaltose complex · Patients with inflammatory bowel disease and iron deficiency; age and sex not reported | 200 mg | 2 weeks | — |
| Iron supplements reduce erythrocyte copper-zinc superoxide dismutase activity in term, breastfed infants 2005 · Iron supplements from 4-9 mo · Healthy, term, breastfed infants in Sweden and Honduras | 1 mg/kg | 152 days | — |
| Iron supplements reduce erythrocyte copper-zinc superoxide dismutase activity in term, breastfed infants 2005 · Iron supplements from 6-9 mo · Healthy, term, breastfed infants in Sweden and Honduras | 1 mg/kg | 13 weeks | — |
| A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD 2005 · Oral ferrous sulfate · Adults with nondialysis-dependent CKD stages 3 to 5, hemoglobin ≤11 g/dL, transferrin saturation ≤25%, and ferritin ≤300 ng/mL | 975 mg | 8 weeks | — |
| Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial 2005 · oral iron polymaltose complex · Pregnant women with iron-deficiency anemia, hemoglobin 8–10.5 g/dL and ferritin below 13 microg/L | 300 mg | — | — |
| Iron and/or zinc supplementation did not reduce blood lead concentrations in children in a randomized, placebo-controlled trial 2006 · Iron and zinc · First-grade children attending schools within 3.5 km of a metal foundry; lead-exposed | 30 mg | 26 weeks | — |
| Iron and zinc supplementation improved iron and zinc status, but not physical growth, of apparently healthy, breast-fed infants in rural communities of northeast Thailand 2006 · iron and zinc supplementation · Apparently healthy, breast-fed Thai infants aged 4–6 months | 10 mg | 26 weeks | — |
| Milk folate secretion is not impaired during iron deficiency in humans 2006 · multivitamin with iron · Breast-feeding mothers; age not reported | 18 mg | — | — |
| Intravenous versus oral iron therapy for postpartum anaemia 2006 · group O · Postpartum women with iron deficiency anaemia, haemoglobin <9 g/dl and ferritin <15 microgram/l at 24–48 hours after delivery | 400 mg | 6 weeks | — |
| Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women 2007 · iron polymaltose complex (IPC) group · Pregnant women aged 20–40 years at 14–27 weeks’ gestation with iron deficiency anemia, hemoglobin <9 g/dL and serum ferritin <12 mcg/L | 100 mg | 8 weeks | — |
| Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women 2007 · ferrous sulphate (FS) group · Pregnant women aged 20–40 years at 14–27 weeks’ gestation with iron deficiency anemia, hemoglobin <9 g/dL and serum ferritin <12 mcg/L | 120 mg | 8 weeks | — |
| The efficacy of micronutrient supplementation in reducing the prevalence of anaemia and deficiencies of zinc and iron among adolescents in Sri Lanka 2008 · iron+zinc group · Schoolchildren aged 12–16 years; the study reports a high prevalence of low iron stores, low serum zinc, and anaemia at baseline. | 50 mg | 24 weeks | — |
| Effect of oral tetracycline on iron absorption from iron(III)-hydroxide polymaltose complex in patients with iron deficiency anemia / a single-centre randomized controlled isotope study 2007 · Treatment A · Patients with iron-deficiency anemia | 100 mg | 15 days | — |
| Effect of oral tetracycline on iron absorption from iron(III)-hydroxide polymaltose complex in patients with iron deficiency anemia / a single-centre randomized controlled isotope study 2007 · Treatment B · Patients with iron-deficiency anemia | 100 mg | 15 days | — |
| Short-term ferrous sulfate supplementation in female blood donors 2008 · ferrous sulfate · Female blood donors | 150 mg | 7 days | — |
| Ferumoxytol for treating iron deficiency anemia in CKD 2008 · Oral iron group · Patients with chronic kidney disease and iron deficiency anemia; age and sex not reported | 200 mg | 3 weeks | — |
| Hematologic effects of levothyroxine in iron-deficient subclinical hypothyroid patients: a randomized, double-blind, controlled study 2009 · iron group · Patients with iron-deficiency anemia and subclinical hypothyroidism | 240 mg | — | — |
| Hematologic effects of levothyroxine in iron-deficient subclinical hypothyroid patients: a randomized, double-blind, controlled study 2009 · iron/levothyroxine group · Patients with iron-deficiency anemia and subclinical hypothyroidism | 240 mg | — | — |
| Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study 2009 · oral iron group · Patients with preoperative anemia due to menorrhagia, hemoglobin below 9.0 g/dL, scheduled for surgery | 80 mg | 3 weeks | — |
| Effect of education and pill count on hemoglobin status during prenatal care in Nepalese women: a randomized controlled trial 2009 · control · Pregnant women receiving prenatal care in Nepal | 60 mg | 90 days | — |
| Effect of education and pill count on hemoglobin status during prenatal care in Nepalese women: a randomized controlled trial 2009 · education · Pregnant women receiving prenatal care in Nepal | 60 mg | 90 days | — |
| Effect of education and pill count on hemoglobin status during prenatal care in Nepalese women: a randomized controlled trial 2009 · pill count · Pregnant women receiving prenatal care in Nepal | 60 mg | 90 days | — |
| Effect of education and pill count on hemoglobin status during prenatal care in Nepalese women: a randomized controlled trial 2009 · education with pill count · Pregnant women receiving prenatal care in Nepal | 60 mg | 90 days | — |
| Oral calcium supplementation reverses the biochemical pattern of parathyroid hormone resistance in underprivileged Indian toddlers 2009 · Calcium supplement group · Toddlers aged 2.4 years on average from an urban slum in Pune, India, with low dietary calcium intake and vitamin D replete status | 20 mg | 8 weeks | — |
| Multiple micronutrients including iron are not more effective than iron alone for improving hemoglobin and iron status of Malian school children 2009 · P + iron · Malian anemic schoolchildren infected with Schistosoma haematobium | 60 mg | 12 weeks | — |
| FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease 2010 · oral iron · Adults with iron deficiency anemia and chronic kidney disease, including nondialysis-dependent patients and patients undergoing hemodialysis | 200 mg | 3 weeks | — |
| Supplementation of iron alone and combined with vitamins improves haematological status, erythrocyte membrane fluidity and oxidative stress in anaemic pregnant women 2010 · group I · Pregnant women with anaemia | 60 mg | 60 days | — |
| Lactoferrin efficacy versus ferrous sulfate in curing iron disorders in pregnant and non-pregnant women 2010 · Arm B (pregnant women) · Pregnant women of child-bearing age suffering from iron deficiency or iron-deficiency anemia | 520 mg | — | — |
| Lactoferrin efficacy versus ferrous sulfate in curing iron disorders in pregnant and non-pregnant women 2010 · Arm B (non-pregnant women) · Non-pregnant women of child-bearing age suffering from iron deficiency or iron-deficiency anemia | 520 mg | — | — |
| Efficacy and tolerability of a prolonged release ferrous sulphate formulation in iron deficiency anaemia: a non-inferiority controlled trial 2012 · V0355 · Italian women aged 18–50 years diagnosed with iron deficiency anaemia | 80 mg | 12 weeks | — |
| Efficacy and tolerability of a prolonged release ferrous sulphate formulation in iron deficiency anaemia: a non-inferiority controlled trial 2012 · Ferrograd® · Italian women aged 18–50 years diagnosed with iron deficiency anaemia | 105 mg | 12 weeks | — |
| Universal iron supplementation: a simple and effective strategy to reduce anaemia among low-income, postpartum women 2012 · group II · Low-income postpartum women | 65 mg | 60 days | — |
| Effects of iron supplementation on serum hepcidin and serum erythropoietin in low-birth-weight infants 2011 · 1 mg/kg group · Low-birth-weight infants, from 6 weeks to 6 months of age; otherwise healthy | 1 mg/kg | 138 days | — |
| Effects of iron supplementation on serum hepcidin and serum erythropoietin in low-birth-weight infants 2011 · 2 mg/kg group · Low-birth-weight infants, from 6 weeks to 6 months of age; otherwise healthy | 2 mg/kg | 138 days | — |
| Effects of prenatal micronutrient and early food supplementation on maternal hemoglobin, birth weight, and infant mortality among children in Bangladesh: the MINIMat randomized trial 2012 · 30 mg iron and 400 μg folic acid; early food invitation · Pregnant women in poor communities in Bangladesh | 30 mg | — | — |
| Effects of prenatal micronutrient and early food supplementation on maternal hemoglobin, birth weight, and infant mortality among children in Bangladesh: the MINIMat randomized trial 2012 · 30 mg iron and 400 μg folic acid; usual food invitation · Pregnant women in poor communities in Bangladesh | 30 mg | — | — |
| Effects of prenatal micronutrient and early food supplementation on maternal hemoglobin, birth weight, and infant mortality among children in Bangladesh: the MINIMat randomized trial 2012 · MMS containing 15 micronutrients, including 30 mg iron and 400 μg folic acid; early food invitation · Pregnant women in poor communities in Bangladesh | 30 mg | — | — |
| Effects of prenatal micronutrient and early food supplementation on maternal hemoglobin, birth weight, and infant mortality among children in Bangladesh: the MINIMat randomized trial 2012 · MMS containing 15 micronutrients, including 30 mg iron and 400 μg folic acid; usual food invitation · Pregnant women in poor communities in Bangladesh | 30 mg | — | — |
| Increased protein carbonylation and decreased antioxidant status in anemic H. pylori infected patients: effect of treatment 2012 · Group I · Adults aged 30–49 with iron-deficiency anemia and H. pylori infection | 600 mg | 30 days | — |
| Increased protein carbonylation and decreased antioxidant status in anemic H. pylori infected patients: effect of treatment 2012 · Group II · Adults aged 30–49 with iron-deficiency anemia and H. pylori infection | 600 mg | 30 days | — |
| Effect of oral JTT-751 (ferric citrate) on hyperphosphatemia in hemodialysis patients: results of a randomized, double-blind, placebo-controlled trial 2012 · 1.5-grams/day group · Japanese hemodialysis patients with serum phosphorus levels between 6.1 and 10.0 mg/dl | 1.5 g | 4 weeks | — |
| Effect of oral JTT-751 (ferric citrate) on hyperphosphatemia in hemodialysis patients: results of a randomized, double-blind, placebo-controlled trial 2012 · 3-grams/day group · Japanese hemodialysis patients with serum phosphorus levels between 6.1 and 10.0 mg/dl | 3 g | 4 weeks | — |
| Effect of oral JTT-751 (ferric citrate) on hyperphosphatemia in hemodialysis patients: results of a randomized, double-blind, placebo-controlled trial 2012 · 6-grams/day group · Japanese hemodialysis patients with serum phosphorus levels between 6.1 and 10.0 mg/dl | 6 g | 4 weeks | — |
| Treatment of iron deficiency anemia in children: a comparative study of ferrous ascorbate and colloidal iron 2013 · ferrous ascorbate group · Children aged 6 months to 12 years with iron deficiency anemia | 3 mg/kg | 12 weeks | — |
| Treatment of iron deficiency anemia in children: a comparative study of ferrous ascorbate and colloidal iron 2013 · colloidal iron group · Children aged 6 months to 12 years with iron deficiency anemia | 3 mg/kg | 12 weeks | — |
| The effect of iron-vitamin C co-supplementation on biomarkers of oxidative stress in iron-deficient female youth 2013 · 50 mg/day elemental iron + 500 mg/day ascorbic acid · Iron-deficient, non-anemic girls | 50 mg | 12 weeks | — |
| 5-aminolevulinic acid, a precursor of heme, reduces both fasting and postprandial glucose levels in mildly hyperglycemic subjects 2013 · 5 mg ALA-P and 0.6 mg iron · Adults aged 35–70 years with mild hyperglycemia (fasting plasma glucose 105–125 mg/dL or HbA1c 6.1%–7.1%) | 600 mcg | 12 weeks | — |
| A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia 2014 · Group B · Patients with iron deficiency anemia who responded inadequately to oral iron | 975 mg | 2 weeks | — |
| Randomised clinical trial: oral vs. intravenous iron after upper gastrointestinal haemorrhage--a placebo-controlled study 2014 · oral iron · Patients with nonvariceal acute upper gastrointestinal bleeding and anaemia | 200 mg | 90 days | — |
| Effects of iron supplements and perinatal factors on fetal hemoglobin disappearance in LBW infants 2014 · 1 mg/kg/d iron group · Low-birth-weight infants weighing 2,000–2,500 g | 1 mg/kg | 137 days | — |
| Effects of iron supplements and perinatal factors on fetal hemoglobin disappearance in LBW infants 2014 · 2 mg/kg/d iron group · Low-birth-weight infants weighing 2,000–2,500 g | 2 mg/kg | 137 days | — |
| Lactoferrin versus ferrous sulphate for the treatment of iron deficiency anemia during pregnancy: a randomized clinical trial 2016 · ferrous sulphate · Pregnant women in the second trimester with iron deficiency anemia | 150 mg | 8 weeks | — |
| Effects of oral supplementation of iron on hepcidin blood concentrations among non-anaemic female blood donors: a randomized controlled trial 2016 · iron supplementation · Premenopausal female blood donors with iron deficiency without anaemia and ferritin below 30 ng/ml | 80 mg | 4 weeks | — |
| Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency 2017 · 30 mg twice-daily group · Iron-deficient adults with inflammatory bowel disease, with or without anemia | 60 mg | 8 days | — |
| Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency 2017 · 60 mg twice-daily group · Iron-deficient adults with inflammatory bowel disease, with or without anemia | 120 mg | 8 days | — |
| Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency 2017 · 90 mg twice-daily group · Iron-deficient adults with inflammatory bowel disease, with or without anemia | 180 mg | 8 days | — |
| Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP) 2017 · FS · Pregnant women at gestational weeks 16–33 with iron deficiency anemia | 200 mg | 12 weeks | — |
| Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial 2017 · Oral iron · Adults aged 18 years or older with non-dialysis chronic kidney disease, iron-deficiency anemia, and no recent erythropoiesis-stimulating agent therapy | 608 mg | 52 weeks | — |
| The effect of oral iron with or without multiple micronutrients on hemoglobin concentration and hemoglobin response among nonpregnant Cambodian women of reproductive age: a 2 x 2 factorial, double-blind, randomized controlled supplementation trial 2017 · Fe group · Nonpregnant women aged 18–45 with hemoglobin concentrations ≤117 g/L | 60 mg | 12 weeks | — |
| Effects of micronised dispersible ferric pyrophosphate combined with alpha-lactalbumin in pregnant women affected by iron deficiency anemia: results from a prospective, double-blind, randomized controlled trial 2018 · FG group · Second-trimester pregnant women with iron-deficiency anemia | 80 mg | 30 days | — |
| Acceptability and Utilization of Three Nutritional Supplements during Pregnancy: Findings from a Longitudinal, Mixed-Methods Study in Niger 2018 · MMN group · Pregnant women enrolled before 30 weeks’ gestation in rural Niger | 30 mg | 26 weeks | — |
| Comparison of Therapeutic Efficacy of Ferrous Ascorbate and Iron Polymaltose Complex in Iron Deficiency Anemia in Children: A Randomized Controlled Trial 2019 · FA group · Children aged 1–12 years with iron deficiency anemia | 6 mg/kg | 90 days | — |
| Comparison of Therapeutic Efficacy of Ferrous Ascorbate and Iron Polymaltose Complex in Iron Deficiency Anemia in Children: A Randomized Controlled Trial 2019 · IPC group · Children aged 1–12 years with iron deficiency anemia | 6 mg/kg | 90 days | — |
| Delayed iron improves iron status without altering malaria risk in severe malarial anemia 2020 · Immediate arm · Iron-deficient Ugandan children aged 18 months to 5 years with cerebral malaria, severe malarial anemia, or asymptomatic community status | 2 mg/kg | 90 days | — |
| Delayed iron improves iron status without altering malaria risk in severe malarial anemia 2020 · Delayed arm · Iron-deficient Ugandan children aged 18 months to 5 years with cerebral malaria, severe malarial anemia, or asymptomatic community status | 2 mg/kg | 90 days | — |
| The Inclusion of Folic Acid in Weekly Iron-Folic Acid Supplements Confers no Additional Benefit on Anemia Reduction in Nonpregnant Women: A Randomized Controlled Trial in Malaysia 2021 · 60 mg Fe with 2.8 mg folic acid · Nonpregnant women aged 18–45 years in Malaysia | 8.57 mg | 16 weeks | — |
| Ferric Citrate Dosing in Iron Deficiency Anemia in Nondialysis-Dependent Chronic Kidney Disease 2021 · FC TID 3 g/day · Adults with anemia and nondialysis-dependent chronic kidney disease, with eGFR ≥20 and <60 mL/min | 3 g | 48 weeks | — |
| Ferric Citrate Dosing in Iron Deficiency Anemia in Nondialysis-Dependent Chronic Kidney Disease 2021 · FC BID 4 g/day · Adults with anemia and nondialysis-dependent chronic kidney disease, with eGFR ≥20 and <60 mL/min | 4 g | 48 weeks | — |
| Preoperative Sucrosomial Iron Supplementation Increases Haemoglobin and Reduces Transfusion Requirements in Elective Heart Surgery Patients: A Prospective Randomized Study 2021 · sucrosomial iron · Patients undergoing elective heart surgery with low preoperative haemoglobin; age and sex not stated | 60 mg | 30 days | — |
| Co-Administration of Iron and Bioavailable Curcumin Reduces Levels of Systemic Markers of Inflammation and Oxidative Stress in a Placebo-Controlled Randomised Study 2022 · FS65_Plac (ferrous sulphate—65 mg elemental iron + placebo) · Generally healthy adults aged 18–40 years with ferritin in the normal range; men and women | 65 mg | 6 weeks | — |
| Effectiveness of Combined Vitamin D and Iron Supplementation on Iron Status in Children with Iron Deficiency Anemia: A Randomized Controlled Trial 2025 · Group A · Children with iron deficiency anemia; age range and sex not stated | 3 mg/kg | 4 weeks | — |
| Comparison of high dose therapy of rhEPO, given two or three times a week in premature infants 1995 · 300 U/kg rhEPO three times a week group · Premature infants | 6.6 mg/kg | 6 weeks | — |
| Comparison of high dose therapy of rhEPO, given two or three times a week in premature infants 1995 · 450 U/kg rhEPO two times a week group · Premature infants | 6.6 mg/kg | 6 weeks | — |
| The response to iron supplementation of pregnant women with the haemoglobin genotype AA or AS 1995 · oral iron · Multigravid pregnant women in a rural area of The Gambia; haemoglobin genotypes AA or AS | 60 mg | — | — |
| Supplementation with vitamin A and iron for nutritional anaemia in pregnant women in West Java, Indonesia 1993 · iron and placebo vitamin A · Pregnant women aged 17–35 years, 16–24 weeks’ gestation, with haemoglobin 80–109 g/L and parity 0–4 | 60 mg | 8 weeks | — |
| [Effectiveness of oral versus parenteral iron substitution in autologous blood donors] 1994 · Group O · Male and female patients undergoing autologous blood donation before total hip replacement | 300 mg | 8 weeks | — |
| The effects of iron supplementation during pregnancy, given by traditional birth attendants, on the prevalence of anaemia and malaria 1994 · iron supplementation · Multigravid pregnant women in a rural area of The Gambia | 200 mg | — | — |
| Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response 1994 · Group I · Healthy, iron-replete men | 300 mg | 10 days | — |
| Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response 1994 · Group II · Healthy, iron-replete men | 300 mg | 10 days | — |
| Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response 1994 · Group III · Healthy, iron-replete men | 300 mg | 10 days | — |
| Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis 1994 · Protocol I: r-HuEPO 300 U/kg on days 1, 4, 7, and 10, with oral iron · Healthy adult volunteers; age and sex not specified | 300 mg | 10 days | — |
| Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis 1994 · Protocol II: r-HuEPO 400 U/kg on days 1, 5, and 9, with oral iron · Healthy adult volunteers; age and sex not specified | 300 mg | 10 days | — |
| Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis 1994 · Protocol III: r-HuEPO 600 U/kg on days 1 and 10, with oral iron · Healthy adult volunteers; age and sex not specified | 300 mg | 10 days | — |
| Prevalence and type of anaemia in female cotton mill workers in Beijing, China 1993 · 60 mg Fe/d · Women diagnosed as iron deficient or with iron-deficiency anaemia; ages and sex-specific details beyond female are not reported | 60 mg | 12 weeks | — |
| Prevalence and type of anaemia in female cotton mill workers in Beijing, China 1993 · 120 mg Fe/d · Women diagnosed as iron deficient or with iron-deficiency anaemia; ages and sex-specific details beyond female are not reported | 120 mg | 12 weeks | — |
| Low dose iron supplementation does not cover the need for iron during pregnancy 1993 · 100 mg iron group · Healthy nulliparous women with normal singleton pregnancies; normal hemoglobin concentration and intact iron stores at week 16 | 100 mg | — | — |
| Zoladex (goserelin acetate) and the anemic patient: results of a multicenter fibroid study 1996 · goserelin acetate once monthly plus 600 mg/d iron · Premenopausal women with menorrhagia or metrorrhagia and anemia associated with uterine leiomyomata awaiting hysterectomy | 600 mg | 12 weeks | — |
| Zoladex (goserelin acetate) and the anemic patient: results of a multicenter fibroid study 1996 · sham injection once monthly plus 600 mg/d iron · Premenopausal women with menorrhagia or metrorrhagia and anemia associated with uterine leiomyomata awaiting hysterectomy | 600 mg | 12 weeks | — |
| A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin 1996 · oral group (OG) · Preterm infants under 33 weeks' gestation, birth weight under 1500 g, and hematocrit under 38% | 12 mg/kg | — | — |
| Efficacy of oral iron supplementation is not enhanced by additional intravenous iron during autologous blood donation 1998 · Group 2 (oral iron supplementation) · Iron-replete patients scheduled to donate 3 units of autologous blood | 286 mg | 3 weeks | — |
| Prenatal Iron Supplementation Reduces Maternal Anemia, Iron Deficiency, and Iron Deficiency Anemia in a Randomized Clinical Trial in Rural China, but Iron Deficiency Remains Widespread in Mothers and Neonates 2015 · iron/folate · Pregnant women aged 18 years or older with uncomplicated singleton pregnancies at 20 weeks’ gestation or earlier and hemoglobin ≥100 g/L | 300 mg | — | 823 |
| Effects of an Iodine-Containing Prenatal Multiple Micronutrient on Maternal and Infant Iodine Status and Thyroid Function: A Randomized Trial in The Gambia 2020 · FeFol · Pregnant women aged 18–45 years in rural West Kiang, The Gambia, with moderate iodine deficiency | 60 mg | — | 219 |
| A Prenatal Multiple Micronutrient Supplement Produces Higher Maternal Vitamin B-12 Concentrations and Similar Folate, Ferritin, and Zinc Concentrations as the Standard 60-mg Iron Plus 400-μg Folic Acid Supplement in Rural Bangladeshi Women 2016 · Fe60F · Pregnant women in rural Bangladesh enrolled before 14 weeks of pregnancy | 60 mg | 114 days | 216 |
| The effects of a lipid-based nutrient supplement and antiretroviral therapy in a randomized controlled trial on iron, copper, and zinc in milk from HIV-infected Malawian mothers and associations with maternal and infant biomarkers 2018 · LNS · HIV-infected lactating women in Malawi | 15 mg | 28 weeks | 185 |
| Impact of nutritional supplementation during pregnancy on antibody responses to diphtheria-tetanus-pertussis vaccination in infants: A randomised trial in The Gambia 2019 · MMN · Pregnant women aged 18–45 years, enrolled before 20 weeks’ gestation in rural Gambia | 60 mg | 186 days | 179 |
| Impact of nutritional supplementation during pregnancy on antibody responses to diphtheria-tetanus-pertussis vaccination in infants: A randomised trial in The Gambia 2019 · FeFol · Pregnant women aged 18–45 years, enrolled before 20 weeks’ gestation in rural Gambia | 60 mg | 186 days | 178 |
| Mineral status of non-anemic Peruvian infants taking an iron and copper syrup with or without zinc from 6 to 18 months of age: a randomized controlled trial 2013 · iron + copper + zinc group · Non-anemic Peruvian infants randomized at 6 months of age, born at term and weighing more than 2500 g; followed until 18 months | 10 mg | 1 year | 129 |
| Mineral status of non-anemic Peruvian infants taking an iron and copper syrup with or without zinc from 6 to 18 months of age: a randomized controlled trial 2013 · iron + copper group · Non-anemic Peruvian infants randomized at 6 months of age, born at term and weighing more than 2500 g; followed until 18 months | 10 mg | 1 year | 122 |
| A community-based randomized controlled trial providing weekly iron-folic acid supplementation increased serum- ferritin, -folate and hemoglobin concentration of adolescent girls in southern Ethiopia 2021 · WIFAS · Apparently healthy adolescent girls aged 10–19 years in southern Ethiopia | 8.57 mg | 90 days | 113 |
| Weekly iron-folic acid supplements containing 2.8 mg folic acid are associated with a lower risk of neural tube defects than the current practice of 0.4 mg: a randomised controlled trial in Malaysia 2020 · 0.4 mg folic acid group · Women aged 18–45 years, predominantly 18–21, non-pregnant and not planning pregnancy | 8.57 mg | 16 weeks | 110 |
| Small-Quantity Lipid-Based Nutrient Supplements Do Not Affect Plasma or Milk Retinol Concentrations Among Malawian Mothers, or Plasma Retinol Concentrations among Young Malawian or Ghanaian Children in Two Randomized Trials 2021 · SQ-LNS (Malawi mothers) · Women aged over 15 years, pregnant at enrollment (≤20 weeks), in Malawi | 20 mg | — | 107 |
| Small-Quantity Lipid-Based Nutrient Supplements Do Not Affect Plasma or Milk Retinol Concentrations Among Malawian Mothers, or Plasma Retinol Concentrations among Young Malawian or Ghanaian Children in Two Randomized Trials 2021 · MMN (Malawi mothers) · Women aged over 15 years, pregnant at enrollment (≤20 weeks), in Malawi | 20 mg | — | 106 |
| Small-Quantity Lipid-Based Nutrient Supplements Do Not Affect Plasma or Milk Retinol Concentrations Among Malawian Mothers, or Plasma Retinol Concentrations among Young Malawian or Ghanaian Children in Two Randomized Trials 2021 · IFA (Malawi mothers) · Women aged over 15 years, pregnant at enrollment (≤20 weeks), in Malawi | 60 mg | — | 105 |
| Consumption of multiple micronutrients or small-quantity lipid-based nutrient supplements containing iodine at the recommended dose during pregnancy, compared with iron and folic acid, does not affect women's urinary iodine concentration in rural Malawi: a secondary outcome analysis of the iLiNS DYAD trial 2021 · iron–folic acid group (IFA) · Pregnant women enrolled at no more than 20 completed weeks of pregnancy in rural Malawi | 60 mg | — | 104 |
| Supplementation during pregnancy with small-quantity lipid-based nutrient supplements or multiple micronutrients, compared with iron and folic acid, increases women's urinary iodine concentration in semiurban Ghana: A randomized controlled trial 2018 · IFA group · Pregnant women aged 18 years or older, enrolled at 20 weeks of gestation or earlier, in semiurban Ghana | 60 mg | — | 94 |
| The effects of a lipid-based nutrient supplement and antiretroviral therapy in a randomized controlled trial on iron, copper, and zinc in milk from HIV-infected Malawian mothers and associations with maternal and infant biomarkers 2018 · ARV + LNS · HIV-infected lactating women in Malawi | 15 mg | 28 weeks | 90 |
| Maternal multiple micronutrient supplementation in rural Pakistan increased some milk micronutrient concentrations, but not infant growth, at three-months postpartum: a randomized controlled trial substudy 2025 · Standard of care · Adolescent and young mothers aged 15–23 years in rural Pakistan; mothers in the substudy were breastfeeding infants aged about 3 months | 60 mg | — | 89 |
| Weekly vitamin A and iron supplementation during pregnancy increases vitamin A concentration of breast milk but not iron status in Indonesian lactating women 2001 · weekly iron and folic acid group · Pregnant Indonesian women; age and specific health conditions not stated | 17.1 mg | — | 88 |
| Small-quantity lipid-based nutrient supplements containing different amounts of zinc along with diarrhea and malaria treatment increase iron and vitamin A status and reduce anemia prevalence, but do not affect zinc status in young Burkinabe children: a cluster-randomized trial 2017 · LNS-Zn0 · Children aged 9–10 months at enrollment, followed to 18 months; children with severe anemia, severe wasting, or illness requiring hospital referral were excluded. | 6 mg | 274 days | 84 |
| Weekly vitamin A and iron supplementation during pregnancy increases vitamin A concentration of breast milk but not iron status in Indonesian lactating women 2001 · weekly vitamin A, iron, and folic acid group · Pregnant Indonesian women; age and specific health conditions not stated | 17.1 mg | — | 82 |
| Small-quantity lipid-based nutrient supplements containing different amounts of zinc along with diarrhea and malaria treatment increase iron and vitamin A status and reduce anemia prevalence, but do not affect zinc status in young Burkinabe children: a cluster-randomized trial 2017 · LNS-Zn10 · Children aged 9–10 months at enrollment, followed to 18 months; children with severe anemia, severe wasting, or illness requiring hospital referral were excluded. | 6 mg | 274 days | 79 |
| Small-quantity lipid-based nutrient supplements containing different amounts of zinc along with diarrhea and malaria treatment increase iron and vitamin A status and reduce anemia prevalence, but do not affect zinc status in young Burkinabe children: a cluster-randomized trial 2017 · LNS-Zn5 · Children aged 9–10 months at enrollment, followed to 18 months; children with severe anemia, severe wasting, or illness requiring hospital referral were excluded. | 6 mg | 274 days | 75 |
| mRNA Levels of Placental Iron and Zinc Transporter Genes Are Upregulated in Gambian Women with Low Iron and Zinc Status 2017 · FeFol group · Pregnant women aged 18–45 years with singleton pregnancies under 20 weeks in rural Gambia | 60 mg | 184 days | 75 |
| Small-quantity lipid-based nutrient supplements containing different amounts of zinc along with diarrhea and malaria treatment increase iron and vitamin A status and reduce anemia prevalence, but do not affect zinc status in young Burkinabe children: a cluster-randomized trial 2017 · LNS-TabZn5 · Children aged 9–10 months at enrollment, followed to 18 months; children with severe anemia, severe wasting, or illness requiring hospital referral were excluded. | 6 mg | 274 days | 73 |
| Effect of iron supplementation on serum zinc status of lactating women in Addis Ababa, Ethiopia 2005 · daily iron-supplemented group · Anaemic lactating women in urban slum communities of Addis Ababa | 300 mcg | 90 days | 71 |
| Effect of iron supplementation on serum zinc status of lactating women in Addis Ababa, Ethiopia 2005 · weekly iron-supplemented group · Anaemic lactating women in urban slum communities of Addis Ababa | 42.9 mcg | 90 days | 71 |
| Micronized, Microencapsulated Ferric Iron Supplementation in the Form of >Your< Iron Syrup Improves Hemoglobin and Ferritin Levels in Iron-Deficient Children: Double-Blind, Randomized Clinical Study of Efficacy and Safety 2021 · >Your< Iron Syrup arm · Children aged 9 months to 6 years with iron deficiency, with or without mild anemia; sex not specified | 1 mg/kg | 12 weeks | 70 |
| Double-blind, placebo-controlled trial comparing effects of supplementation of two micronutrient sprinkles on fatty acid status in Cambodian infants 2007 · iron/folate · Cambodian infants aged 6 months at enrolment | 12.5 mg | 1 year | 68 |
| Vitamin E levels during early iron supplementation in preterm infants 2009 · 2-week group · Preterm infants assigned to start iron supplementation at 2 weeks of age | 5 mg/kg | 6 weeks | 62 |
| Efficacy and Safety of Ferrous Bisglycinate and Folinic Acid in the Control of Iron Deficiency in Pregnant Women: A Randomized, Controlled Trial 2022 · treatment group · Pregnant women aged 20–40 years at 12–16 weeks of gestation with iron deficiency (serum ferritin <30 µg/L) | 120 mg | 26 weeks | 60 |
| Efficacy and Safety of Ferrous Bisglycinate and Folinic Acid in the Control of Iron Deficiency in Pregnant Women: A Randomized, Controlled Trial 2022 · control group · Pregnant women aged 20–40 years at 12–16 weeks of gestation with iron deficiency (serum ferritin <30 µg/L) | 200 mg | 26 weeks | 60 |
| Changes in blood pressure and lipid levels in young women consuming a vitamin D-fortified skimmed milk: a randomised controlled trial 2013 · D-fortified · Women aged 18–35 with low iron stores; healthy, non-pregnant, and non-breast-feeding | 15 mg | 16 weeks | 55 |
| Vitamin E levels during early iron supplementation in preterm infants 2009 · 4-week group · Preterm infants assigned to start iron supplementation at 4 weeks of age | 5 mg/kg | 4 weeks | 54 |
| Iron absorption and loss, and efficacy of iron supplementation with and without prebiotics in children with virally suppressed HIV: three prospective studies in South Africa 2025 · iron + GOS · children aged 10–15 years with virally suppressed HIV and iron deficiency | 50 mg | 12 weeks | 42 |
| Iron supplementation of breastfed infants from an early age 2009 · iron · Exclusively breastfed infants assigned at 1 month of age | 7 mg | 137 days | 37 |
| Oral Supplementation with Sucrosomial Ferric Pyrophosphate Plus L-Ascorbic Acid to Ameliorate the Martial Status: A Randomized Controlled Trial 2020 · intervention group · Adults aged 18–80 undergoing elective hip or knee replacement | 30 mg | 30 days | 37 |
| Iron supplementation in pregnancy: is less enough? A randomized, placebo controlled trial of low dose iron supplementation with and without heme iron 1997 · Pure non-heme iron with vitamin C · Pregnant women in the second half of pregnancy | 27 mg | — | 30 |
| Iron deficiency in young basketball players: Is a 100 μg/L ferritin cut-off appropriate for iron supplementation?: Results of a randomized placebo-controlled study 2023 · iron supplementation group · male basketball players under 19 years with ferritin below 100 μg/L | 160 mg | 90 days | 26 |
| Maternal Human Milk Oligosaccharide Profile Modulates the Impact of an Intervention with Iron and Galacto-Oligosaccharides in Kenyan Infants 2019 · FeGOS group · Generally healthy infants aged 6.5–9.5 months; no stated diagnosed condition | 5 mg | 120 days | 25 |
| Liposomal Mineral Absorption: A Randomized Crossover Trial 2022 · Liposomal MVM condition · Healthy adults aged 18–65 years | 9.4 mg | 1 day | 25 |
| Liposomal Mineral Absorption: A Randomized Crossover Trial 2022 · Standard MVM condition · Healthy adults aged 18–65 years | 10.1 mg | 1 day | 25 |
| Oral use of iron with vitamin C in hemodialyzed patients 2003 · Sorbifer Durules · Adults with end-stage renal disease receiving hemodialysis and recombinant human erythropoietin | 100 mg | 4 weeks | 24 |
| Effect of phosphate binders on supplemental iron absorption in healthy subjects 2002 · iron with calcium carbonate · healthy subjects; age and sex not stated | 65 mg | 1 day | 23 |
| Effect of phosphate binders on supplemental iron absorption in healthy subjects 2002 · iron with calcium acetate · healthy subjects; age and sex not stated | 65 mg | 1 day | 23 |
| High Bioavailability from Ferric Pyrophosphate-Fortified Bouillon Cubes in Meals is Not Increased by Sodium Pyrophosphate: a Stable Iron Isotope Study in Young Nigerian Women 2019 · 3:1 NaPP:57Fe ratio · Women aged 18–35 with low iron status, recruited in Nigeria | 5.04 mg | 5 days | 23 |
| High Bioavailability from Ferric Pyrophosphate-Fortified Bouillon Cubes in Meals is Not Increased by Sodium Pyrophosphate: a Stable Iron Isotope Study in Young Nigerian Women 2019 · 6:1 NaPP:57Fe ratio · Women aged 18–35 with low iron status, recruited in Nigeria | 5.04 mg | 5 days | 23 |
| Iron bioavailability of a casein-based iron fortificant compared with that of ferrous sulfate in whole milk: a randomized trial with a crossover design in adult women 2019 · iron–casein complex · Healthy, nonanemic women aged 19–40 with normal iron status | 5 mg | 1 day | 21 |
| Iron absorption from a breakfast cereal: effects of EDTA compounds and ascorbic acid 2001 · Hydrogen reduced iron plus ascorbic acid · Non-anaemic female volunteers | 3.75 mg | 2 days | 20 |
| Effect of NaFeEDTA-fortified soy sauce on zinc absorption in children 2015 · NaFeEDTA group · Children; age and health status not reported | 6 mg | — | 20 |
| Effect of NaFeEDTA-fortified soy sauce on zinc absorption in children 2015 · FeSO₄ group · Children; age and health status not reported | 6 mg | — | 20 |
| Cofortification of ferric pyrophosphate and citric acid/trisodium citrate into extruded rice grains doubles iron bioavailability through in situ generation of soluble ferric pyrophosphate citrate complexes 2016 · CA/TSC-extruded rice · Iron-sufficient young women | 4 mg | 1 day | 20 |
| Cofortification of ferric pyrophosphate and citric acid/trisodium citrate into extruded rice grains doubles iron bioavailability through in situ generation of soluble ferric pyrophosphate citrate complexes 2016 · CA/TSC solution · Iron-sufficient young women | 4 mg | 1 day | 20 |
| Prenatal iron supplements impair zinc absorption in pregnant Peruvian women 2000 · iron group (Fe) · Pregnant Peruvian women receiving prenatal supplements; studied in the third trimester | 60 mg | — | 16 |
| Effect of Vitamin E With Therapeutic Iron Supplementation on Iron Repletion and Gut Microbiome in US Iron Deficient Infants and Toddlers 2016 · iron + vitamin E (Fe + E group) · Infants and toddlers aged 9–24 months with iron deficiency or iron deficiency anemia | 6 mg/kg | 8 weeks | 15 |
| A short-term intervention of ingesting iron along with methionine and threonine leads to a higher hemoglobin level than that with iron alone in young healthy women: a randomized, double-blind, parallel-group, comparative study 2023 · FEMT group · Healthy women aged 20–39 years, without a stated diagnosis of iron deficiency anemia | 6 mg | 6 weeks | 15 |
| Prenatal iron supplements impair zinc absorption in pregnant Peruvian women 2000 · iron and zinc supplemented group (Fe + Zn) · Pregnant Peruvian women receiving prenatal supplements; studied in the third trimester | 60 mg | — | 14 |
| Low β-carotene bioaccessibility and bioavailability from high fat, dairy-based meal 2024 · β-carotene with iron · Healthy men aged 18–45 years | 25 mg | 1 day | 12 |
| Iron supplements inhibit zinc but not copper absorption in vivo in ileostomy subjects 2003 · 100 mg Fe as ferrous gluconate · 11 adults with an ileostomy; mean age 55 ± 9 years; sex not specified | 100 mg | 1 day | 11 |
| Iron supplements inhibit zinc but not copper absorption in vivo in ileostomy subjects 2003 · 400 mg Fe as ferrous gluconate · 11 adults with an ileostomy; mean age 55 ± 9 years; sex not specified | 400 mg | 1 day | 11 |
| Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate 2000 · [57Fe]ferrous fumarate with 25 mg ascorbic acid (study 2) · Infants; age and health status not reported | 2.5 mg | 4 days | 9 |
| Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate 2000 · [57Fe]ferrous fumarate with 50 mg ascorbic acid (study 2) · Infants; age and health status not reported | 2.5 mg | 4 days | 9 |
| A single high dose of ascorbic acid and iron is not correlated with oxidative stress in healthy volunteers 2008 · 2 g of AA plus 150 mg of iron carbonyl · Healthy, nonsmoking men aged 20–31 years | 150 mg | 1 day | 9 |
| Synbiotic Supplementation Improves Response to Iron Supplementation in Female Athletes during Training 2022 · Daily synbiotic supplement plus iron · Female athletes with low iron status | 140 mg | 8 weeks | 9 |
| Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate 2000 · [57Fe]ferric pyrophosphate with 25 mg ascorbic acid (study 1) · Infants; age and health status not reported | 2.5 mg | 4 days | 8 |
| Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate 2000 · [57Fe]ferrous fumarate with 25 mg ascorbic acid (study 1) · Infants; age and health status not reported | 2.5 mg | 4 days | 8 |
| Adding zinc to prenatal iron and folate supplements improves maternal and neonatal zinc status in a Peruvian population 1999 · Prenatal supplements with zinc · Pregnant women in a shantytown in Lima, Peru, beginning supplementation between gestation weeks 10 and 24 | 60 mg | — | — |
| Adding zinc to prenatal iron and folate supplements improves maternal and neonatal zinc status in a Peruvian population 1999 · Prenatal supplements without zinc · Pregnant women in a shantytown in Lima, Peru, beginning supplementation between gestation weeks 10 and 24 | 60 mg | — | — |
| Changes in iron status during pregnancy in peruvian women receiving prenatal iron and folic acid supplements with or without zinc 2000 · Iron and folic acid · Pregnant women in Peru, from 10–24 weeks gestation to 4 weeks postpartum | 60 mg | — | — |
| Changes in iron status during pregnancy in peruvian women receiving prenatal iron and folic acid supplements with or without zinc 2000 · Iron, folic acid, and zinc · Pregnant women in Peru, from 10–24 weeks gestation to 4 weeks postpartum | 60 mg | — | — |
| Cofortification of iron-fortified flour with zinc sulfate, but not zinc oxide, decreases iron absorption in Indonesian children 2002 · Iron-fortified flour with zinc oxide · Children aged 4–8 years in Indonesia | 60 mg/kg | 1 day | — |
| Cofortification of iron-fortified flour with zinc sulfate, but not zinc oxide, decreases iron absorption in Indonesian children 2002 · Iron-fortified flour with zinc sulfate · Children aged 4–8 years in Indonesia | 60 mg/kg | 1 day | — |
| Zinc plus beta-carotene supplementation of pregnant women is superior to beta-carotene supplementation alone in improving vitamin A status in both mothers and infants 2004 · beta-carotene · Pregnant women; age and specific condition not stated | 30 mg | — | — |
| Effect of oral aluminium hydroxide on iron absorption from iron(III)-hydroxide polymaltose complex in patients with iron deficiency anemia / a single-centre randomized controlled isotope study 2007 · Treatment B · Patients with iron-deficiency anemia | 100 mg | 15 days | — |
| A randomised double-blind study comparing sodium feredetate with ferrous fumarate in anaemia in pregnancy 2007 · Group A · Pregnant women at 12–26 weeks’ gestation with iron-deficiency anaemia | 66 mg | 75 days | — |
| A randomised double-blind study comparing sodium feredetate with ferrous fumarate in anaemia in pregnancy 2007 · Group B · Pregnant women at 12–26 weeks’ gestation with iron-deficiency anaemia | 132 mg | 75 days | — |
| A randomised double-blind study comparing sodium feredetate with ferrous fumarate in anaemia in pregnancy 2007 · Group C · Pregnant women at 12–26 weeks’ gestation with iron-deficiency anaemia | 200 mg | 75 days | — |
| Maternal multiple micronutrient supplementation has limited impact on micronutrient status of Bangladeshi infants compared with standard iron and folic acid supplementation 2010 · MMS · Pregnant women in Bangladesh, receiving supplementation from week 14 of gestation through 3 months postpartum | 30 mg | — | — |
| A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy 2010 · intravenous plus oral iron · Pregnant women with moderate iron deficiency anaemia | 80 mg | — | — |
| Plasma zinc concentration responds to short-term zinc supplementation, but not zinc fortification, in young children in Senegal1,2 2011 · control group · Children aged 9–17 months in Senegal | 30 g | 15 days | — |
| Plasma zinc concentration responds to short-term zinc supplementation, but not zinc fortification, in young children in Senegal1,2 2011 · ZnSuppl group · Children aged 9–17 months in Senegal | 30 g | 15 days | — |
| Plasma zinc concentration responds to short-term zinc supplementation, but not zinc fortification, in young children in Senegal1,2 2011 · ZnFort group · Children aged 9–17 months in Senegal | 30 g | 15 days | — |
| Vitamin B12 supplementation during pregnancy and postpartum improves B12 status of both mothers and infants but vaccine response in mothers only: a randomized clinical trial in Bangladesh 2016 · B12 supplementation · Bangladeshi pregnant women aged 18–35 years, 11–14 weeks pregnant, with hemoglobin <110 g/L | 60 mg | — | — |
| Sodium pyrophosphate enhances iron bioavailability from bouillon cubes fortified with ferric pyrophosphate 2016 · FePP+NaPP · Iron-deficient women | 2.5 mg | 1 day | — |
| Sodium pyrophosphate enhances iron bioavailability from bouillon cubes fortified with ferric pyrophosphate 2016 · FeSO4+NaPP · Iron-deficient women | 2.5 mg | 1 day | — |
| Effects of a lipid-based nutrient supplement during pregnancy and lactation on maternal plasma fatty acid status and lipid profile: Results of two randomized controlled trials 2017 · iron and folic acid (IFA) · Pregnant women in Ghana and Malawi; Ghana participants were at least 18 years old, and Malawi participants were at least 15 years old | 60 mg | — | — |
| Effects of a lipid-based nutrient supplement during pregnancy and lactation on maternal plasma fatty acid status and lipid profile: Results of two randomized controlled trials 2017 · multiple micronutrients (MMN) · Pregnant women in Ghana and Malawi; Ghana participants were at least 18 years old, and Malawi participants were at least 15 years old | 20 mg | — | — |
| Effects of a lipid-based nutrient supplement during pregnancy and lactation on maternal plasma fatty acid status and lipid profile: Results of two randomized controlled trials 2017 · small-quantity lipid-based nutrient supplement (SQ-LNS) · Pregnant women in Ghana and Malawi; Ghana participants were at least 18 years old, and Malawi participants were at least 15 years old | 20 mg | 56 weeks | — |
| Serum Hepcidin Concentrations Decline during Pregnancy and May Identify Iron Deficiency: Analysis of a Longitudinal Pregnancy Cohort in The Gambia 2017 · iron-folic acid (standard care) · Pregnant women aged 18–45 years in rural Gambia, enrolled at 10–20 weeks of gestation | 60 mg | — | — |
| Serum Hepcidin Concentrations Decline during Pregnancy and May Identify Iron Deficiency: Analysis of a Longitudinal Pregnancy Cohort in The Gambia 2017 · multiple micronutrients (including iron-folic acid) · Pregnant women aged 18–45 years in rural Gambia, enrolled at 10–20 weeks of gestation | 60 mg | — | — |
| Serum Hepcidin Concentrations Decline during Pregnancy and May Identify Iron Deficiency: Analysis of a Longitudinal Pregnancy Cohort in The Gambia 2017 · protein energy plus iron-folic acid · Pregnant women aged 18–45 years in rural Gambia, enrolled at 10–20 weeks of gestation | 60 mg | — | — |
| Effect of Nutritional Interventions on Micronutrient Status in Pregnant Malawian Women with Moderate Malnutrition: A Randomized, Controlled Trial 2018 · CSB+IFA · Pregnant Malawian women aged 16–38 with moderate malnutrition | 60 mg | 10 weeks | — |
| The Effect of Lactobacillus plantarum 299v on Iron Status and Physical Performance in Female Iron-Deficient Athletes: A Randomized Controlled Trial 2020 · LpFe · Female athletes aged 16–40 years with low iron stores, non-anemic, and regularly training at least 5 hours per week | 20 mg | 12 weeks | — |
| Effect of Fortification with Multiple Micronutrient Powder on the Prevention and Treatment of Iron Deficiency and Anaemia in Brazilian Children: A Randomized Clinical Trial 2021 · Group A: Anaemic—MNP + elemental iron · Children aged 6–42 months at recruitment with anaemia | 3.2 mg/kg | 15 weeks | — |
| Effect of Fortification with Multiple Micronutrient Powder on the Prevention and Treatment of Iron Deficiency and Anaemia in Brazilian Children: A Randomized Clinical Trial 2021 · Group C: Anaemic—elemental iron + folic acid · Children aged 6–42 months at recruitment with anaemia | 4.2 mg/kg | 15 weeks | — |
| Effect of Fortification with Multiple Micronutrient Powder on the Prevention and Treatment of Iron Deficiency and Anaemia in Brazilian Children: A Randomized Clinical Trial 2021 · Group D: Non-anaemic—elemental iron + folic acid · Children aged 6–42 months at recruitment without anaemia | 1.4 mg/kg | 15 weeks | — |
| Effectiveness of intermittent iron and high-dose vitamin A supplementation on hemoglobin, iron and vitamin A status of schoolchildren in southern Ethiopia: a randomized placebo controlled trial 2026 · iron and high-dose vitamin A · Schoolchildren aged 7–10 years in rural Ethiopia | 6 mg | 330 days | — |
| Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin 1995 · Chromagen · Dialysis patients receiving recombinant human erythropoietin | 200 mg | 26 weeks | — |
| Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin 1995 · Feosol · Dialysis patients receiving recombinant human erythropoietin | 200 mg | 26 weeks | — |
| Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin 1995 · Niferex · Dialysis patients receiving recombinant human erythropoietin | 200 mg | 26 weeks | — |
| Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin 1995 · Tabron · Dialysis patients receiving recombinant human erythropoietin | 200 mg | 26 weeks | — |
| Feeding iron-fortified premature formula during initial hospitalization to infants less than 1800 grams birth weight 1993 · Breast-fed infants receiving iron-containing multivitamin after hospitalization · Premature infants with birth weight less than 1800 g who were breast-fed | 10 mg | — | — |
| Comparative assessment of the bioavailability, efficacy and safety of a modified-release (MR) carbonyl iron tablet and oral conventional iron preparation in adult Indian patients with nutritional iron deficiency anaemia 2005 · Ferrous fumarate · Adult Indian patients with clinical and laboratory diagnosis of nutritional iron deficiency anaemia | 300 mg | 12 weeks | — |
| Effectiveness of routine antihelminthic treatment on anaemia in pregnancy in Rufiji District, Tanzania: a cluster randomised controlled trial 2011 · control arm · Pregnant women attending antenatal care in Rufiji District, Tanzania | 36 mg | — | 1,605 |
| Effectiveness of routine antihelminthic treatment on anaemia in pregnancy in Rufiji District, Tanzania: a cluster randomised controlled trial 2011 · study arm · Pregnant women attending antenatal care in Rufiji District, Tanzania | 36 mg | — | 1,475 |
| Effectiveness of weekly vitamin A (10,000 IU) and iron (60 mg) supplementation for adolescent boys and girls through schools in rural and urban East Java, Indonesia 2004 · VAFe group · Adolescent boys and girls aged 12–15 years attending junior high schools in rural and urban East Java, Indonesia | 8.57 mg | 14 weeks | 1,042 |
| Effectiveness of weekly vitamin A (10,000 IU) and iron (60 mg) supplementation for adolescent boys and girls through schools in rural and urban East Java, Indonesia 2004 · Fe group · Adolescent boys and girls aged 12–15 years attending junior high schools in rural and urban East Java, Indonesia | 8.57 mg | 14 weeks | 978 |
| Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial 2023 · intervention · Women planning pregnancy; generally healthy, recruited before conception | 12 mg | — | 870 |
| Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial 2023 · control · Women planning pregnancy; generally healthy, recruited before conception | 12 mg | — | 859 |
| Antenatal Multiple Micronutrient Supplementation Compared to Iron-Folic Acid Affects Micronutrient Status but Does Not Eliminate Deficiencies in a Randomized Controlled Trial Among Pregnant Women of Rural Bangladesh 2019 · MM · Pregnant women aged 12–45 years in rural Bangladesh | 27 mg | 165 days | 749 |
| Effects of lipid-based nutrient supplements or multiple micronutrient supplements compared with iron and folic acid supplements during pregnancy on maternal haemoglobin and iron status 2018 · IFA group · Pregnant Malawian women aged over 15 years, enrolled at up to 20 gestational weeks | 60 mg | — | 460 |
| Maternal cortisol and stress are associated with birth outcomes, but are not affected by lipid-based nutrient supplements during pregnancy: an analysis of data from a randomized controlled trial in rural Malawi 2015 · IFA · Pregnant women aged 15–49 years in rural Malawi, enrolled at up to 20 weeks of gestation | 60 mg | — | 413 |
| Impact of small-quantity lipid-based nutrient supplement on hemoglobin, iron status and biomarkers of inflammation in pregnant Ghanaian women 2017 · IFA · Pregnant women in a semi-urban setting in Ghana | 60 mg | — | 349 |
| Provision of Lipid-Based Nutrient Supplements to Mothers During Pregnancy and 6 Months Postpartum and to Their Infants from 6 to 18 Months Promotes Infant Gut Microbiota Diversity at 18 Months of Age but Not Microbiota Maturation in a Rural Malawian Setting: Secondary Outcomes of a Randomized Trial 2020 · IFA group · Pregnant women aged 15 years or older, enrolled at 20 or more weeks of gestation; mothers and infants in the IFA group, with no direct infant supplementation | 60 mg | 548 days | 290 |
| The effectiveness of weekly iron supplementation in pregnant women of rural northern Malawi 2000 · daily iron/folate group · Pregnant women living in rural Malawi | 60 mg | 10 weeks | 211 |
| Including 60 mg Elemental Iron in a Multiple Micronutrient Supplement Blunts the Increase in Serum Zinc after 12 Weeks of Daily Supplementation in Predominantly Anemic, Nonpregnant Cambodian Women of Reproductive Age 2019 · Fe + MMN · Predominantly anemic, nonpregnant women aged 18–45 years | 60 mg | 12 weeks | 206 |
| The effectiveness of weekly iron supplementation in pregnant women of rural northern Malawi 2000 · weekly iron/folate group · Pregnant women living in rural Malawi | 17.1 mg | 10 weeks | 202 |
| Prenatal nutrition supplementation and growth biomarkers in preadolescent Bangladeshi children: A birth cohort study 2022 · Fe60F · Pregnant women in rural Bangladesh; age and sex beyond pregnancy not specified | 60 mg | — | 184 |
| Impact of nutritional supplementation during pregnancy on antibody responses to diphtheria-tetanus-pertussis vaccination in infants: A randomised trial in The Gambia 2019 · PE + MMN · Pregnant women aged 18–45 years, enrolled before 20 weeks’ gestation in rural Gambia | 60 mg | 186 days | 182 |
| Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh 2020 · MM · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified | 27 mg | — | 176 |
| Impact of nutritional supplementation during pregnancy on antibody responses to diphtheria-tetanus-pertussis vaccination in infants: A randomised trial in The Gambia 2019 · PE · Pregnant women aged 18–45 years, enrolled before 20 weeks’ gestation in rural Gambia | 60 mg | 186 days | 170 |
| Effect of supplementation with a lipid-based nutrient supplement on the micronutrient status of children aged 6-18 months living in the rural region of Intibucá, Honduras 2014 · intervention group · Children enrolled at 5–18 months of age, living in rural Intibucá, Honduras, without stated medical conditions | 27 mg | 1 year | 160 |
| A prospective, partially randomized study of pregnancy outcomes and hematologic responses to oral and intramuscular iron treatment in moderately anemic pregnant women 2004 · Daily oral iron group · Pregnant women with moderate anemia | 100 mg | — | 148 |
| Impact of anaemia prophylaxis in pregnancy on maternal haemoglobin, serum ferritin & birth weight 1991 · study group · Pregnant women at 16–24 weeks of gestation | 60 mg | 100 days | 137 |
| The effect of Lactiplantibacillus plantarum 299v together with a low dose of iron on iron status in healthy pregnant women: A randomized clinical trial 2021 · Lp group · Healthy, non-anemic pregnant women aged 18–42 years, with singleton pregnancies and iron-replete status at enrollment | 8.4 mg | — | 120 |
| Relative efficacy of weekly and two differing doses of daily iron-folate supplementation in improving hemoglobin in mild and moderately anemic children between 3 and 5 years of age: a cluster randomized trial 2013 · Daily dose doubled (B) · Children aged 3–5 years with mild or moderate anemia (hemoglobin 7–10 g/dL) | 40 mg | 100 days | 114 |
| Relative efficacy of weekly and two differing doses of daily iron-folate supplementation in improving hemoglobin in mild and moderately anemic children between 3 and 5 years of age: a cluster randomized trial 2013 · NNACP daily dose (A) · Children aged 3–5 years with mild or moderate anemia (hemoglobin 7–10 g/dL) | 20 mg | 100 days | 112 |
| Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial 2011 · Daily multiple micronutrients supplementation (DS) · Children aged 6–53 months in rural Lao PDR, apparently healthy and receiving complementary food; children were not selected for a diagnosed condition | 10 mg | 24 weeks | 110 |
| Relative efficacy of weekly and two differing doses of daily iron-folate supplementation in improving hemoglobin in mild and moderately anemic children between 3 and 5 years of age: a cluster randomized trial 2013 · Weekly dose (C) · Children aged 3–5 years with mild or moderate anemia (hemoglobin 7–10 g/dL) | 5.71 mg | 100 days | 110 |
| Compliance with home-based fortification strategies for delivery of iron and zinc: its effect on haematological and growth markers among 6-24 months old children in north India 2014 · Rice-fortified complementary food and nutrition education (Cf) · Children aged 6–24 months in North Delhi, India; children were not selected for a diagnosed condition or documented nutrient deficiency. | 7.9 mg | 26 weeks | 101 |
| Antenatal iron supplements consumed daily produce oxidative stress in contrast to weekly supplementation in Mexican non-anemic women 2012 · weekly supplementation · Pregnant non-anemic women; 30% were iron-deficient at week 20; ages and sex beyond pregnancy not specified | 17.1 mg | 8 weeks | 100 |
| Effectiveness of Health Information Package Program on Knowledge and Compliance among Pregnant Women with Anemia: A Randomized Controlled Trial 2022 · intervention group · Pregnant women aged 18–45 years with anemia, at 14–16 weeks of gestation and with hemoglobin <11 g/dL and hematocrit <30%. | 150 mg | 90 days | 98 |
| Effectiveness of Health Information Package Program on Knowledge and Compliance among Pregnant Women with Anemia: A Randomized Controlled Trial 2022 · control group · Pregnant women aged 18–45 years with anemia, at 14–16 weeks of gestation and with hemoglobin <11 g/dL and hematocrit <30%. | 150 mg | 90 days | 98 |
| Haematological response to iron supplementation is reduced in children with asymptomatic Helicobacter pylori infection 2005 · Fe syrup group · Children aged 1–10 years, either sex, asymptomatic and without signs or symptoms of infection; included children with and without H. pylori infection | 40 mg | 8 weeks | 86 |
| Red blood cell metallothionein as an indicator of zinc status during pregnancy 2008 · supplement without zinc · Pregnant women in coastal Peru, enrolled at 10–16 weeks gestation and considered low risk, carrying a singleton fetus | 60 mg | — | 86 |
| Weekly iron supplementation does not block increases in serum zinc due to weekly zinc supplementation in Bangladeshi infants 2005 · 1 mg riboflavin + 20 mg iron and 20 mg zinc · 6-month-old Bangladeshi infants | 2.86 mg | 26 weeks | 85 |
| Weekly iron supplementation does not block increases in serum zinc due to weekly zinc supplementation in Bangladeshi infants 2005 · 1 mg riboflavin + 20 mg iron · 6-month-old Bangladeshi infants | 2.86 mg | 26 weeks | 83 |
| mRNA Levels of Placental Iron and Zinc Transporter Genes Are Upregulated in Gambian Women with Low Iron and Zinc Status 2017 · PE group · Pregnant women aged 18–45 years with singleton pregnancies under 20 weeks in rural Gambia | 60 mg | 184 days | 76 |
| mRNA Levels of Placental Iron and Zinc Transporter Genes Are Upregulated in Gambian Women with Low Iron and Zinc Status 2017 · MMN group · Pregnant women aged 18–45 years with singleton pregnancies under 20 weeks in rural Gambia | 60 mg | 184 days | 75 |
| mRNA Levels of Placental Iron and Zinc Transporter Genes Are Upregulated in Gambian Women with Low Iron and Zinc Status 2017 · PE+MMN group · Pregnant women aged 18–45 years with singleton pregnancies under 20 weeks in rural Gambia | 60 mg | 184 days | 75 |
| Red blood cell metallothionein as an indicator of zinc status during pregnancy 2008 · supplement with zinc · Pregnant women in coastal Peru, enrolled at 10–16 weeks gestation and considered low risk, carrying a singleton fetus | 60 mg | — | 72 |
| Daily versus weekly iron supplementation and prevention of iron deficiency anaemia in lactating women 2003 · daily supplementation group · Lactating anaemic mothers in urban slum communities; age range and sex beyond lactating mothers not stated | 60 mg | — | 71 |
| Lactoferrin: A Promising New Player in Treatment of Iron Deficiency Anemia in Patients on Regular Hemodialysis: A Randomized Controlled Trial 2023 · ferrous glycine sulfate group · Patients on regular hemodialysis with iron deficiency anemia | 1.35 g | 26 weeks | 70 |
| Double-blind, placebo-controlled trial comparing effects of supplementation with two different combinations of micronutrients delivered as sprinkles on growth, anemia, and iron deficiency in cambodian infants 2006 · MMN · Infants aged 6 months living in Kompong Chhnang Province, Cambodia | 12.5 mg | 1 year | 68 |
| Double-blind, placebo-controlled trial comparing effects of supplementation with two different combinations of micronutrients delivered as sprinkles on growth, anemia, and iron deficiency in cambodian infants 2006 · FFA · Infants aged 6 months living in Kompong Chhnang Province, Cambodia | 12.5 mg | 1 year | 68 |
| Double-blind, placebo-controlled trial comparing effects of supplementation of two micronutrient sprinkles on fatty acid status in Cambodian infants 2007 · mineral/micronutrient (MMN) · Cambodian infants aged 6 months at enrolment | 12.5 mg | 1 year | 68 |
| Weekly iron folate supplementation in adolescent girls--an effective nutritional measure for the management of iron deficiency anaemia 2013 · Daily IFA Supplementation Group · Adolescent girls aged 10–19 years with anaemia (haemoglobin <12 g/dL) | 300 mg | 90 days | 60 |
| A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia 2008 · Intervention group · Postpartum women with hemorrhagic anemia (Hb 6.5–8.5 g/100 ml) | 200 mg | 12 weeks | 59 |
| Weekly iron as a safe alternative to daily supplementation for nonanemic pregnant women 2006 · Daily supplementation (DS) · Pregnant women with singleton pregnancies, at gestational week 20, with hemoglobin >115 g/L; nonanemic | 60 mg | 16 weeks | 56 |
| Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial 2017 · Group A - Oral group · Pregnant women aged 18–45 years with iron-deficiency anemia, at 14–34 weeks of pregnancy | 200 mg | 4 weeks | 56 |
| Efficacy and safety of emulsified microsomal ferric pyrophosphate vs. Ferrous Ascorbate in pregnancy with iron-deficiency anemia- a randomized, comparative study 2025 · Group B (control) · Pregnant women aged 20–35 years, at 13–16 weeks’ gestation, with iron-deficiency anemia (hemoglobin 9–10.5 g/dL and serum ferritin <15 mcg/L) | 100 mg | 4 weeks | 56 |
| Low iron status as a factor of increased bone resorption and effects of an iron and vitamin D-fortified skimmed milk on bone remodelling in young Spanish women 2014 · Fe+D group · Young iron-deficient women | 15 mg | 16 weeks | 55 |
| Intermittent iron supplementation regimens are able to maintain safe maternal hemoglobin concentrations during pregnancy in Venezuela 2004 · weekly (WS) · Pregnant women at 10–30 weeks of gestation | 17.1 mg | 14 weeks | 52 |
| Efficacy and Mechanism of Buxue Yimu Pills on Gynecological Anemia: A Combination of Clinical and Network Pharmacology Study 2022 · Combined treatment group · Patients with gynecological anemia due to gynecological conditions, hemoglobin 70–110 g/L | 900 mg | 4 weeks | 50 |
| Comparison of efficacy & safety of iron polymaltose complex & ferrous ascorbate with ferrous sulphate in pregnant women with iron-deficiency anaemia 2021 · Group A (FS) · Pregnant women aged approximately 23–24 years, at 12–26 weeks’ gestation, with moderate iron-deficiency anaemia | 120 mg | 90 days | 50 |
| Comparison of efficacy & safety of iron polymaltose complex & ferrous ascorbate with ferrous sulphate in pregnant women with iron-deficiency anaemia 2021 · Group B (IPC) · Pregnant women aged approximately 23–24 years, at 12–26 weeks’ gestation, with moderate iron-deficiency anaemia | 100 mg | 90 days | 50 |
| Comparison of efficacy & safety of iron polymaltose complex & ferrous ascorbate with ferrous sulphate in pregnant women with iron-deficiency anaemia 2021 · Group C (FeA) · Pregnant women aged approximately 23–24 years, at 12–26 weeks’ gestation, with moderate iron-deficiency anaemia | 100 mg | 90 days | 50 |
| An Animal-Source Food Supplement Increases Micronutrient Intakes and Iron Status among Reproductive-Age Women in Rural Vietnam 2017 · ASF group · Women aged 18–30 years, nonpregnant, of reproductive age in rural Vietnam | 8.9 mg | 26 weeks | 47 |
| A combination of iron and retinol supplementation benefits iron status, IL-2 level and lymphocyte proliferation in anemic pregnant women 2010 · Group IF · Anemic pregnant women with hemoglobin 80 to less than 110 g/L | 60 mg | 60 days | 46 |
| A combination of iron and retinol supplementation benefits iron status, IL-2 level and lymphocyte proliferation in anemic pregnant women 2010 · Group IR · Anemic pregnant women with hemoglobin 80 to less than 110 g/L | 60 mg | 60 days | 46 |
| Efficacy of different strategies to treat anemia in children: a randomized clinical trial 2010 · Iron plus folic acid supplement (IFS) · Children aged 6–42 months with anemia in rural communities in Mexico | 12.5 mg | 120 days | 42 |
| Impact of daily versus weekly hematinic supplementation on anemia in pregnant women 2002 · Group I (daily therapy) · Pregnant women; age range and anemia status not specified | 335 mg | 14 weeks | 40 |
| Impact of daily versus weekly hematinic supplementation on anemia in pregnant women 2002 · Group II (weekly therapy) · Pregnant women; age range and anemia status not specified | 47.9 mg | 14 weeks | 40 |
| A randomized trial of once daily versus twice daily dosing of oral iron in CKD 2023 · OD group · Adults aged 18–70 with stage 3–4 chronic kidney disease and transferrin saturation ≤30% and serum ferritin ≤500; both sexes | 100 mg | 12 weeks | 40 |
| A randomized trial of once daily versus twice daily dosing of oral iron in CKD 2023 · BD group · Adults aged 18–70 with stage 3–4 chronic kidney disease and transferrin saturation ≤30% and serum ferritin ≤500; both sexes | 200 mg | 12 weeks | 40 |
| Efficacy of different strategies to treat anemia in children: a randomized clinical trial 2010 · Multiple micronutrients supplement (MMS) · Children aged 6–42 months with anemia in rural communities in Mexico | 10 mg | 120 days | 36 |
| An open-label, randomized, parallel-group comparative study of the efficacy of sorghum bicolor extract in preoperative anemia 2017 · test group · Patients with preoperative anemia booked for myomectomy; age and sex details not stated | 600 mg | 3 weeks | 34 |
| Pharmacokinetic Analyses of Liposomal and Non-Liposomal Multivitamin/Mineral Formulations 2023 · Non-liposomal multivitamin (NL) · Healthy males and females aged 18–65 years | 9 mg | 1 day | 34 |
| Pharmacokinetic Analyses of Liposomal and Non-Liposomal Multivitamin/Mineral Formulations 2023 · Liposomal multivitamin (L) · Healthy males and females aged 18–65 years | 9 mg | 1 day | 34 |
| Micronutrient deficiency in obese subjects undergoing low calorie diet 2012 · LCD intervention group (low-calorie formula diet) · Adults with obesity (BMI ≥30 kg/m²), men and women; age approximately 47 years on average | 20 mg | 12 weeks | 32 |
| Rapid recovery time of hemoglobin level in female regular blood donors with ferrous fumarate and high dose of ascorbic acid supplement 2013 · Group II · Female regular blood donors; age range and health conditions beyond regular blood donation not specified | 200 mg | 30 days | 32 |
| Rapid recovery time of hemoglobin level in female regular blood donors with ferrous fumarate and high dose of ascorbic acid supplement 2013 · Group III · Female regular blood donors; age range and health conditions beyond regular blood donation not specified | 200 mg | 30 days | 32 |
| An open-label, randomized, parallel-group comparative study of the efficacy of sorghum bicolor extract in preoperative anemia 2017 · control group · Patients with preoperative anemia booked for myomectomy; age and sex details not stated | 600 mg | 3 weeks | 32 |
| Acute Administration of Bioavailable Curcumin Alongside Ferrous Sulphate Supplements Does Not Impair Iron Absorption in Healthy Adults in a Randomised Trial 2021 · FS65_Curc (ferrous sulphate–65 mg elemental iron + 500 mg curcumin) · Healthy adults aged 18–40 years with ferritin in the normal UK range | 200 mg | 1 day | 31 |
| An active new formulation of iron carried by aspartyl casein for iron-deficiency anemia: results of the ACCESS trial 2023 · Fe-ASP · Adults with iron-deficiency anemia, either sex; mean age approximately 62.7 years | 80 mg | 12 weeks | 30 |
| Efficacy and safety of PT20, an iron-based phosphate binder, for the treatment of hyperphosphataemia: a randomized, double-blind, placebo-controlled, dose-ranging, Phase IIb study in patients with haemodialysis-dependent chronic kidney disease 2021 · PT20 400 mg · Adults aged 18–90 with haemodialysis-dependent CKD and hyperphosphataemia | 1.2 g | 4 weeks | 26 |
| Efficacy and safety of PT20, an iron-based phosphate binder, for the treatment of hyperphosphataemia: a randomized, double-blind, placebo-controlled, dose-ranging, Phase IIb study in patients with haemodialysis-dependent chronic kidney disease 2021 · PT20 800 mg · Adults aged 18–90 with haemodialysis-dependent CKD and hyperphosphataemia | 2.4 g | 4 weeks | 25 |
| Efficacy and safety of PT20, an iron-based phosphate binder, for the treatment of hyperphosphataemia: a randomized, double-blind, placebo-controlled, dose-ranging, Phase IIb study in patients with haemodialysis-dependent chronic kidney disease 2021 · PT20 1600 mg · Adults aged 18–90 with haemodialysis-dependent CKD and hyperphosphataemia | 4.8 g | 4 weeks | 25 |
| Comparison of Ferric Sodium EDTA in Combination with Vitamin C, Folic Acid, Copper Gluconate, Zinc Gluconate, and Selenomethionine as Therapeutic Option for Chronic Kidney Disease Patients with Improvement in Inflammatory Status 2022 · Group 2 (Ferachel Forte; ferric sodium EDTA combination) · Adults over 18 with functional iron-deficiency anemia and moderate CKD stage 3a–3b | 30 mg | 26 weeks | 22 |
| Do iron and vitamin C co-supplementation influence platelet function or LDL oxidizability in healthy volunteers? 1999 · Group A · Healthy adult volunteers; sex and age range not stated | 14 mg | 12 weeks | 20 |
| Oral Sucrosomial Iron Is as Effective as Intravenous Ferric Carboxy-Maltose in Treating Anemia in Patients with Ulcerative Colitis 2021 · SI group · Adults aged 18 years or older with ulcerative colitis in remission and mild-to-moderate iron-deficiency anemia | 90 mg | 12 weeks | 20 |
| Fortified breakfast cereal consumed daily for 12 wk leads to a significant improvement in micronutrient intake and micronutrient status in adolescent girls: a randomised controlled trial 2016 · Fortified cereal, morning · Females aged 16–19 years who regularly skipped breakfast and had low riboflavin status and haemoglobin; no diagnosed illness | 6.5 mg | 12 weeks | 18 |
| Fortified breakfast cereal consumed daily for 12 wk leads to a significant improvement in micronutrient intake and micronutrient status in adolescent girls: a randomised controlled trial 2016 · Fortified cereal, evening · Females aged 16–19 years who regularly skipped breakfast and had low riboflavin status and haemoglobin; no diagnosed illness | 6.5 mg | 12 weeks | 16 |
| Zinc absorption from micronutrient powder is low but is not affected by iron in Kenyan infants 2014 · MNP + Fe · Breastfed infants enrolled just before 6 months of age and followed to approximately 9 months; healthy, with hemoglobin ≥10 g/dL and no malaria parasites at enrollment | 12.5 mg | 90 days | 15 |
| Safety and efficacy of Ninjin'yoeito along with iron supplementation therapy for preoperative anemia, fatigue, and anxiety in patients with gynecological disease: an open-label, single-center, randomized phase-II trial 2022 · NYT group · Women aged 20 or older with preoperative iron deficiency anemia scheduled for gynecological surgery | 100 mg | 40 days | 15 |
| The effects of gum arabic oral treatment on the metabolic profile of chronic renal failure patients under regular haemodialysis in Central Sudan 2008 · group B · Patients with chronic renal failure receiving regular haemodialysis; age and sex not reported | 200 mg | 90 days | 14 |
| Feasibility Study of Lactobacillus Plantarum 299v Probiotic Supplementation in an Urban Academic Facility among Diverse Pregnant Individuals 2023 · probiotic LP299V + prenatal vitamin with iron (PNVI) · Pregnant women with hemoglobin 10.0–12.0 g/dL at the initial prenatal visit; mean age 28.9 years | 27 mg | — | 12 |
| Effect of Iron Supplementation on the Modulation of Iron Metabolism, Muscle Damage Biomarkers and Cortisol in Professional Cyclists 2019 · Iron-treated group (ITG) · Professional male cyclists, ages 25.7 ± 6.4 years; medically screened and free of disease | 80 mg | 4 weeks | 9 |
| Treatment for iron deficiency anaemia with a combined supplementation of iron, vitamin A and zinc in women of Dinajpur, Bangladesh 1999 · Group B (iron and vitamin A) · Non-pregnant women aged 15–45 years with anaemia and haemoglobin ≤100 g/L | 60 mg | 60 days | — |
| Treatment for iron deficiency anaemia with a combined supplementation of iron, vitamin A and zinc in women of Dinajpur, Bangladesh 1999 · Group C (iron, vitamin A and zinc) · Non-pregnant women aged 15–45 years with anaemia and haemoglobin ≤100 g/L | 60 mg | 60 days | — |
| Anthelminthic treatment and haemoglobin concentrations during pregnancy 2000 · iron-folate supplements · Pregnant women in Sierra Leone | 36 g | — | — |
| Changes in markers of anemia and iron metabolism and how they are influenced by antianemics in postpartum period 2001 · second group · Women after spontaneous delivery; age and postpartum condition details not reported | 80 mg | 60 days | — |
| Albendazole therapy and reduced decline in haemoglobin concentration during pregnancy (Sierra Leone) 2001 · iron-folate supplements · Pregnant women in Sierra Leone | 36 mg | — | — |
| The effect of weekly iron supplementation on anaemia and on iron deficiency among female tea pluckers in Bangladesh 2001 · weekly iron supplementation · Adult female tea pluckers in Bangladesh | 28.6 mg | 24 weeks | — |
| Concomitant supplemental vitamin A enhances the response to weekly supplemental iron and folic acid in anemic teenagers in urban Bangladesh 2001 · iron + folic acid + vitamin A · Teenage women in urban Bangladesh with hemoglobin concentrations of 80–120 g/L | 17.1 mg | 12 weeks | — |
| A randomised trial in Mali of the effectiveness of weekly iron supplements given by teachers on the haemoglobin concentrations of schoolchildren 2002 · weekly iron tablets · Schoolchildren aged 6–19 years in rural community schools in Kolondieba district, Mali | 9.29 mg | 10 weeks | — |
| Iron plus folate is more effective than iron alone in the treatment of iron deficiency anaemia in pregnancy: a randomised, double blind clinical trial 2002 · Iron plus folinic acid · Pregnant women between 14 and 27 weeks with iron deficiency anaemia | 80 mg | 60 days | — |
| Supplementation with micronutrients in addition to iron and folic acid does not further improve the hematologic status of pregnant women in rural Nepal 2003 · folic acid plus iron · Pregnant women in rural Nepal | 60 mg | — | — |
| Randomized controlled trial of prenatal zinc supplementation and fetal bone growth 2004 · supplements containing 60 mg Fe and 250 microg folic acid, without 25 mg Zn · Pregnant women in Peru, enrolled at 10–16 weeks of gestation | 60 mg | — | — |
| Randomized controlled trial of prenatal zinc supplementation and fetal bone growth 2004 · supplements containing 60 mg Fe and 250 microg folic acid, with 25 mg Zn · Pregnant women in Peru, enrolled at 10–16 weeks of gestation | 60 mg | — | — |
| Zinc plus beta-carotene supplementation of pregnant women is superior to beta-carotene supplementation alone in improving vitamin A status in both mothers and infants 2004 · beta-carotene plus zinc · Pregnant women; age and specific condition not stated | 30 mg | — | — |
| Short-term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster-randomised trial 2006 · daily group · Children aged 3–6 years in a kindergarten in northern China | 30 mg | 13 weeks | — |
| The effect of weekly iron and vitamin A supplementation on hemoglobin levels and iron status in adolescent schoolgirls in western Kenya 2009 · Iron and vitamin A supplementation · Schoolgirls aged 12–18 years attending public primary schools in Kisumu, western Kenya | 17.1 mg | 150 days | — |
| Effect of consumption of micronutrient fortified candies on the iron and vitamin A status of children aged 3-6 years in rural Haryana 2007 · full dose candy daily · Children aged 3–6 years in rural Haryana | 14 mg | 13 weeks | — |
| Effect of consumption of micronutrient fortified candies on the iron and vitamin A status of children aged 3-6 years in rural Haryana 2007 · full dose candy 3 days a week · Children aged 3–6 years in rural Haryana | 14 mg | 13 weeks | — |
| Effect of consumption of micronutrient fortified candies on the iron and vitamin A status of children aged 3-6 years in rural Haryana 2007 · half dose candy daily · Children aged 3–6 years in rural Haryana | 7 mg | 13 weeks | — |
| Regular consumption of a complementary food fortified with ascorbic acid and ferrous fumarate or ferric pyrophosphate is as useful as ferrous sulfate in maintaining hemoglobin concentrations >105 g/L in young Bangladeshi children 2009 · ferrous fumarate group · Children aged 7–24 months with hemoglobin >105 g/L | 9.3 mg | 270 days | — |
| Regular consumption of a complementary food fortified with ascorbic acid and ferrous fumarate or ferric pyrophosphate is as useful as ferrous sulfate in maintaining hemoglobin concentrations >105 g/L in young Bangladeshi children 2009 · ferric pyrophosphate group · Children aged 7–24 months with hemoglobin >105 g/L | 9.3 mg | 270 days | — |
| Regular consumption of a complementary food fortified with ascorbic acid and ferrous fumarate or ferric pyrophosphate is as useful as ferrous sulfate in maintaining hemoglobin concentrations >105 g/L in young Bangladeshi children 2009 · ferrous sulfate group · Children aged 7–24 months with hemoglobin >105 g/L | 9.3 mg | 270 days | — |
| Multiple micronutrients including iron are not more effective than iron alone for improving hemoglobin and iron status of Malian school children 2009 · Iron plus multiple micronutrient supplement (MM) · Malian anemic schoolchildren infected with Schistosoma haematobium | 18 mg | 12 weeks | — |
| Leaf concentrate as an alternative to iron and folic acid supplements for anaemic adolescent girls: a randomised controlled trial in India 2010 · Fe and folic acid (IFA) · Anaemic adolescent girls aged 14–18 years | 60 mg | 90 days | — |
| Leaf concentrate as an alternative to iron and folic acid supplements for anaemic adolescent girls: a randomised controlled trial in India 2010 · Leaf concentrate (LC) · Anaemic adolescent girls aged 14–18 years | 5 mg | 90 days | — |
| Community-level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India 2010 · multiple micronutrients (treatment group) · Schoolchildren aged 6–10 years in Himalayan villages of India | 10 mg | 240 days | — |
| A comparison of iron and folate with folate alone in hematologic recovery of children treated for acute malaria 2010 · iron plus folate group · Children aged 6–60 months with smear-positive malaria and anemia (hematocrit <33%) | 2 mg/kg | 4 weeks | — |
| Patterns of compliance with prenatal iron supplementation among Peruvian women 2014 · Iron and folate without zinc · Pregnant women enrolled at 10–24 weeks of gestation and followed through 4 weeks postpartum | 60 mg | — | — |
| Patterns of compliance with prenatal iron supplementation among Peruvian women 2014 · Iron, folate, and zinc · Pregnant women enrolled at 10–24 weeks of gestation and followed through 4 weeks postpartum | 60 mg | — | — |
| Effects of prenatal micronutrient and early food supplementation on maternal hemoglobin, birth weight, and infant mortality among children in Bangladesh: the MINIMat randomized trial 2012 · 60 mg iron and 400 μg folic acid; early food invitation · Pregnant women in poor communities in Bangladesh | 60 mg | — | — |
| Effects of prenatal micronutrient and early food supplementation on maternal hemoglobin, birth weight, and infant mortality among children in Bangladesh: the MINIMat randomized trial 2012 · 60 mg iron and 400 μg folic acid; usual food invitation · Pregnant women in poor communities in Bangladesh | 60 mg | — | — |
| Iron supplementation in HIV-infected Malawian children with anemia: a double-blind, randomized, controlled trial 2013 · Iron and multivitamins · HIV-infected Malawian children aged 6–59 months with moderate anemia | 3 mg/kg | 90 days | — |
| Serum Hepcidin Concentrations Decline during Pregnancy and May Identify Iron Deficiency: Analysis of a Longitudinal Pregnancy Cohort in The Gambia 2017 · protein energy plus multiple micronutrients (including iron-folic acid) · Pregnant women aged 18–45 years in rural Gambia, enrolled at 10–20 weeks of gestation | 60 mg | — | — |
| The effect of oral iron with or without multiple micronutrients on hemoglobin concentration and hemoglobin response among nonpregnant Cambodian women of reproductive age: a 2 x 2 factorial, double-blind, randomized controlled supplementation trial 2017 · Fe+MMN group · Nonpregnant women aged 18–45 with hemoglobin concentrations ≤117 g/L | 60 mg | 12 weeks | — |
| Lipid-Based Nutrient Supplements During Pregnancy and Lactation Did Not Affect Human Milk Oligosaccharides and Bioactive Proteins in a Randomized Trial 2017 · IFA group · Pregnant women over 15 years old, enrolled at no more than 20 weeks’ gestation, in Malawi; continued postpartum for the breast-milk assessment | 60 mg | — | — |
| Lipid-Based Nutrient Supplements During Pregnancy and Lactation Did Not Affect Human Milk Oligosaccharides and Bioactive Proteins in a Randomized Trial 2017 · MMN group · Pregnant women over 15 years old, enrolled at no more than 20 weeks’ gestation, in Malawi; continued supplementation through 6 months postpartum | 20 mg | — | — |
| Effects of micronised dispersible ferric pyrophosphate combined with alpha-lactalbumin in pregnant women affected by iron deficiency anemia: results from a prospective, double-blind, randomized controlled trial 2018 · MDFP-AL group · Second-trimester pregnant women with iron-deficiency anemia | 30 mg | 30 days | — |
| Acceptability and Utilization of Three Nutritional Supplements during Pregnancy: Findings from a Longitudinal, Mixed-Methods Study in Niger 2018 · IFA group · Pregnant women enrolled before 30 weeks’ gestation in rural Niger | 60 mg | 26 weeks | — |
| Is Iron Supplementation Influenced by Sub-Clinical Inflammation?: A Randomized Controlled Trial Among Adolescent Schoolgirls in Myanmar 2019 · IFA+VA group · Post-menarcheal adolescent schoolgirls in grades 8–10 with anemia, aged approximately 13–16 years | 8.57 mg | 12 weeks | — |
| Bioavailability and incorporation of nonheme iron from a representative Chinese diet in young urban Chinese women 2019 · rice group · Healthy urban Chinese women aged 20–23 years | 9.75 mg | 2 days | — |
| Bioavailability and incorporation of nonheme iron from a representative Chinese diet in young urban Chinese women 2019 · steamed buns group · Healthy urban Chinese women aged 20–23 years | 9.75 mg | 2 days | — |
| Changes in Bone Turnover, Inflammatory, Oxidative Stress, and Metabolic Markers in Women Consuming Iron plus Vitamin D Supplements: a Randomized Clinical Trial 2021 · D-Fe · Women aged 18–45 years with hemoglobin ≤12.7 g/dL and 25OHD ≤29 ng/mL | 27 mg | 12 weeks | — |
| Impact of daily-supervised administration of a package of iron and folic acid and vitamin B(12) on hemoglobin levels among adolescent girls (12-19 years): a cluster randomized control trial 2021 · Experimental group-IFA with vitamin B12 · Adolescent girls aged 12–19 years with mild or moderate anemia | 60 mg | 90 days | — |
| Impact of daily-supervised administration of a package of iron and folic acid and vitamin B(12) on hemoglobin levels among adolescent girls (12-19 years): a cluster randomized control trial 2021 · Control group-IFA · Adolescent girls aged 12–19 years with mild or moderate anemia | 60 mg | 90 days | — |
| The Inclusion of Folic Acid in Weekly Iron-Folic Acid Supplements Confers no Additional Benefit on Anemia Reduction in Nonpregnant Women: A Randomized Controlled Trial in Malaysia 2021 · 60 mg Fe with 0.4 mg folic acid · Nonpregnant women aged 18–45 years in Malaysia | 8.57 mg | 16 weeks | — |
| Co-Administration of Iron and Bioavailable Curcumin Reduces Levels of Systemic Markers of Inflammation and Oxidative Stress in a Placebo-Controlled Randomised Study 2022 · FS65_Curc (ferrous sulphate—65 mg elemental iron + 500 mg curcumin) · Generally healthy adults aged 18–40 years with ferritin in the normal range; men and women | 65 mg | 6 weeks | — |
| Effectiveness of Combined Vitamin D and Iron Supplementation on Iron Status in Children with Iron Deficiency Anemia: A Randomized Controlled Trial 2025 · Group B · Children with iron deficiency anemia; age range and sex not stated | 3 mg/kg | 4 weeks | — |
| Supplementation with vitamin A and iron for nutritional anaemia in pregnant women in West Java, Indonesia 1993 · vitamin A and iron · Pregnant women aged 17–35 years, 16–24 weeks’ gestation, with haemoglobin 80–109 g/L and parity 0–4 | 60 mg | 8 weeks | — |
| Therapeutic availability of iron administered orally as the ferrous gluconate together with magnesium-L-aspartate hydrochloride 1996 · Healthy volunteers: Fe-gluc plus MAH · Healthy volunteers | 100 mg | — | — |
| [Iron supplementation during erythropoietin therapy in patients on hemodialysis] 1996 · Group A (Actiferrin; oral iron) · Adults with chronic renal failure receiving haemodialysis and erythropoietin, with serum ferritin below 300 ng/ml or transferrin below 0.20 | 104 mg | 6 weeks | — |
| Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents 1997 · daily supplementation group · female Indonesian high-school adolescents | 60 mg | 90 days | — |
| Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents 1997 · weekly supplementation group (60 mg Fe) · female Indonesian high-school adolescents | 8.57 mg | 90 days | — |
| Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents 1997 · weekly supplementation group (120 mg Fe) · female Indonesian high-school adolescents | 17.1 mg | 90 days | — |
| Efficacy of oral iron supplementation is not enhanced by additional intravenous iron during autologous blood donation 1998 · Group 3 (oral iron plus intravenous iron supplementation) · Iron-replete patients scheduled to donate 3 units of autologous blood | 286 mg | 3 weeks | — |
| Impact of micronutrient fortification of yoghurt on micronutrient status markers and growth - a randomized double blind controlled trial among school children in Bangladesh 2013 · Fortified yoghurt (FY group) · Children aged 6–9 years attending primary schools in rural Bangladesh; boys and girls, with a high prevalence of anemia and suboptimal micronutrient status | 3.3 mg | 1 year | 501 |
| Effects of lipid-based nutrient supplements or multiple micronutrient supplements compared with iron and folic acid supplements during pregnancy on maternal haemoglobin and iron status 2018 · MMN group · Pregnant Malawian women aged over 15 years, enrolled at up to 20 gestational weeks | 20 mg | 270 days | 463 |
| Randomized, double-blind, placebo-controlled trial of selenium supplements among HIV-infected pregnant women in Tanzania: effects on maternal and child outcomes 2008 · selenium group · Pregnant women aged about 27.5 years on average, at 12–27 weeks of gestation, living with HIV in Dar es Salaam, Tanzania | 200 mg | — | 456 |
| Effects of lipid-based nutrient supplements or multiple micronutrient supplements compared with iron and folic acid supplements during pregnancy on maternal haemoglobin and iron status 2018 · SQ-LNS group · Pregnant Malawian women aged over 15 years, enrolled at up to 20 gestational weeks | 20 mg | 270 days | 454 |
| Effects of prenatal micronutrient and early food supplementation on metabolic status of the offspring at 4.5 years of age. The MINIMat randomized trial in rural Bangladesh 2016 · MMS · Pregnant women in rural Bangladesh; offspring assessed at 4.5 years | 30 mg | — | 439 |
| Maternal cortisol and stress are associated with birth outcomes, but are not affected by lipid-based nutrient supplements during pregnancy: an analysis of data from a randomized controlled trial in rural Malawi 2015 · LNS · Pregnant women aged 15–49 years in rural Malawi, enrolled at up to 20 weeks of gestation | 20 mg | — | 418 |
| Maternal cortisol and stress are associated with birth outcomes, but are not affected by lipid-based nutrient supplements during pregnancy: an analysis of data from a randomized controlled trial in rural Malawi 2015 · MMN · Pregnant women aged 15–49 years in rural Malawi, enrolled at up to 20 weeks of gestation | 20 mg | — | 415 |
| Micronutrient Sprinkles reduce anemia among 9- to 24-mo-old children when delivered through an integrated health and nutrition program in rural Haiti 2007 · Sprinkles-WSB (S-WSB) · Children aged 9–24 months in rural Haiti receiving take-home fortified wheat-soy blend rations | 12.5 mg | 60 days | 254 |
| Fortified Balanced Energy-Protein Supplements Increase Nutrient Adequacy without Displacing Food Intake in Pregnant Women in Rural Burkina Faso 2021 · Intervention (IFA+BEP) · Pregnant women aged 18–34 years, at 12–34 weeks’ gestation, in rural Burkina Faso | 22 mg | 122 days | 217 |
| Multiple micronutrient supplementation improves micronutrient status in primary school children in Hai Phong City, Vietnam: a randomised controlled trial 2021 · intervention · Children aged 6–9 years, apparently healthy, in rural Hai Phong City, Vietnam; included undernourished, normal-weight, and overweight/obese children | 10 mg | 22 weeks | 175 |
| Efficacy and safety of emulsified microsomal ferric pyrophosphate vs. Ferrous Ascorbate in pregnancy with iron-deficiency anemia- a randomized, comparative study 2025 · Group A (test) · Pregnant women aged 20–35 years, at 13–16 weeks’ gestation, with iron-deficiency anemia (hemoglobin 9–10.5 g/dL and serum ferritin <15 mcg/L) | 27 mg | 4 weeks | 55 |
| Effect of daily and weekly micronutrient supplementation on micronutrient deficiencies and growth in young Vietnamese children 1999 · daily group · children aged 6–24 months in Vietnam | 8 mg | 90 days | 55 |
| Effect of daily and weekly micronutrient supplementation on micronutrient deficiencies and growth in young Vietnamese children 1999 · weekly group · children aged 6–24 months in Vietnam | 2.86 mg | 90 days | 54 |
| A randomized, masked study of weekly erythropoietin dosing in preterm infants 2012 · Once-weekly Epo group · Preterm infants born at gestational age ≤32 weeks and birth weight ≤1,500 g, with hematocrit ≤48%, at least 7 days old | 6 mg/kg | 4 weeks | 10 |
| A randomized, masked study of weekly erythropoietin dosing in preterm infants 2012 · Thrice-weekly Epo group · Preterm infants born at gestational age ≤32 weeks and birth weight ≤1,500 g, with hematocrit ≤48%, at least 7 days old | 6 mg/kg | 4 weeks | 10 |
| Prophylactic iron supplementation in pregnant women in Norway 2001 · 15 mg iron daily · Non-anaemic pregnant women, allocated at about 10 weeks of pregnancy | 15 mg | — | — |
| Supplementation with micronutrients in addition to iron and folic acid does not further improve the hematologic status of pregnant women in rural Nepal 2003 · folic acid plus iron and zinc · Pregnant women in rural Nepal | 60 mg | — | — |
| Supplementation with micronutrients in addition to iron and folic acid does not further improve the hematologic status of pregnant women in rural Nepal 2003 · folic acid plus iron, zinc and multiple micronutrients · Pregnant women in rural Nepal | 60 mg | — | — |
| Host iron status and erythropoietic response to iron supplementation determines susceptibility to the RBC stage of falciparum malaria during pregnancy 2017 · Reference (standard-of-care) arm · Pregnant women aged 18–45 years, recruited at 14–22 weeks’ gestation in rural Gambia; healthy at enrolment, with varying anaemia and iron status | 60 mg | 12 weeks | — |
| Vitamin B12 Supplementation in Addition to Folic Acid and Iron Improves Hematological and Biochemical Markers in Pregnancy: A Randomized Controlled Trial 2020 · intervention group · Healthy, nonanemic pregnant women; age and sex details beyond pregnancy not reported | 350 mg | 100 days | — |
| Vitamin B12 Supplementation in Addition to Folic Acid and Iron Improves Hematological and Biochemical Markers in Pregnancy: A Randomized Controlled Trial 2020 · control group · Healthy, nonanemic pregnant women; age and sex details beyond pregnancy not reported | 350 mg | 100 days | — |
| Effect of antenatal multiple micronutrient supplementation on anthropometry and blood pressure in mid-childhood in Nepal: follow-up of a double-blind randomised controlled trial 2014 · control group (iron and folic acid supplement) · Pregnant women attending antenatal care in Nepal; no specific age range or deficiency criterion stated | 60 mg | — | 600 |
| Effects of prenatal micronutrient and early food supplementation on metabolic status of the offspring at 4.5 years of age. The MINIMat randomized trial in rural Bangladesh 2016 · Fe30F · Pregnant women in rural Bangladesh; offspring assessed at 4.5 years | 30 mg | — | 458 |
| Effects of prenatal micronutrient and early food supplementation on metabolic status of the offspring at 4.5 years of age. The MINIMat randomized trial in rural Bangladesh 2016 · Fe60F · Pregnant women in rural Bangladesh; offspring assessed at 4.5 years | 60 mg | — | 454 |
| Effect of prenatal micronutrient-fortified balanced energy-protein supplementation on maternal and newborn body composition: A sub-study from the MISAME-III randomized controlled efficacy trial in rural Burkina Faso 2023 · Control · Pregnant women aged 15–40 years, enrolled before 21 completed weeks of gestation; maternal and newborn body composition were assessed postpartum | 65 mg | — | 440 |
| Small-Quantity Lipid-Based Nutrient Supplements Do Not Affect Plasma or Milk Retinol Concentrations Among Malawian Mothers, or Plasma Retinol Concentrations among Young Malawian or Ghanaian Children in Two Randomized Trials 2021 · MMN (Ghana mothers) · Women aged 18 years or older, pregnant at enrollment (≤20 weeks), in Ghana | 20 mg | — | 99 |
| Small-Quantity Lipid-Based Nutrient Supplements Do Not Affect Plasma or Milk Retinol Concentrations Among Malawian Mothers, or Plasma Retinol Concentrations among Young Malawian or Ghanaian Children in Two Randomized Trials 2021 · IFA (Ghana mothers) · Women aged 18 years or older, pregnant at enrollment (≤20 weeks), in Ghana | 60 mg | — | 97 |
| Intermittent oral iron supplementation during pregnancy 2001 · daily · Women aged 14 to 24 weeks pregnant | 100 mg | 20 weeks | 31 |
| Synbiotic Supplementation Improves Response to Iron Supplementation in Female Athletes during Training 2022 · Placebo synbiotic plus iron supplementation · Female athletes with low iron status | 140 mg | 8 weeks | 10 |
| [Short donation intervals in preoperative autologous blood donation in the concept of autologous transfusion] 1994 · Group II (iron prescribed if deferred) · Adults aged 37–77 scheduled for hip arthroplasty and participating in an autologous blood donation programme; iron was prescribed to the three patients deferred for low haemoglobin | 300 mg | — | 3 |
| [Short donation intervals in preoperative autologous blood donation in the concept of autologous transfusion] 1994 · Group I (iron prescribed if deferred) · Adults aged 39–69 scheduled for hip arthroplasty and participating in an autologous blood donation programme; iron was prescribed to the one patient deferred for low haemoglobin | 300 mg | — | 1 |
| Effects of an energy and micronutrient supplement on motor development and motor activity in undernourished children in Indonesia 2000 · M · Undernourished children in Indonesia recruited at 12 or 18 months of age | 12 mg | 1 year | — |
| Redistribution of vitamin A after iron supplementation in Indonesian infants 2003 · 10 mg each of Fe and Zn · Indonesian infants aged 4 months | 10 mg | 26 weeks | — |
| Simultaneous weekly supplementation of iron and zinc is associated with lower morbidity due to diarrhea and acute lower respiratory infection in Bangladeshi infants 2003 · 20 mg elemental iron with 1 mg riboflavin · Infants aged 6 months at enrollment, followed until 12 months | 2.86 mg | 183 days | — |
| Maternal multiple micronutrient supplementation has limited impact on micronutrient status of Bangladeshi infants compared with standard iron and folic acid supplementation 2010 · Fe30Fol · Pregnant women in Bangladesh, receiving supplementation from week 14 of gestation through 3 months postpartum | 30 mg | — | — |
| Maternal multiple micronutrient supplementation has limited impact on micronutrient status of Bangladeshi infants compared with standard iron and folic acid supplementation 2010 · folic acid and 60 mg iron · Pregnant women in Bangladesh, receiving supplementation from week 14 of gestation through 3 months postpartum | 60 mg | — | — |
| Prenatal and Postnatal Supplementation with Lipid-Based Nutrient Supplements Reduces Anemia and Iron Deficiency in 18-Month-Old Bangladeshi Children: A Cluster-Randomized Effectiveness Trial 2018 · IFA-Control · Pregnant women in Bangladesh; no child supplement was given | 60 mg | — | — |
| Malaria early in the first pregnancy: Potential impact of iron status 2020 · ferrous gluconate and folic acid · Young non-pregnant nulliparous women aged 15–24 years in rural Burkina Faso; some became pregnant during follow-up | 8.57 mg | 548 days | — |
| Fortified balanced energy-protein supplementation during pregnancy and lactation and infant growth in rural Burkina Faso: A 2 × 2 factorial individually randomized controlled trial 2023 · Prenatal and postnatal IFA only supplementation · Pregnant women aged 15–40 years in rural Burkina Faso who continued into lactation | 65 mg | — | — |
| Maternal Adiposity and Inflammation: Risk Factors for Iron Deficiency in Pregnancy 2025 · 10 μg vitamin D group (placebo) · Pregnant women aged 18 years or older, first trimester, singleton pregnancy, BMI ≥18.5 kg/m² | 17 mg | — | — |
| Maternal Adiposity and Inflammation: Risk Factors for Iron Deficiency in Pregnancy 2025 · 20 μg vitamin D group · Pregnant women aged 18 years or older, first trimester, singleton pregnancy, BMI ≥18.5 kg/m² | 17 mg | — | — |